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Abstract
This Thesis describes synthetic studies directed towards evaluating the biosynthetic
relationships between several novel polycyclic diterpenes, including bielschowskysin
1, verrillin 2, plumarellide 3 and intricarene 4, and their probable furanobutenolide -
based cembrane precursors, e.g. bipinnatin J (5) and bipinnatin G (6). These
interesting natural products have all been isolated from marine corals in recent years.
The Introduction describes a general overview of biologically active compounds
isolated from natural sources, followed by the isolation, structure and biological
profile of the aforementioned marine natural products.
The Discussion section introduces the family of furanobutenolide - based cembrane
natural products and then discusses the structures of bielschowskysin 1, verrillin 2,
plumarellide 3 and intricarene 4 and their proposed biogenetic origins from simple
furanocembranes via transannular pericyclic cycloaddition processes. A synthetic
study towards the model bielschowskysin structures 106 and 132 from rubifolide
analogues, i.e. 102 and 125 is then described. Difficulties with the stabilities of
various substrates led to abandonment of this route, but an alternative strategy
produced the 14-membered furanocembrane structure 142 which lacked a ~11,12_
alkene bond. Further manipulation of 142 into the modified bielschowskysin structure
125 could not be achieved, due to the dearth of material.
The oxidation chemistry of 2-alkenylfurans was next studied. Model studies
established that treatment of the alkenylfuran 162 with peroxy reagents led to the Z-
dienedione 163. When 163 was left in the presence of p-TSA in THF-H20 it was first
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converted into the ~-hydroxyketone 165 and then into the vicinal diol 178,
presumably via the transient enol ether species 166. In complementary studies,
treatment of the Z-dienedione 163 with K2C03 in THF-H20 led to the 4-
hydroxycyclopent-2-enone 193 (53%), and isomerisation in the presence of iodine
gave the corresponding E-isomer 194 (90%). These observations may have
significance for the origins of coralloidolide F (195) and the macrocyclic E-
dienedione 196 from furanocembrane precursors in corals.
A brief review of the syntheses of furanobutenolide - based cembranes is presented
and then two synthetic approaches towards deoxybipinnatin G (188b/ 188e), using
Aldol/Stille/Nozaki-Hiyama-Kishi (NHK) and ring-closing metathesis
(RCM)/StilieINHK reactions, are presented. The RCM/StillelNHK approach produced
the macrocyclic precursor 275b which, unfortunately, upon exposure to CrCh in THF,
produced the acyclic intermediate 318. In contemporaneous studies, attempts were
made to form the furanobutenolide - based cembrane bis-deoxylopholide 319 en route
to plumarellide 3, via a ReM approach. Unfortunately, exposure of the vinyl furan
322 to Grubbs 2nd generation catalyst in refluxing DCM only led to the
phenylvinylfuran 338 and to the dimer 339.
In a separate study, treatment of isoepilophodione B (159), derived from bipinnatin J
(5) via rubifolide 49, with p-TSA in THF-H20 led to the novel and unusual 19-
hydroxyrubifolide 353, presumably via the enol ether intermediate 354 and allylic
transposition.
The Experimental section contains full details of the preparative work carried out,
and collects together spectroscopic and analytical data for all the new compounds
described.
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INTRODUCTION
The work presented in this Thesis describes synthetic investigations directed towards
understanding the biosynthetic interrelationships between the novel polycyclic
diterpenes bielschowskysin 1, I verrillin 2,2 plumarellide 33 and intricarene 44 recently
isolated from the gorgonian corals of the genius Pseudopterogorgia and Plumarella.
These natural products co-occur with a variety of macrocyclic furanobutenolide -
based cembranes, viz S5 and 6,6 which are believed to be their biological precursors by
oxidation of an alkenylfuran substituent followed by a series of intriguing
transannular cycloaddition reactions. In addition to their novel structural features the
diterpenoids 1-4 exhibit a variety of biological activities, e.g. antitumour, antimalarial
and hemolytic activity, which adds to their interest as significant targets for synthesis
and possible scope in medicine.
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Indeed, biologically active natural products are present in a wide array of organisms
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and they have been utilised for making herbal remedies and ancient medicines for
centuries. One example is arnica, isolated from Arnica montana, which is a
herbaceous, perennial species belonging to the sunflower species. Arnica is applied
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topically to the skin in order to reduce bruising and inflammation.' There are two
active components within the mixture, helenalin 7 from the main body of the plant
and thymol 8 from the roots. Helenalin 7 is a sesquiterpene lactone with potent anti-
inflammatory and antitumour activity.8.9 This compound has also been shown to be
highly toxic, but only when large quantities of the plant are ingested. Thymol 8 is a
simple monoterpene-derived phenol'" and is a strong antiseptic. I I The combined
application of henenalin (anti-inflammatory) and thymol (antiseptic) allow faster
transport of blood and fluid away from the affected region due to dilation of the
subcutaneous blood capillaries.l ' For this reason arnica has been used to treat
bruising, strains and sprains for centuries.
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The physiological results obtained from herbal medicines led chemists to begin
isolating the active constituents found in plants and their fruits. One of the first natural
products to be isolated was the sugar, glucose 9. This carbohydrate was isolated in
1747 by Marggraf from raisins.l ' although it wasn't until later that Lavoisier
determined its elemental composition. D-Glucose 9 is a simple monosaccharide, along
with L-mannose 10 and ,B-L-fructose 11, which act as a rapid source of energy and
metabolic intermediate for all living cells." It is also one of the main products from
photosynthesis and initiates cellular respiration.l ' The simple monosaccharides 9, 10
and 11 are complemented by polysaccharides, e.g. starch 12,16 which offer long-term
energy storage for organisms.
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Another important medicine, derived from natural sources, which emerged and
became the most successful medication in history, was aspirin 15.17 Aspirin 15 has
I . d .. fl . 1819 Th I .. 15'ana gesic an anti-m ammatory properties.": e natura precursor to aspmn IS
salicin 13 which is produced by the bark of the willow tree and has been utilised since
ancient Egyptian times as a pain relieving agent." In 1828 Andreas was able to
prepare a relatively pure sample of salicin 13 which, in 1838, was transformed by
Piria et al. into salicylic acid 14,21 a precursor to aspirin 15. Aspirin 15 was first
synthesised in 1853 by Gerhardt but he was unable to purify the compound or identify
the structure.f Finally, in 1897, Hoffmann prepared a pure sample of acetylsalicylic
acid (later trademarked as aspirin) which was free from the impurities which caused
side-effects like gastrointestinal ulcers.
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In 1803, the alkaloid morphine 16 was isolated from crude opium by Sertumer.i''
Crude opium gum is formed upon drying the milky solution extruded from the
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unripened seed-head of the opium poppy. Morphine 16 has analgesic properties and it
is a narcotic due to its ability to bind to the central nervous system thereby inducing
pain relief.24-27Other opiates, e.g. codeine 17, also occur naturally in the opium poppy
and display similar biological activity." In 1874 the synthetic opiate diacetylmorphine
18 (more commonly known as heroin) was formed in a similar process to the
production of aspirin 15 from salicylic acid 14. Heroin 18 was initially used as a
treatment for morphine addiction but it soon became apparent that it was even more
addictive29 and was later classified as an illegal drug. In 1855, Gaedcke identified the
tropane alkaloid cocaine 19 from coca leavesr'" Cocaine is used medically as a
stimulant of the central nervous system and acts by inhibiting the uptake of
catecholamine by nerve endings. Due to its mode of action, cocaine 19 is also
addictive.i'r" Later, the extremely toxic alkaloid strychnine 20 was extracted from the
seeds of the Strychnos nux vomica tree,33 and initially found use as a pesticide due to
its ability to cause asphyxiation via intense muscular convulsion.34-36 The difficult
task of synthesising the complex structure of strychnine 20 was first achieved in 1954
by Woodward,37,38who was later awarded the Nobel prize in chemistry.
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Many toxic compounds like strychnine 20 have been isolated from plants, but other
natural products with equally beneficial medical usage have also been isolated. The
alkaloid quinine 21, for example, has a wide variety of biological properties ranging
from antipyretic (fever-reducingj.'" analgesic" to anti-inflammatory activity but it is
most commonly known for its antimalarial properties." Quinine 21 has long been
used by the quechua indians of Peru to treat fevers. The natural product is produced
within the bark of the cinchona tree42 which is native to the forest of the Andes
mountains, and was isolated by Pelletier and Caventou in 1817. Since the 1940s
alternative antimalarial drugs have been developed, e.g. chloroquine 22 and
pyrimethamine 23, which are now used in preference to quinine 21.
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The active components of food, i.e. vitamins, became a fascination during the 1920s.
In 1921, both Szent-Gyorgyi and Zilva prepared crude samples of ascorbic acid 24
from lemon juice and the bovine adrenal cortex, respectively. Pure ascorbic acid
crystals, commonly known as vitamin C (24) were later obtained by Szent-
Gyorgyi43,44 by the extraction of peppers and the compound was first synthesised
independently by Haworth and by Reichstein in 1933.45 Vitamin C (24) was the first
vitamin to be mass-produced in an industrial process by Hoffmann-La Roche, and in
1934 it became available to the public. Vitamin C (24) acts as an anti-oxidant and is
an essential nutrient for a balanced diet." If vitamin C is not consumed, the deficiency
causes scurvy, a disease which induces bleeding from mucous membranes.V'" Many
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other essential vitamins are now commercially available as dietary supplements, e.g.
vitamin 86 (25) and vitamin D2 (26).
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Taxol® 27 is another important natural product which was shown to have anti-cancer
activity." Taxol® 27 was isolated from the bark of the Pacific yew tree genus Taxus
brevifolia in 1962, but it was not until 1971 that its structure was established by x-ray
crystallography.Y'" It took 1200 kg of bark in order to accumulate 109 of pure taxol,
and harvesting caused the death of the tree. Later Potier discovered that the foliage of
the European yew tree, Taxus baccata, represented a renewable source of 10-
deacetylbaccatin III (28),52 which upon a short synthetic sequence could produce
taxol® 27.53 The natural product 27, along with its derivative Taxotere® (docetaxel)
2954 (which has an improved pharmacological profile) are mitotic inhibitors used in
cancer chemotherapy, due to their ability to stabilise microtubules during cell
division. 55-57 This mode of action constituted an entirely new mechanism of
intervention during cell division from the previous microtubule-destabilising agents
which result from known natural products.
In the early 1990s another group of natural products was discovered, which matched
the anti-cancer properties of taxol® 27, although publication was delayed until 1996.
Hofle and Reichenbach extracted epothilones A (30) and 8 (31) from a culture of
myxobacterium Sorangium cellulosum found in the banks of the Zambezi river.58
These polyketide-derived epothilones were tested against multiple cancer cell lines
7
and were shown to exhibit antitumour activity even against taxol®-resistant tumour
cells,59.60with epothilone B (31) being the most potent naturally occurring compound.
They act in an identical mode to taxol® 27, stabilising microtubules by binding to the
same site on the same protein target.
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Another group of natural products which exhibit anti-cancer activity is rhizoxin 32
and its analogues. The rhizoxins are produced by Rhizopus microsporus, a pathogenic
plant fungus." The natural products possess antimitotic activity, acting by disrupting
the formation of microtubules during cell division and they can also depolymerise
pre- formed microtubules.Y''"
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Initially plants constituted the main source of natural products. Later attention turned
to microorganisms and animals to determine which active components they
accommodated. In 1928, penicillin 33, possibly the most important natural product to
be discovered was isolated by Fleming'" from the fungus, Penicillium notatum'"
Fleming noticed that a culture of the mold formed on nutritional agar had no bacterial
colonies surrounding its periphery/" Later, Fleming demonstrated the mold extruded
a substance with antibiotic properties (the active component being named penicillin),
which caused cell death to bacteria upon exposure.68•69 Penicillins G (33) and V (34)
are p-Iactam antibiotics which are widely used for the treatment of bacterial
infections, along with thienamycin 35 and amoxycillin 36.70
33 34
35 36
Humans have also been indirectly analysed for natural products. Oestrogens, e.g.
oestrone 37, are steroids which were first isolated from the urine of pregnant women,
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independently by Doisy and by Butenandt in 1928.71,72 The most potent oestrogen is
oestradiol 38, which was isolated by Doisy in 1936 by processing 4 tons of fresh sow
ovaries in order to gain 25 mg of the steroid.73 The oestrogens are sex hormones,
produced in the ovaries and are responsible for female sex characteristics.Y'" Further
isolation and characterisation revealed several other steroidal compounds, e.g.
progesterone 39, discovered in 1934.77 Progesterone is another female sex hormone
. Id' h I I 767879Th . id c. d . d .InVO ve In t e menstrua eye e. " e mam steroi roun In man was reporte III
1935, and is the sex hormone, testosterone 40,80 which is produced in the testes and is
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Another family of complex natural products which are produced within the human
body and help its self-regulation are the prostaglandins, Prostaglandins were first
discovered in 1934 by von Euler from prostate gland secretions of sheep.82,83Later it
was discovered that prostaglandins were not solely formed within the prostate gland
but within every nucleated cell and they perform a variety of functions. In 1971,
simple aspirin-like drugs were shown to inhibit prostaglandin production." Each
prostaglandin has a unique biological function, e.g. prostaglandin 12 (PGI2) (41)85
causes dilation of vascular smooth muscle cells, inhibits platelet aggregation and
10
dilation of smooth muscle in the lungs. PGE2 (42) has numerous applications, from
gastric acid/ mucus secretion to uterus contraction, and PGF2a (43) functions by
inducing contraction of the smooth muscle within the lungs.86 The prostaglandin
family is also supplemented by synthetic compounds, e.g. latanoprost 44, which is
used for the treatment of glaucoma.
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It was not until the late I960s that the attentions of natural product chemists turned to
the seas and the oceans as a source of biologically active compounds. Over the past 50
years thousands of biologically active compounds have been isolated from sponges,
corals, plants, fish and marine bacteria. In 1981, for example Clardy and Nakanishi
isolated brevetoxin B (45) from blooming monocellular algae,87 which cause a
phenomenon known as "red tides". The red colouration of the tide is produced by a
dense growth of algae which contain the carotenoid pigment, peridinin. The
brevetoxins are produced by phytoplankton of the genus Ptychodiscus brevis. This
family of polycyclic ether compounds exhibit neurotoxic activity," causing the death
11
of fish and the poisonmg of mollusks by activating the sodium channels within
neurons, causing a continuous influx of sodium ions which disable the neurons.89
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There are other natural products which have been isolated from marine sources which
have beneficial medicinal properties, for example the phorboxazole family of
compounds. The 21-membered macrolide structures of phorboxazole A (46) and B
(47) were described in 1993 by Molinski from the marine sponge Phorbas .'lp.
Extraction of 236 g of the sponge yielded only 95 mg of phorboxazole A (46) and 41
mg of phorboxazole B (47). Both phorboxazole A (46) and B (47) exhibit antifungal
and anti-cancer activity by causing cell arrest in the Ssphase." Another marine natural
product which shows anti-cancer activity is the macrocyclic peptide diazonamide A
(48). This natural product was isolated from the ascidian Diazona angulata by Fenical
and Clardy in 1991.91 Initially the structure of diazonamide A was assigned
incorrectly, but re-evaluation gave the true structure of the natural product which was
later confirmed in synthetic studies by Harran92-94 and by Nicolaou.95 Diazonamide A
(48) was shown to exhibit antimicrobial, antiviral and cytotoxic activity against
ovarian and breast cancer, along with taxol®-resistant cancer cell lines by inhibiting
tubulin assembly into microtubules.
Natural products provide a synthetic challenge to chemists due to their diverse
structural array and complexity, and their varied biological activity. Chemists have
been fascinated with natural products since they were first isolated and characterised.
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The chemical synthesis of natural products allows access to these complex structures
when their abundance in Nature is low, e.g. oestradiol 38 and phorboxazole A (46)
and B (47). This access enables further biological evaluation and pharmaceutical
trials, where previously these would not have been feasible. Total synthesis has also
allowed the confirmation of the structure of natural products like diazonamide A (48).
Indeed, chemical synthesis has now become an essential part of the natural product
process.
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The gorgonian octocorals are marine organisms of the class Anthozoa, of which,
Pseudoplerogorgia kallos, Gersemia rubiformis, Lophogorgia and Pseudopterogorgia
bipinnata, are just a few examples. Several research groups have studied and analysed
these Caribbean octocorals for biologically active compounds, and a range of diverse
and structurally intriguing natural products have been discovered. The novel
polycyclic diterpenes bielschowskysin 1,1 verrillin 2,2 intricarene 44 (discovered by
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Rodriguez et al.) and plumarellide 33 (discovered by Stonik et al.) were isolated from
octocorals between 2000 and 2005. They each possess unusual, unprecedented
polycyclic structures, and demonstrate interesting biological activity. Biclschowskysin
11 was reported in 2004 from the gorgonian octocoral, Pseudopterogorgia kallos in
the south western Caribbean sea. It possesses a tricyclo[9.3.0.02•lo]-tetradecane ring
system containing a cyclobutane ring at its core, a 5-membered lactol and a cyclic
hemi-ketal function. This compound also exhibited interesting biological activity in
the NCI antitumour screening program, namely antimalarial activity against
Plasmodium falciparum, and strong anticancerous properties against lung and renal
cancer cell lines. Verrillin 22 was reported in 2000 from the gorgonian octocoral
Pseudopterogorgia bipinnata found close to Colombia. This compound contains a
cis-bicyclo[9.3.0]-tetradecane nucleus encompassing two 5-membered lactone units, a
6-membered ring containing an ether-bridge and a dihemi-ketal functionality.
Unfortunately, due to lack of material, the biological activity of verrillin 2 could not
be fully analysed. Plumarellide 33 was reported in 2002 from the coral species
Plumarella in the North-Western Pacific Ocean. This diperpene contains a
pentasubstituted-cyclohexene at its core, a 5-membered lactone unit and a hemi-ketal
functionality. Biological testing demonstrated this compound produced moderate
hemolytic activity. Intricarene 4 reported in 2005 from Pseudopterogorgia kallos off
the coast of Providencia island, Columbia," has a carbon skeleton containing a novel
tetracyclic core with a lactone, an a,~-unsaturated ketone and an ether bridge
substituent. The biological activity of intricarene 4 was tested against tuberculosis but
showed no appreciable toxicity. Unfortunately further analysis could not be achieved
due to the dearth of material.
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We believe that bielschowskysin 1, verrillin 2, plumarellide 3 and intricarene 4 show
a unique and interesting biosynthetic relationship. As indicated at the beginning of the
Introduction, the aim of the work described in this Thesis was to probe this
relationship by examining routes to the total synthesis of 1, 2 and 3 using a design
based on biosynthetic speculation from a furanobutenolide - based cembrane
precursor, viz 5 and 6.
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The polycyclic diterpenes bielschowskysin 1, verrillin 2,
plumarellide 3 and intricarene 4, and their furanobutenolide
cembrane congeners
The complex polycyclic diterpenes bielschowskysin 1,1 verrillin 2,2 plumarellide 33
and intricarene 44 co-occur with less complex furanobutenolide - based cembrane
structures in corals. Naturally occurring furanobutenolide - based cembranes can be
divided into two categories, i.e. those that are substituted at the C4 position by CH3
and those that have a higher oxidation state, i.e. CH20H, CHO or C02Me. The former
category is represented by bipinnatin J (5),5 bipinnatin G (6),6 and rubifolide 49,96 and
the latter by lophotoxin 50,97 pukalide 51,98 and providencin 52.99 Pukalide 51
occupies a special place in natural product chemistry since it was the first member of
the family of furanobutenolide - based cembranoids to be described, in 1975, from
corals, i.e. Sinnlaria abrupta/" Since then pukalide 51 has been isolated from many
other coral species.!" and has also been found in the dendronoid nudibranch Tochuina
tetraquetra, together with rubifolide 49.101
Analysis of the structures and stereochemistries of naturally occurring, oxidised
furanocernbranes.l'" reveals a number of interesting features. Thus: i) the natural
products containing a C7,C8 epoxide, e.g. bipinnatin G (6)6 and D (53),103are derived
from L\7,8-alkene bond precursors which have the E-configuration; ii) the compounds
containing a C7,C8-epoxy furan are present with both a methyl group and the electron
withdrawing ester and aldehyde substituents, at the C3-furan position, e.g. bipinnatin
G (6) and leptolide 54;104iii) all of the Z-d7,8-alkene bond cembranoids that have been
17
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isolated from marine corals, and characterised, carry a methyl rather than an electron
withdrawing group on their alkene units, e.g. bipinnatin J (5)5 and rubifolide 49.96
These structural features combine to highlight the importance of the stereochemistry
of the ~ 7,8-alkene bond, and the nature of the substitution at the C4 position in
determining the patterns of oxidation of alkenylfuranocembranes in vivo, and the
subsequent transformations of the oxidised members leading to the rich variety of
unusual polycyclic diterpenes produced in corals.
The furanocembranes within the "lophotoxin" family are biologically active and
exhibit neurotoxicity. Lophotoxin 50 and other family members act by irreversibly
binding to the nicotinic acetylcholinergic receptors on the Tyr-l 90 amino acid in the
a.-subunit of the autonomic ganglia receptor, causing paralysis and asphyxiation. The
neurotoxicity of lophotoxin is thought to be associated with the structural similarity
between its butenolide fragment and acetylcholine 55.105,106
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The gorgonian octocoral reefs are relatively abundant in the temperate waters of the
Caribbean, but predation within these reefs is scarce apart from some specialist
feeders (e.g. butterflyfish, molluscs, etc.). Field studies on twenty eight species
demonstrated that the gorgoman octocorals .major defence utilises the
furanocembranolide diterpenes, e.g. pukalide 51, lophotoxin 50 and other metabolites,
as potent feeding deterrents.107-109Within the gorgonians species of soft coral, the
cembrane and furanocembrane structures are produced biosynthetically from the
common starting material dimethylallyl pyrophosphate 56 (Scheme I). The isoprene
unit is first elongated to the C20 diterpene, geranylgeranyl pyrophosphate 57. This
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key intermediate 57 folds into the conformation 58 which then undergoes an
intramolecular electrophilic cyclisation between the terminal alkene and the
pyrophosphate to produce a macrocyclic intermediate 59. Upon oxidation of the
neocembrane structure 59, depending on the level of oxidation achieved, either a
cembrane or a furanocembrane is finally produced. Further oxidation produces a
butenolide, various epoxidel alkene functionality and the alcohols seen in
furanocembrane natural products (5, 6 and 49_54).5,6,96.104
~DPP DPP
56 57 1Polyene folding
MacrocyclisationCembranes andl or Oxidation
Furanocembranes
59 58
Scheme 1. Biosynthesis ofa furanocembrane structure.
In Nature, we believe that the complex structures ofbielschowskysin 1, verrillin 2 and
plumarellide 3 are synthesised by cyclisations of the intermediate 14-membered
neocembrane ring 59 (Scheme 2). Cyclisation across the C7,Cll position reveals a
verrillane carbon skeleton 60 and by a further cyclisation procedure across the C6,C 12
positions the bielschowskyane carbon skeleton 61 is produced. Alternatively,
cyclisation between the C6,C 14 positions of the verrillane carbon skeletal
intermediate 60 produces the 6-membered ring at the core of the plumarellide carbon
skeleton 62. Further elaboration of these basic verrillane 60, bielschowskyane 61 and
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plumarellidc 62 structures via enantioselective and regiospecific enzymatic oxidations
would produce the novel natural products. I
59
C6-C 14 cyclisation
61 60 62
Scheme 2. Biosynthesis of the skeletal structures of bielschowskysin 61, verrillin 60 and plumarellide
62.
It is plausible that the octocorals enzymatically oxidise the basic skeleta, i.e. 60, 61
and 62, to the natural products, bielschowskysin 1, verrillin 2 and plumarellide 3.
With the furanobutenolide family of compounds being co-metabolites within the
corals, it is possible enzymatic oxidation occurs on the basic cembrane 59 in order to
produce furanobutenolide - based cembrane structures which could, in-tum, be
transformed into the three more complex polycyclic compounds (Scheme 3).
The idea of transforming a furanobutenolide - based cembrane into a polycyclic
diterpene was supported by contemporaneous work within our research groupllO and
work from the group of Traunerlll on the total synthesis of (+ )-intricarene 4. The
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Scheme 3. Proposed formation of bielschowskysin I, verrillin 2 and plumarellide 3 from a
furanobutenolide precursor.
biomimetic conversion into intricarene 4 could occur from the furanocembrane
bipinnatin ] (5) as shown in Scheme 4. If the furan ring of bipinnatin ] (5) was
oxidised to the corresponding dienedione 63, this would be in equilibrium with the
hydroxypyrone 64a. This oxidative ring expansion of the furan unit in 5 now allows
the oxidopyrylium ion 65 to be formed by elimination of the hydroxyl functionality or
an alternative leaving group. The intermediate 6S can then undergo a transannular
[5+2] cycloaddition between the oxidopyrylium ion and the alkene contained in the
butenolide function. This novel [5+2] cycloaddition would then form intricarene 4 in
a single transformation from the hydroxypyrone 64a.
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Scheme 4. Proposed chemical relationship between bipinnatin J (5) and intricarene 4.
To investigate the biomimetic synthesis of (+)-intricarene 4 shown in Scheme 4, a
collegue, Bencan Tang treated (-)-bipinnatin J (5) with VO(acach and tBuOOH
(Scheme 5), which resulted in oxidative ring cleavage of the furan ring and led to the
formation of the hydroxypyrone 64a via the dienedione intermediate 63.112
Acetylation of the enedione-hydroxypyrone mixture 63 and 64a, using AC20 and
Et3N, next gave the 6-acetoxypyranone 64b as a 5: 1 mixture of epimers at the C6
position. Treatment of the 6-acetoxypyranone 64b with DBU in refluxing acetonitrile
resulted in elimination of the acetoxy group and formation of the presumed
id I' , 65 113 114 The i diate i '65 h d hOXI opyry mm IOn " e mterme late IOnIC species t en un erwent t e
[5+2] transannular cycloaddition leading to (+)-intricarene 4 in a yield of 10%,
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Scheme 5. Reagents and conditions: (a) VO(acach, tBuOOH, CH2Clz, -20°C, 2 hrs; (b) Ac-O, Et3N,
DMAP, CHzClz, r.t., 3 hrs, 30% (over 2 steps); (c) DBU, MeCN, reflux, I hr, 10%.
The same sequence was followed by Trauner et at. but utilising different reagents and
conditions (Scheme 6). Thus, the furan ring in (-)-bipinnatin J (5) underwent
oxidative cleavage using mCPBA in DCM to form the hydroxypyrone 64a.
Subsequent acetylation of intermediate 64a next produced the 6-acetoxypyranone
64b, which upon addition of the hindered secondary amine base, TMP 66, in the polar
solvent, DMSO, at 150°C in a sealed tube formed (+)-intricarene 4. These conditions
produced (+)-intricarene 4 in yields of 10-26%.
The total synthesis of intricarene 4, was first achieved by our own group in 2006 and
then later by Trauner et al.IIO,1I1 Buoyed by this success we hoped that a similar
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transannular process could be applied to the synthesis of the polycyclic structures
bielschowskysin 1, verrillin 2 and plumarellide 3.
a,b
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Scheme 6. Reagents and conditions: (a) mCPBA, CH2C12, 0 DC, I hr; (b) AC20, pyridine, DMAP,
CH2CI2, r.t., 2 hrs, 81% (over 2 steps); (c) 66, DMSO, 140°C (sealed tube), 16 hrs, 26%.
Proposal for the origins of bielschowskysin 1, verrillin 2 and
plumarellide 3 from furanobutenolide precursors
Our proposed biosynthetic route to bielschowskysin 1,1 verrillin 22 and plumarellide
33 starts from the simple furanobutenolide - based cembrane molecule, rubifolide
49.96 Selective enzymatic oxidations lead to the macrocyclic structure of iso-
bipinnatin G (67), containing an epoxide function between the C7,C8 position and
oxgenation at the C2 and C13 positions in the form of protected alcohols (Scheme 7).
iso-Bipinnatin G (67) possesses the opposite ~7,8-epoxide diastereoisomer to the
natural product 6. Bielschowskysin 1 could be formed from iso-bipinnatin G (67) via
an intramolecular [2+2] cycloaddition process across the furanobutenolide - based
cembrane macrocycle. An acid catalysed epoxide ring opening of 67 utilising the
electron density located in the furan reveals the oxonium ion 68. Quenching 68 with
water leads to the enol ether 69 containing a Z-exo-alkene. For the [2+2]
cycloaddition to occur the exo-cyclic alkene and the butenolide alkene must be held in
close proximity. Isomerisation of the Z-exo-alkene 69 to the E-exo-alkene 70, by acid
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catalysis or exposure to light, draws the two alkenes functions into close vicinity.
Utilising light allows the key [2+2] cycloaddition 115 to occur between the butenolide
and the exo-cyclic alkene contained within the enol ether herni-ketal functionality to
produce the key cyclobutane tetracyclic core 71.116-119 Finally, acetyl deprotection and
ally lie oxidation of the isopropenyl side-chain would form the cyclic herni-acetal and
lock the macrocycle into position to produce bielschowskysin 1.
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Scheme 7. Proposed chemical relationship between iso-bipinnatin G (67) and bielschowskysin I.
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An alternative formation of the key cyclobutane tetracyclic core 71 could occur under
the acidic conditions which are used to open the epoxide function (Scheme 8). After
the exo-cyclic alkene has been isomerised to form the intermediate 70, the butenolide
and the exo-cyclic alkene are close enough to undergo a simple Michael addition into
the ~-position of the butenolide facilitated by the enol ether functionality. The enolate
generated 72 from the Michael addition can then add back into the oxonium ion via an
aldol-type addition to generate the cyclobutane tetracyclic core 79.120-122 Finally cyclic
hemi-acetal formation again leads to bielschowskysin 1.
Michael
addition
70 72
""OH
ii. Allylic oxidation
1 71
Scheme 8. Alternative biosynthesis ofbielschowskysin I.
Verrillin 2 could be formed along a similar sequence to bielschowskysin 1 but using a
Michael addition followed by formation of the ether-bridge (Scheme 9). Similar
selective enzymatic oxidations of rubifolide 49 produce the macrocyclic structure of
13-deacetylbipinnatin G (73). Acid-catalysed epoxide opening of the furanobutenolide
- based cembrane 73 followed by quench of the cationic furan species by water,
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produces the enol ether intermediate 74. Similar to bielschowskysin 1, the exo-cyclic
alkene of the enol ether hem i-ketal 74 undergoes isomerisation to produce the E-exo-
alkene 75. This again disposes the butenolide and the enol ether functional groups into
close enough proximity for them to react. An acid-catalysed Michael addition into the
p-position of the butenolide forms the enolate 76 in an identical manner to the
alternative bielschowskysin 1 proposal. The enolate 76 produced from the Michael
addition in then able to undergo proton exchange with the C 13 secondary alcohol
group to form the oxy anion species 77. The enol group in 77 can undergo keto-enol
tautomerism to reinstall the lactone functionality. The core structure of verrillin 78 is
then elaborated upon ether bridge formation between the oxonium ion species and the
butenolide oxy anion species. All that is now required to produce the natural product 2
is deprotection of the secondary alcohol functional group in 78, allylic oxidation with
in-situ lactonisation and finally a regiosepecific conjugate reduction of the exo-a,p-
unsaturated lactone substituent. The reduction of the a-methylene lactone may be
aided by the inherent conformation bias of the core macrocyc1e. This final
transformation produces the natural product verrillin 2.
The proposed biosynthesis of plumarellide 3 would utilise the same structural motif as
that shown previously in the biosynthesis of bielschowskysin 1 and verrillin 2, namely
the enol ether cyclic hemi-ketal 70 and 75. The proposed biosynthesis is shown in
Scheme 10 and starts from the furanobutenolide - based cernbrane, iso-13-
acetoxypukalide 79123 which could be produced in vivo by selective enzymatic
oxidation of rubifolide 49.96 The furanocembrane intermediate 80 required for the
biomimetic transformation contains an epoxy furan, substituted with a CH20H group
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Scheme 9. Proposed chemical relationship between l3-deacetylbipinnatin G (73) and verrillin 2.
at the C4 and an alkene unit at C13,CI4 in conjugation with the butenolide
functionality. This intermediate could be produced from iso-13-acetoxypukalide 79
upon reduction of the C4 ester functionality to form the hydroxymethyl furan
substituent and elimination of the Cl3 acetyl-protected secondary alcohol could
introduce the diene functionality. Treatment of intermediate 80 with acidic aqueous
conditions should allow the same process to occur as that shown for both
29
bielschowskysin 1 and verrill in 2, to form the enol ether cyclic hemi-ketal 81. It is this
key motif which is again used for a transannular cyclisation, specifically the Diels-
Alder process. Isomerisation of intermediate 81 places the alkene functionality of the
E-enol ether 82 and the conjugated butenolide in close enough proximity to allow a
[4+2] transannular cycloaddition process to OCCUr.124,125 The cyclohexene
functionality produced from the Diels-Alder cycloaddition process forms the core
structure of plumarellide 3.
",,( [0]
"( i. Reduce "''("~ ~
ii. Eliminate
0 0 0
49 79 80
1~H,O'
OH
OH
OH OH
HO[4+2] Alkene ",,(
Cycloaddition isomerisation
0 0
~
0
3 82
81
Scheme 10. Proposed conversion ofrubifolide 49 into plumarellide 3 based on biomimetic speculation.
OH
The initial stage in the biosynthesis of bielschowskysin 1, verrillin 2 and plumarellide
3 is the acid catalysed ring opening of the C7,C8 epoxide to produce the enol ether
cyclic hemi-ketal intermediates 69, 74 and 81. Four enol ether cyclic herni-ketal
natural products, i.e. 83a, 83b, 84 and 85, have been isolated by Fenical et al., 107
Abramson et al.,105 Venkateswarlu cl al.126 and by Slattery et al.127 The southern
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portions in these structures, containing the butenolides, vary in oxidation pattern and
functionality but the northern portions remain essentially unchanged. The structural
features which remain constant throughout these enol ether natural products are: i)
they contain a C3-methoxy group; ii) there is an unsubstituted iso-propyl side-chain;
iii) the macrocycles are devoid of a hydroxyl group at the C2 position; iv) an electron-
withdrawing substituent is present at the C4 position, namely a C02Me or CHO
group; v) there is a tertiary alcohol substituent at the C8 position of the macrocyclic
compounds. The isolation of 83a, 83b, 84 and 85 suggests that the proposed
biosyntheses, via the enol ether hem i-ketal structural motif, has some creditability.
We believe that more elaborate metabolites to further elucidate the biosynthesis of
either bielschowskysin 1, verrillin 2 or plumarellide 3 have still to be isolated.
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To date, there have been no syntheses of bielschowskysin 1, verrillin 2 and
plumarellide 3. However, there have been publications which support the proposed
biomimetic formation of the cyclobutane ring in bielschowskysin 1. Thus, in 2006,
Sulikowski et al. reported the formation of the cycJobutane - containing tetracycJic
structure 98,128 via an intramolecular [2+2] cycloaddition process (Scheme 11). The
synthesis started from malic acid, which was first converted over several steps to the
1,3-dioxane acetal compound 86. Oxidation of the primary alcohol group in 86 using
OMP next afforded the aldehyde 87 which was then used in a Still-Gennari
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modified.i " Wadworth-Emmons olefinationl3O to produce the Z-enoate 88a. A
Sonogashira cross-coupling reaction'<' between the acetylene functionality in 88a and
the vinyl iodide 89 led to the allylic alcohol 90, which was then transformed into the
corresponding carboxylic acid 91 utilising sequential oxidation via the aldehyde
functionality. The y-alkylidene butenolide 92 was produced as a single geometric
isomer by treatment of the carboxylic acid 91 with AgN03 in methanol under
Negishi's conditions.132 Finally, treatment of the y-alkylidene butenolide 92 with
aqueous acetic acid removed the acetal protecting group allowing the secondary
alcohol functionality to cyclise on to the methyl ester substituent to form the
butenolide 93.
A solution of the butenolide 93 in acetone was irradiated with light through pyrex
glass for 72 hours (Scheme 12),115.1 16 which led initially to a photoequilibrium
mixture of the geometric isomers 93 and 94. However, upon prolonged exposure the
butenolide and the alkylidene butenolide alkenes were excited and produced radical
species, which cyc1ised following the "rule of five" to form the biradical intermediates
95 and 96.133.134 The intermediates 95 and 96, could interchange via simple bond
rotation or via re-formation of the precursor compounds 93 and 94, which could
interconvert via photoisomerisation. The final stage in this process was the formation
of the cyclobutane ring structures 97 and 98 as a 1:5 mixture in 50% yield.
This study demonstrated that an intramolecular [2+2] cycloaddition process could
potentially be applied to the E-enol ether 70 to produce the cyclobutane functionality
in bielschowskysin 1. The investigations by Sulikowski et at. 128 was complemented
by a synthesis of the analogous tricyclic compound 101 published by Lear et al. in
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2009.135 The synthesis again utilised an intramolecular [2+2] cycloaddition process
but this time involving an allene and a butenolide (Scheme 13). The synthesis initially
followed a similar synthetic sequence to Sulkowski et al. in order to transform malic
acid into the Z-enoate 88b using several straightforward steps. Treatment of the Z-
enoate 88b with aqueous sulfuric acid in methanol deprotected the acetal functionality
a b
86 87
88a
~
OH
c
d,e
91 90
o
9
92 93
Scheme It. Reagents and conditions: (a) DMP, CH2CI2, r.t., 2 hrs, 85%; (b) KHMDS,
(CF3CH20)2P(O)CH2C02Me, THF, -78°C to r.t., I hrs, 71%; (c) 89, Pd(PPh)4, Cui, Et3N, MeCN, r.t.,
16 hrs, 75%; (d) DMP, CH2Ch, r.t., 2 hrs; (e) NaHPO).H20, NaCI02, H20, H202, MeCN, 0 -c, 90
mins, 59% (over 2 steps); (t) AgNOJ, MeOH, r.t., I hr, 75%; (g) AcOH, H20, r.t., 15 hrs, 43%.
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Scheme 12. Reagents and conditions: (a) hv, Me2eO, pyrex, r.t., 72 hrs, 50%.
allowing cyclisation to form a y-butenolide, which upon protection of the tertiary
alcohol functional group, produced the TMS-silyl ether 99. The allene 100 was
formed upon homologation of the acetylene unit in 99 by treatment with (CH20)n,
ipr2NH and CuBr in refluxing dioxane. Initially the tricyclic precursor 100 was heated
to investigate a thermal [2+2] cycloaddition, but this reaction did not result in the
tricyclic core 101. Instead, exposure of 100 to light in hexane! DCM for 12 hours
induced the intramolecular [2+2] cycloaddition process I IS leading to tricyclic
compound 101 as a single diastereoisomer in a 70% yield.
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Scheme 13. Reagents and conditions: (a) H2S04, MeOH, r.t., 15 hrs, 70%; (b) TMSOTf, 2,6-lutidine,
CH2CI2, 0 QC to r.t., 2 hrs, 62%; (c) (CH20)", ipr2NH, CuBr, dioxane, reflux, 3 hrs, 68%; (d) hv,
hexane, CH2CI2, r.t., 12 hrs, 70%.
The syntheses of the cyclobutane containing ring systems 98 and 101 represent the
most significant synthetic development towards the natural products bielschowskysin
1published so far.
Planned model study with the simplified
furanobutenolide - based structures 102 and 125
To achieve our proposed biomimetic synthesis of the natural products,
bielschowskysin 1,I verrillin 22 and plumarellide 3,3 a furanobutenolide - based
cembrane structure would have to be synthesised. The required epoxyfuran structures
are represented by iso-bipinnatin G (67), 13-deacetylbipinnatin G (73) and the
furanodiene 80. Syntheses of anyone of these structures with all the substituents
present, is synthetically demanding. Therefore, it was considered more advantageous
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to first undertake the synthesis of a more simple model substrate analogous to
rubifolide 49.96
o
67
o
73
o
OH
o
80
Initially, in order to exam me the [2+2] cycloaddition process,115-121only a 14-
membered macrocyclic structure with an a,p-unsaturated ester, in the form of a
butenolide and an enol ether substituent is required. Simplification ofrubifolide 49 led
us to the macrocyclic furanobutenolide 102 (Scheme 14). Oxidative ring cleavage of
the furan functionality in 102 would be expected to lead to the enedione 103136 which,
following tautomerism forms the required enol ether hemi-ketal structure 104.
Isomerisation of the alkene bond in the Z-enol ether 104 to the E-enol ether 105 would
then bring the butenolide into close enough proximity to allow the [2+2]
cycloaddition 115,120 and generate the cyclobutane ring functionality in the
bielschowskysin core 106.
Thus, starting with the much more simple furanobutenolide structure 102,
retrosynthetic analysis reveals the intermediate 107 containing a C2 hydroxyl group
and an isopropenyl substituent which would be elaborated via a Nozaki-Hiyama-Kishi
(NHK) macrocyclisation process from the furan aldehyde 108 (Scheme 15). The furan
aldehyde 108 could, in-tum, be produced via a Wittig olefination using the stabilised
phosphorane 111, and a Trost Alder-ene reaction between the propargylic
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Scheme 14. Proposed transformation into the bielschowskysin core 106 from a rubifolide analogue 102
utilising a bioinspired sequence.
alcohol 109 and allyl alcohol 110, would form the butenolide functionality. Removal
of the propargylic alcohol substituent in 109 leads back to the aldehyde 112, which
ultimately could be derived from the known furanmethanol 113.
Alternatively, the butenolide functionality of furan aldehyde 108 could be produced
using an esterification reaction followed by a ring-closing metathesis (ReM) process
between the allylic alcohol 114 and the a,~-unsaturated ester 115 fragments, as shown
in Scheme 16. The allylic alcohol 114 could again be formed from the furan methanol
113 via the aldehyde 112. Removal of the methylene group from the a,~-unsaturated
ester 115 produces the ester 116, which was used previously for our (-)-bipinnatin J
(5)/ (+)-intricarene 4 synthesis.'!"
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Scheme 15. Retrosynthesis of the bielschowskysin model precursor 102.
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Scheme 16. Alternative retrosynthesis of the model furanobutenolide precursor 108.
The synthesis of the model system l02 was initiated by forming the known
furanmethanol 113a 137 (Scheme 17) by straightforward reduction of commercially
available methyl 3-methyl-2-furoate, using LiAIH4. Protection of the alcohol l13a as
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its TBS-ether was then achieved using Corey's conditions.l " i.e. TBS-Cl and
imidazole in DMF, to produce the silyl ether 113b in 96% yield. Addition of l'Bul.i to
l13b at 0 QC resulted in directed deprotonation at the CS furan position which, on
treatment with DMF, gave the furan aldehyde 117.139 Deprotonation of the
commercially available phosphonium salt 118, using IlBuLi at -78 QC led to the
corresponding ylide species which, on addition of the furan aldehyde 117, gave a 3:2
mixture of the E:Z-alkene isomers of the alkenylfuran 119 in 75% yield.14o.141 The
alkenylfuran 119 was reduced to 120, using hydrogen in the presence of 5%
palladium on carbon. To produce the aldehyde 112, the acetal functional group in 120
had to be deprotected selectively in the presence of the silyl ether. A range of
conditions were tried in order to achieve this selective deprotection, but none could be
found. The conditions either, removed both protecting groups, decomposed the
material or selectively deprotected the TBS-silyl ether to form the corresponding
primary alcohol.
The aldehyde 112, required to form the propargylic alcohol 109 and the allylic alcohol
114, could still be formed potentially by altering the phosphonium salt used in the
Wittig reaction (Scheme 18). Thus, the phosphonium salt 121142,143was prepared by
refluxing 3-bromo-I-propanol and Ph3P in MeCN. Deprotonation of 121 using nBuLi
at -20 QC produced the corresponding ylide intermediate which, on addition of the
furan aldehyde 117 led to the E-alkenylfuran 122 in 60% yield, predominantly as the
E-isomer; this followed from the magnitude of the vicinal coupling (J 15.8 Hz)
between the olefinic hydrogens in the IH NMR spectrum. Unfortunately, the previous
hydrogenation conditions only proceeded to decompose this substrate. The problem
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Scheme 17. Reagents and conditions: (a) TBS-CI, 1m, DMF, 0 QC, 10 mins, 96%; (b) "BuLi, THF,
-78 QC to 0 QC, 30 mins, then DMF, -78 QCto r.t., 4 hrs, 77%; (c) 118, "SuLi, THF, -78°C, 40 mins,
then 117, THF, -78°C to r.t., 15 hrs, 75%; (d) 5% Pd/C, H2, EtOAc, r.t., 3 hrs, 93%.
could be overcome be changing the solvent to THF and running the reaction in the
presence of a base, i.e. Et3N, in order to generate the furan 123. Oxidation of the
primary alcohol functional group in 123 using TPAP and NMO, cleanly afforded the
aldehyde 112, which upon addition of the lithiated ethyl propiolate species formed the
propargylic alcohol 109. With the propargylic alcohol 109 in-hand the Alder-ene
reaction144,145could be examined. The highest yields and greatest regiochemical
selectivity are obtained when the Trost Alder-ene reaction is preformed under acidic
conditions,146-148but the substrate 109 has previously proven to be sensitive to acid. It
was therefore hoped the reaction could be performed under neutral conditions so as to
avoid decomposition of the substrate. Thus, the propargylic alcohol 109 was treated
with RuCp(MeCNhPF6 and allyl alcohol HO in DMF at room temperature, but none
of the required butenolide 124 was observed.v" Unfortunately the reaction conditions
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only proceeded to decompose the starting material. Addition of base to the reaction,
e.g. K2C03 and Et3N, did not produce any of the butenolide 124 and returned only the
starting materials. These results are unsurprising since the active catalyst is CpRu +, a
Lewis acid, which presumably causes the decomposition of the substrate; upon
addition of base the catalyst was presumably deactivated and therefore the original
substrate was returned.
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Scheme 18. Reagents and conditions: (a) 121, "BuLi, THF, -20 DC,30 mins, then 117, THF, -20 DCto
r.t., 15 hrs, 60%; (b) 5% Pd/C, H2, Et3N, THF, r.t., 15 hrs; (c) TPAP, NMO, 4 A MS, CH2CI2, r.t., 1 hr;
(d) LOA, ethyl propiolate, THF, -78 DC, 2 hrs, 61% (over 3 steps); (e) allyl alcohol 110, 10 mol%
RuCp(MeCNhPF6, OMF, r.t, 20 hrs.
The problem encountered during the Alder-ene process with 109 led us to examine the
alternative RCM method, in order to form the butenolide functionality of 108
(Scheme 19). The E-alkenylfuran 122 produced from a Wittig reaction, again
underwent hydrogenation, oxidation and upon treatment of the resulting aldehyde
with vinylmagnesium bromide in THF at -78 QCproduced the allylic alcohol fragment
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114 in a combined 50% yield. The synthesis of the a,l3-unsaturated ester fragment
115 commenced from the allylic alcohol 116a, 110 which was first protected as the silyl
ether 116b using TBDPS-CI and imidazole in DMF.138 Unfortunately attempts to
transform the silyl ether 116b into the a,l3-unsaturated ester 115 by deprotonation and
addition of the enolate species into Eschenmoser's salt!" failed. ISO This result was
disappointing and abruptly interrupted the synthesis towards the furanobutenolide
102.
OTBS a OTBS b, C OTBS
122 123 114
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d ~ R = TSDPS 116b
Scheme 19. Reagents and conditions: (a) 5% Pd/C, H2oEtJN, THF, r.t., 15 hrs; (b) TPAP, NMO, 4 A
MS, CH2CI2, r.t., I hr; (c) vinylmagnesium bromide, THF, -78 DC, I hr, 50% (over 3 steps); (d)
TBDPS-CI, 1m, DMF, 0 DC, 10 mins, 86%.
115
Due to the problems encountered during this model system it was decided to change
the target structure in order to avoid the difficulties observed with stability and
reactivity.
Simplification ofrubifolide 49 led us to the intermediate 125 with a furan and an a,l3-
unsaturated ester substituent (Scheme 20). Construction of the macrocycle in the
furanocembrane 125 could be achieved via a Reformatsky-type process within the
compound 126. A Wadsworth-Emmons olefination reaction would install the a-
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bromoester functionality of aldehyde 126 from the protected diol 127. Addition of
both side-chains to the furan ring of intermediate 127 could be achieved utilising
Wittig reactions between the furan aldehyde 129 and the two phosphonium salts 128
and 130.
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Scheme 20. Retrosynthesis of the alternative bielschowskysin model structure 125.
Installation of the C 13 hydroxyl group, not only provided a method for
macrocyclisation but it also allowed access to both bielschowskysin and verrillin core
structures, i.e. 132 and 134, respectively, as shown in Scheme 21. Thus,
transformation of the macrocyclic intermediate 125 into the enol ether 131 could be
achieved along a similar sequence to that shown in the previous model system
(Scheme 14) via oxidative ring cleavage, IJ2 tautomerism and isomerisation. A [2+2]
transannular cycloadditionl15.120 on precursor 131 produces the bielschowskysin core
132. Alternatively, the verrillin core 134 could be produced via a transannular
Michael addition to form the oxonium intermediate 133 which upon ether-bridge
formation secures the core structural motif.
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Scheme 2 I. Formation of the bielschowskysin and verrillin cores 132 and 134 from the
furanocembrane 125.
The starting point for the model structure 125 was the known furan aldehyde 129
(Scheme 22),151 produced by treatment of the furanmethanol 113a (used in the
previous model system 102) with Mn02 in DCM. Deprotonation of the phosphonium
salt 130152,153 using nBuLi gave the corresponding ylide which, on addition of the
furan aldehyde 129 gave the Z-alkenylfuran 135; this followed from the magnitude of
the vicinal coupling (J 11.8 Hz) between the olefinic hydrogens in the IH NMR
spectrum. Reduction of 135 under hydrogenation conditions, next gave the furan 136.
Directed deprotonation at the CS furan position, followed by quenching of the
intermediate lithiated species with DMF at -78 QCnext produced the furan aldehyde
137.154 The Wittig reaction was used again by reacting the aldehyde 137 with the
ylide derived from the phosphonium salt 128.155 Subsequent hydrogenation of the
alkene bond, formed in the Wittig process, then produced the protected diol 127. The
protected diol 127 was next converted into the aldehyde 138 by selective cleavage of
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the primary TBS-ether under mildly acidic conditions, i.e. PPTS in MeOH and OCM,
followed by Swem oxidation of the alcohol functional group. With the aldehyde
functionality in place, a Wadsworth-Emmons reaction'<'' using the fluorophosphonate
reagent 139, in a Still-Gennari modificationl29 was performed on 138. After work-up
and chromatography the IH NMR spectroscopic data showed a signal at 8H 6.65 ppm,
which corresponded to the E-alkene isomer of the c-bromoester 140a (cl IH NMR
spectroscopic data for ethyl 2-bromo-2-nonenoate: the Z-alkene isomer showed a
signal at 8H 7.23 ppm, whereas the E-alkene isomer showed a signal at 8~16.60
ppm).156 Deprotection of the TBDPS-ether in t40a was achieved with the HF.Py
complex, and oxidation of the resulting alcohol using Dess-Martin periodinane
produced the macrocycle precursor 126, in a straightforward manner.
With the aldehyde 126 in hand the macrocyclisation process via a Reformatsky-type
reaction was investigated (Scheme 23). Previous work by Nagamitsu et al., 157on the
total synthesis of borrelidin, demonstrated that the Reformatsky reaction 158was not as
effective as a Sml- mediated'" Reformatsky-type reactionl6o,161for the intramolecular
macrocyclisation process. With this in mind, the macrocyc1isation was examined with
Smh.159-161Thus, the aldehyde 126 was treated with Sml, at -78°C, but unfortunately
the macrocyclic structure 125 was not produced. Instead, the o-bromoester substituent
of intermediate 126 was reduced to the corresponding Z- and E-a,p-unsaturated esters
14ta and 14th, in a combined 70% yield (i.e. .J 11.6 Hz for the Z-isomer 141h and.J
15.6 Hz for the E-alkene isomer 141h). Interestingly, the aldehyde functional group
remained unaffected and was not reduced by Sml-. The result was disappointing but it
was thought that the macrocycJisation could be achieved by simply reversing the
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Scheme 22. Reagents and conditions: (a) 130, "Bul.i, THF, -20°C, 30 mins, then 129, THF, -78°C to
r.t., 15 hrs, 99%; (b) 10% Pd/C, H2, MeOH, r.t., 4 hrs, 85%; (c) "BuLi, THF, -78 °C to r.t., 45 mins,
then OMF, -78 DC to r.t., 15 hrs, 50%; (d) 128, "BuLi, THF, -20°C, 30 mins, then 137, THF, -78°C to
r.t., 15 hrs, 72%; (e) 5% Pd/C, H2, MeOH, pentane, r.t., 4 hrs, 91%; (f) PPTS, CH2CIz, MeOH, r.t., 24
hrs, 84%; (g) OMSO, oxalyl chloride, Et3N, CH2Ch, -78°C, 2 hrs; (h) i: 139, NaH, THF, -30°C, 30
mins, then Br2, -30°C to r.t.; ii: NaH, -78°C to ~ -30 DC, then 138, THF, -78°C to r.t., 15 hrs, 72%
(over 2 steps); (i) HF.Py, Py, THF, r.t., 24 hrs, 92%; U) OMP, CH2CI2, r.t., 45 mins, 70%.
addition procedure. Thus, the aldehyde 126 was added to a solution of Sml- at -78 DC,
and gratifyingly the Reformatsky-type process took place producing the macrocycle
142. The macrocyclic alcohol 142 was unfortunately devoid of the unsaturation next
to the ester functional group. The intramolecular Reformatsky-type process was
induced by Sml, but the excess reagent used caused simultaneously reduction of the
alkene bond post-macrocyclisation.
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Scheme 23. Reagents and conditions: (a) Sm12, THF, -78°C, 30 mins, 25% (141a), 45% (l4Ib); (b)
Sm1b THF, -78°C, 30 mins, 33%.
The conjugate reduction of the a,~-unsaturated ester functional group in 126 seems
inevitable. The 1111,12-alkene bond could potentially be re-introduced by
deprotonation, formation of a phenyl selenium intermediate and upon oxidation, syn-
elimination would occur, to re-introduce the a,~-unsaturated ester functionality.
Unfortunately due to the dearth of alcohol 142, this series of reactions could not be
investigated.
It was noticed that when the alcohol 140b was oxidised with a large excess of Dess-
Martin periodinane, not only was the corresponding aldehyde produced, but the furan
ring was also cleaved to the enedione 143 (Scheme 24).136 The enedione intermediate
143 could potentially be transformed into the bielschowskysin core structure 132 but
first tautomerisation must occur to form the enol ether cyclic ketal functionality 144.
Formation of the enol ether 144 would allow an intramolecular [2+2]
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I ddi 115120 . h b ~. I deye oa ition ' process mto t e a- romoester runctiona group to pro uce the
cyclobutane motif. Finally, cyc1isation of the a-bromoester substituent into the
aldehyde functionality would produce the bielschowskysin core 132. To investigate
this transformation the enedione 143 was treated with p- TSA in THF_lhO.162.163
Under these conditions the IH NMR spectroscopic data showed a signal at 8H 4.59
ppm. There were doubts that tautomerism of the enedione 143 had occurred to form
the enol ether 144 but this result was supported by treatment of the enedione 143 with
p- TSA in THF-MeOH which produced NMR spectroscopic data at 8H 4.04 ppm,
consistent with the methyl enol ether 145. Under these reaction conditions there was
simultaneous alteration of the aldehyde functional group of intermediate 143 into the
corresponding acetal substituent. Both of the synthesised enol ether compounds, i.e.
144 and 145, were re-subjected to the acidic conditions of p- TSA in THF-H20 in
order to induce the [2+2] cycloaddition via an acid catalysed Michael-aldol process 120·
122but unfortunately the cyclobutanes 146 and 147 were not produced. Irradiation of
the enol ether intermediates 144 and 145 with light in acetone also did not produce the
cyclobutane cores, i.e. 146 and 147, via a photolytic process,115'119 only
decomposition was observed. Although it was disappointing not to produce either of
the cyclobutanes 146 and 147, the enol ether intermediates, i.e. 144 and 145, are
acyclic. Therefore, it was hoped that by forming the enol ether cyclic ketal
functionality within a macrocyclic structure, the inherent conformational bias would
force the [2+2] transannular cycloaddition process to occur. This would produce the
cyclobutane functionality of the bielschowskysin core 132.
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Scheme 24. Reagents and conditions: (a) DMP, CH2CI2, r.t., 45 mins, 50%; (b) p-TSA, THF, H20, r.t.,
4 hrs, 80%; (c) p- TSA, THF, MeOH, r.t., 4 hrs, 80%, (d) hv, Me2CO, r.t., 20hrs.
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Although neither of the bielschowskysin core structures 106 and 132 could be
synthesised, the key structural motif, i.e. the enol ether cyclic ketals 144 and 145, was
thought to have been produced via an acid catalysed tautomerism of the enedione 143.
Therefore, further investigation into the chemistry of alkenylfurans, and hence enol
ethers, was deemed necessary in order to fully understand the reactivity and stability
of these intriguing structural motifs.
Studies of the oxidative cleavage of 2-alkenylfurans
The enol ether cyclic hemi-ketal structural motif is central to our proposed
biosynthesis of the polycyclic natural products, 1, 2 and 3, (see Scheme 7, Scheme 9,
and Scheme 10). There were doubts that tautomerism of the enedione 143 had
49
occurred in our model work to produce the enol ethers 144 and 145. At this point in
our research therefore we decided to study the synthesis of the most simple enol ether
cyclic hemi-ketal structure we could imagine, i.e. 151.
The enol ether cyclic hemi-ketal 151 could be produced from the epoxide 149 upon
treatment with acid to catalyse the epoxide ring-opening and hydration of the
subsequent oxonium species 150 (Scheme 25). Theoretically, there is also an
alternative pathway to form the enol ether 151 from the alkenylfuran 148. This
sequence could be initiated by oxidative cleavage of the furan ring in 148 via
rearrangement of the epoxide 152, to form the dienedione moiety 153. A regiospecific
hydration of the ~7,8-alkene bond in the dienedione 153 would then produce the ~-
hydroxyketone 154 which, via tautomerisation, forms the required enol ether structure
151. Either of these routes are plausible.
The alkenylfuran, epoxyfuran and enol ether structural units 148, 149 and 151 are all
contained within naturally occurring compounds, e.g. acerosolide 155,164 lophotoxin
5097 and sethukarailide 156.165 The dienedione functionality 153 is also present within
several natural products, i.e. lophodione 157,166 epilophodione 15896,
isoepilophodione B (159)167 and coralloidolide E (160).168 These functional groups are
likely to be inter-related but the sequence by which they are produced by the enzymes
within the octocorals is unknown.
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Scheme 25. Divergent formation of the enol ether 151 from the alkenylfuran 148.
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Bielschowskysin 1 and verrillin 2 both carry methyl substituents at C4. Hence, to
effectively mirror the proposed biosynthesis the analogous model alkenylfuran 162
must also contain a methyl substituent at C3. Thus, the model alkenylfuran 162 was
prepared by a Wittig reaction between isopropyltriphenylphosphoranylide and the
commercially available 4,5-dimethylfuran-2-carbaldehyde 161 (Scheme 26).169
Oxidation of the alkenylfuran 162 with a range of oxidising agents, i.e. mCPBA,
dimethyldioxirane (DMDO), Dess-Martin periodinane, resulted in cleavage of the
furan ring and formation of the Z-dienedione 163 as the sole product.l " The
epoxyfuran 164 was not produced under any of these reaction conditions. This result
demonstrated that when the furan possesses a C3 methyl substituent, the furan
becomes more nucleophilic towards the oxidising agents and is oxidised preferentially
over the alkene functional group. Selective oxidation of the furan suggests that the
second pathway, via the dienedione 153, is the preferred route to the required enol
ether intermediates 69, 74 and 81.
riaro>-- ----.If
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Scheme 26. Reagents and conditions: (a) isopropyltriphenylphosphonium iodide, "BuLi, THF, 0 QC,30
mins; (b) mCPBA, CH2CI2, 0 QC, I hr, 57% (over 2 steps).
To examine the transformation of the dienedione 163 into the enol ether intermediate
166 via hydration and tautomerisation, the substrate was treated with p-TSA in THF-
H20, and the reaction was carefully monitored by t.l.c. and IH NMR spectroscopy.
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After a short period of time a new compound was present in the reaction mixture.
Purification and characterisation, identified the product as the ~-hydroxyketone 165,
formed by Michael addition of water into the enone functionality (Scheme 27). Upon
extended exposure of the dienedione 163 to the acidic conditions or by re-subjecting
the [i-hydroxyketone 164 to the reaction conditions, another compound was formed.
After work-up and chromatography the compound showed IH NMR spectroscopic
data, DH 4.38 ppm and Dc 74.7 ppm, which we initially thought corresponded to the
enol ether hemi-ketaI166. By dissolving the dienedione 163 in t:f-THF and adding of
one drop of water and a crystal of p-TSA, the reaction could be monitored efficiently
by IH NMR spectroscopy. This study gave results similar to those obtained for the
enol ether 145, i.e. IH NMR data DH 4.04 ppm and Dc 76.1 ppm.
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___'HO
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Scheme 27. Reagents and conditions: (a) p-TSA (cat), THF, H20, r.t., 20 hrs, 10%; (b) p-TSA, THF,
H20, r.t., 20 hrs, 11%.
Studies by another colleague in our research group, attempted to produce the
analogous C3-methoxycarbonyl substituted enol ether structural motif 173a (Scheme
28) seen in the natural product sethukarailide 156.165 This work demonstrated that the
alkenylfurans, i.e. 167, 169 and 171, bearing an electron-withdrawing substituent at
the C3 furan position, i.e. CO2 Me or CHO, could be oxidised selectively with
mCPBA or dimethyldioxirane (DMDO) to produce the corresponding epoxyfurans
168, 170170 and 172. The variation in the pattern of oxidation of the alkenylfurans
167, 169 and 171 no doubt reflects the impact the ester/ aldehyde functional group has
in deactivating the furan ring towards epoxidation in 171 relative to 162, i.e. behaving
as a vinylogous carbonate.l" Attempts were made to form the enol ether fragment
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1733 from 172 via epoxide ring-opening and quenching the intermediate oxonium
species using p-TSA in methanol. The product obtained after work-up and
chromatography, showed 'n NMR spectroscopic data, DII 6.59 ppm for the a,p-
unsaturated carbonyl and DH 3.95 ppm for the enol ether, and the compound was
assigned to the enol ether structure 173a. This result was supported by the formation
of the enol ether 173b produced by running the oxidation reaction under different
conditions. When the furan 171 was oxidised with DMDO at -40 QCand the reaction
was warmed to room temperature the main product isolated was the enol ether 173b
having IH NMR spectroscopic data, DH 6.56 ppm and Dc 108.7 ppm for the a,p-
unsaturated ester and DH 4.43 ppm and Dc 74.5 ppm for the enol ether substituent.
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Scheme 28. Reagents and conditions: (a) mCPBA, CH2CI2, r.t., 2 hrs, 85%; (b) mCPBA, CH2CI2, r.t., 2
hrs, 43%; (c) DMDO, Me2CO, -40°C, 2.5 hr, 84%; (d) p-TSA (cat.), MeOH, r.t., 1 hr, 87%; (e)
DMDO, Me2CO, -40°C to r.t., 15 hr, 70%.
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Comparison could now be made between the NMR spectroscopic data for the enol
ether compounds 173a and 173b and the natural products, 83a, 84 and 85 shown in
S h 107126.127 Th I h .c erne 29.' e eno et er natural products have NMR spectroscopic data
ranging from OH 6.8-7.1 ppm and Dc 139-143 ppm for the CS alkene, and 0]1 4.9-S.4
ppm and Dc 117-121 ppm for the C7 alkene bond. This spectroscopic data differ with
the observed data for the supposed synthetic enol ethers, i.e. 173a and 173b, by a
minimum OH -0.2 ppm and Dc -30 ppm for the CS alkene but OH -0.4 ppm and Dc -42
ppm for the C7 alkene. The differences in NMR spectroscopic data, especially the
carbon data, between the synthetic and the natural enol ether substituents was
worrying and confusing. A further examination of natural products which have been
isolated from the gorgonian octocorals provided an answer. The spectropscopic data
reported for lophodiol B (174)171 and the acetyl analogue 175107 ditTer from the
supposed synthetic enol ether structures by a minimum of OH -0.1 ppm and Dc -2 ppm
for the CS alkene bond, and Oil -1.8 ppm and Dc -0 ppm for the C7 alkene
functionality. The reason for the C7 alkene proton in the lophodiol natural products
174 and 175 being a lot more deshielded, and hence further downfield, in comparison
to the model system 173a and 173b is unknown. Although, the rigidity enforced by
the macrocycle may cause a deshielding effect on this proton by the furan ring and
produce the large difference in IH NMR spectroscopic data. Therefore, comparison
with the analogous models 176a and 176b172 supports the alternative furanmethanol
structure since the minimum differences in NMR spectroscopic data were, OH. -0.0
ppm and Dc -0 ppm for the furans, and OH -0.1 ppm and Dc -2 ppm for the secondary
alcohol functionalities. With both the proton and carbon NMR spectroscopic data for
the intermediates 173a and 173b and lophodiol B (174), showing close similarity, we
concluded that the enol ether functionality i.e. 166was not formed in our reactions.
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Scheme 29. Spectral data for a range of enol ether and furanmethanol natural products, i.e. 83a, 84-85
and 174-175.
Instead, the products of a presumed isomerisation, i.e. the furanmethanols 177a and
177b, were produced. This outcome also relayed back to the corresponding furan
model substrates, 166, 144 and 145 which, after analysis, also suggested that they had
furanmethanol structures (cl 178-180 shown in Scheme 30), and not the enol ether
functionality as originally thought. These observations would also explain why
difficulties were observed when trying to induce the [2+2] intramolecular
cycloaddition of intermediates 179 and 180. Therefore, it is probably unlikely that the
enol ether natural products 83a, 84 and 85 are produced from the corresponding
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epoxyfuran substrates because acid-catalysed epoxide ring-opening produced the
vicinal dial functionality seen in lophodiol B (174).
R = Me 177a
R = H 177b
178
R = H, R' = CHO 179
R = Me, R' = C(OMe}z 180
Scheme 30. Corrected structures for the furanmethanol intermediates 177-180.
The vicinal diol methyl ether 177a was formed upon treatment of the epoxyfuran 172
with p-TSA in methanol. This result was complemented by altering the conditions to
aqueous 2M HCI in OCM in order to obtain the corresponding chlorohydrin 177c
(Scheme 31) with IH NMR spectroscopic data, bH 6.67 ppm and be 110.7 ppm for the
furan and bH 4.84 ppm and be 64.8 ppm for the chloride functionality. A trace
quantity (6%) of the dienedione 181173 was also observed on oxidation of the
alkenylfuran 171 at room temperature alongside the major product, i.e. the vicinal diol
177b.
The vicinal diol methyl ether 177a, the vicinal diol 177b, and the chlorohydrin 177c
are presumed to be formed via straightforward opening of the epoxide 172 (Scheme
32). This could occur by acid-catalysed ring-opening in a SN2 process or via the
stabilised carbocation intermediate 183. Alternatively, nucleophilic quenching of the
oxonium species 184, an isomer of carbocation 183, with subsequent allylic
transposition of the enol ethers 173a, 173b and 173c, would also result in the products I'
177a, 177b and 177c, but no evidence for this pathway was obtained.
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Scheme 31. Reagents and conditions: (a) p-TSA (cat.), MeOH, r.t., I hr, 87%; (b) 2M HCIII", CH2CI2,
r.t., 12 hr, 57%; (c) DMDO, Me2CO, -40 QCto r.t., 15 hr, 70% (I77b), 6% (181).
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Scheme 32. The proposed formation of the furanmethanol products, 177 from the epoxyfuran 172.
The formation of the furanmethanol structures 177a, 177b and 177c occurs via the
epoxyfuran 172 but the vicinal diol 178 is produced via a different synthetic sequence
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utilising the dienedione 163. With the ~-hydroxyketone 165 present in the reaction, it
suggests that the enol ether cyclic hemi-ketal 166 is a transient species en route to the
vicinal diol178 (Scheme 33). Tautomerisation of the ~-hydroxyketone 165 to the enol
ether 166, would then allow the vicinal diol 178 to be produced by either an
intramolecular allylic transposition or intermolecular isomerisation facilitated by
water. These results suggest that the enol ether functionalities seen in 83a, 84 and 85
are not produced by epoxide ring-opening followed by quenching the oxonium
species with water, even though epoxyfurans are prevalent in Nature. The labile enol
ether functionality is probably produced in Nature via Michael addition of water into a
dienedione substituent, with subsequently tautomerisation. All of the enol ether
natural products isolated i.e. 83-85, contain an electron withdrawing functionality at
the C4 position. Therefore, isolation of an enol ether containing compound could be
achieved if this same sequence is applied to the dienedione 181.
o HO
163 165 166 178
Scheme 33. The formation of the vicinal diol178 from the dienedione 163. via the enol ether 166.
The epoxyfuran - based natural products, bipinnatin G (6),6 lophotoxin 5097 and
pukalide 51,98 could be produced from epilophodione 15896 or isoepilophodione B
(159)167 along a similar sequence to that shown in the model dienedione 163. Thus,
hydration of the ~7.8-alkene bond could take place at either face of the enone
functionality of epilophodione 158 or isoepilophodione B (159) leading to the mixed
~-hydroxyketone functionality found within rubifol 185167 (Scheme 34).
Tautomerisation of rubifol 185 would then lead to form the enol ether 186, which
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upon intramolecular nucleophilic addition of the tertiary alcohol into the enol ether
cyclic hemi-ketal functionality would form the epoxyfuran product 187, and release
water. The hydration and tautomerism processes should be reversible, but upon
production of the epoxyfuran 187, derived form the corresponding E_~7,8 -alkene, the
furan and the epoxide functional groups would be orthogonal, rigidifying the
macrocycle, and hence becoming an irreversible process. The epoxyfuran derived
from the Z-~ 7,8 -alkene would have more degrees of freedom and therefore the furan
could destabilise the epoxide function to reverse the process back into the dienedione
158 or 159 via the enol ether 186. The epoxide and the butenolide substituents in the
epoxyfuran natural products, e.g. 6, 50 and 51, are always disposed anti-relative to
each other. The reversibility of the hydration! tautomerism sequence would allow the
macrocycle to find the lowest energy conformation and hence consistently allow the
epoxide functionality to be formed anti to the butenolide substituent.
Another indication that both bielschowskysin 1 and verrillin 2 are most likely
produced from a dienedione functionality via a hydration/ tautomerism sequence, is
the CS tertiary hydroxyl functional groups. The two natural products, 1 and 2 have
opposite hydroxyl group configurations at CS. Originally, this difference was thought
to be derived from iso-bipinnatin G (67) and the bipinnatin G analogue 73 but if this
were true there would be some epoxyfuran natural products which possess an epoxide
functionality syn to a butenolide substituent, like intermediate 67. This is not the case
and all epoxyfuran natural products show the relative configuration displayed in
intermediate 73 (Scheme 35). Therefore, the alcohol geometry shown within the two
natural products could originate via hydration to either face of the ~ 7,8 -alkene bond of
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the corresponding E- or Z-dienedione functionality leading to a rubifol 185167
analogue which possess a C8 hydroxyl group as a mixture of diastereoisomers.
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Scheme 34. Proposed formation of epoxyfurans, e.g. bipinnatin G (6), lophotoxin 50 and pukalide 51,
from dienediones, e.g. epilophodione 158 and isoepilophodione B (159).
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Scheme 35. Proposed epoxyfuran intermediates 67 and 73 used to access bielschowskysin I and
verrillin 2.
Our proposed biosynthesis of bielschowskysin 1 and verrillin 2 is still thought to
occur via transannular processes involving the enol ether intermediates 69 and 74. The
enol ethers 69 and 74 are now thought to be derived from the alkenylfuran
functionality 188a which, upon oxidative ring cleavage of the furan ring, together
with hydration of the ~7,8-alkene bond in the dienedione product 189 and
tautomerisation produce this key intermediate. Further manipulation of the enol ether
functionality could then produce the epoxyfurans, 6, 50 and 51, the furanmethanols,
174 and 175, and the polycyclic natural products, bielschowskysin 1 and verrillin 2, as
summarised in Scheme 36.
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Scheme 36. Proposed transformation of the enol ethers 69 and 74 into a variety of natural products.
The functionalities seen in the model systems have all been observed previously
within furanobutenolide - based cembrane natural products, except for the vicinal diol
178 containing a methyl group at C3 and the dienedione 181 possessing a methyl ester
substituent at C3. The alkenylfuran functionalities are represented by the
furanocembranes sethukarailin 190165 and coralloidolide A (191).174 The epoxyfuran
lopholide 192100 and the Z-dienedione coralloidolide E (160)168 contain the
functionalities observed when alkenylfurans are oxidised. Under acidic conditions
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within an enzyme system in octocorals, lophodiol B (174)171 and rubifol 185167 could
potentially be produced.
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With the disappointment of not being able to isolate an enol ether cyclic ketal
structures under acidic conditions, we questioned whether or not this functionality
could be obtained under base catalysis. Thus, the dienedione 163 was treated with
K2C03 in THF-H20 at room temperature, but again no evidence was obtained for
formation of an enol ether structure. Instead the 4-hydroxycyclopent-2-enone 193 was
isolated in 53% yield, resulting from intramolecular aldolisation (Scheme 37).
193
a b
163 194
Scheme 37. Reagents and conditions: (a) K2COJ, THF, H20, r.t., 20 hrs. 53%;
(b) h, CHCh, r.t., 20 hrs, 90%.
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Interestingly, some of the cembranoids isolated from the coral Alcyonium corallo ides,
also accommodate 4-hydroxycyclopentenone units within their macrocyclic
structures, e.g. coralloidolide F (195).175 It seems highly likely therefore that these
compounds are produced in vivo by straightforward aldolisation of Z-dienedione -
based cembranoids, similar in constitution to 160. Also, in a separate study, and not
surprisingly, when a solution of the Z-dienedione 163 in chloroform was stood in the
presence of iodine overnight, it was isomerised to the corresponding E-isomer 194 in
essentially quantitative yield (Scheme 37). Once again this observation could have
significance in connection with the likely origin of macrocyclic E-dienediones, e.g.
196, from furanocembrane precursors in corals, i.e. by oxidative cleavage of their
furan rings followed by Z- to E-isomerisation of the resulting Z-dienediones.166
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Although an enol ether functionality had not been isolated and characterised in our
studies, we believe that it could have been produced as a transient species. Therefore,
it was hoped that by forming an enol ether cyclic ketal functionality within a
macrocyclic structure, i.e. structures 69 and 74, conformational bias would allow the
anticipated [2+2] transannular cycloaddition process to occur, leading to the natural
products bielschowskysin 1 and verrillin 2.
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Ring-closing metathesis (ReM) approach to
furanobutenolide - based cembranes 188b and 188c
The deceptively simple 14-membered macrocyclic furanobutenolide - based
cembrane structures 188b and 188c are, in fact, very strained due to the furan and
butenolide substitution patterns which are accommodated in the relatively small ring
system. For this reason furanocembrane structures have been challenging synthetic
targets. Since 1975, when pukalide 51 was isolated by Scheuer," a great deal of work
has been produced in this area of research in order to overcome the problems
associated with the ring strain of the macrocycle and to gain perspective into the
chemistry of furanobutenolide - based cembranes. Over the past 34 years several
methods have been utilised to close the furanocembrane macrocyclic structure
including, Nozaki-Hiyama-Kishi (NHK), Wadsworth-Emmons olefination, Stille
cross-coupling and furan ring formation via a radical cascade. All of these processes
produced the required macrocycle of a furanobutenolide - based cembrane compound,
but with varying degrees of success.
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Paquette et. al. have made large efforts in synthesising furanocembrane natural
products. 176-179 Paquette's method to close the furanocembrane macrocycle was by the
use of a chromium mediated Nozaki-Hiyama-Kishi (NHK) macrocyclisation reaction
from an acyclic precursor. This key process was used in a concise and convergent
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route to the natural product, acerosolide 155 (Scheme 38). The synthesis started with
the allylic stannane 197, which was converted over seven relatively simple steps to
the vinyl furan 198. Functional group conversion from the THP-protected allylic
alcohol to the allylic bromide was achieved with bromine in the presence of
di(phenylphosphine )ethane. Subsequent desilylation of this intermediate using
hydrogen fluoride gave the alcohol 199. The newly formed alcohol function was then
oxidised to the aldehyde 200 using PDC in DCM. This produced the precursor for the
macrocyclisation reaction containing both an aldehyde and an allylic bromide
functional group. The key NHK macrocyclisation event180-182was achieved by
treatment of the precursor 200 with CrCh in THF at room temperature for 36 hours.
During this period of time the allylic bromide 200 underwent transformation into an
allylic chromate species which subsequently coordinated to the aldehyde function,
forming a metal-mediated macrocycle. At the periphery of the macrocycle, a 6-
membered ring transition state 201 is formed which exists in two chair conformations.
MacrocycJisation gave rise to the two diastereomeric products 202a and 202b with the
isopropenyl unit and the alcohol being transposed anti to each other, but unfortunately
only a 20% yield was achieved.
The final stage was to oxidise the alcohol functionality formed during the NHK
reaction to the corresponding ketone. Due to the nature of acerosolide 155, only the
product 202a could be used in the final oxidation reaction. Thus, treatment of
intermediate 202a with PDC in DMF produced the natural product acerosolide 155 in
a low 25% yield.
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Scheme 38. Reagents and conditions: (a) dppe, Br2, CH2CI2, 0 "C, 2 hrs, 64%; (b) HF, MeCN, r.t., 3
hrs, 68%; (c) POC, 4 A MS, CH2Ch, 0 -c, 3hrs, 46%; (d) ocr, THF, 20°C, 36 hrs, 20%; (e) POC,
4 A MS, OMF, r.t., 2 hrs, 25%.
The total synthesis of acerosolide 155 achieved by Paquette et al. was based on
previous work reported by Still et al. in 1983,183 which used the NHK
macrocyclisation process to form the 14-membered cembranoid structure of asperdiol
215. The synthesis started with iso-hexenylmagnesium bromide 204 (Scheme 39)
which was added to the substituted tetrolic acid 203 at -78 QC in the presence of
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Li2CuCk This formed the corresponding organocuprate in-situ which, underwent
conjugate addition into reagent 203 to form the corresponding E-hydroxy acid 205.
Protection of the hydroxyl group in 205 as the (benzyloxy)mcthyl derivative followed
by reduction of the carboxylic acid with LiAlH4 produced an allylic alcohol. The
allylic alcohol was subsequently protected as the silyl-ether utilising TBOPS-CI
which formed intermediate 206. The epoxy alcohol 207 was simply formed by an
allylic oxidation using Se02 and 'BuOOH which implemented the hydroxyl group to
direct the stereoselective epoxidation. Mesylation of the epoxy alcohol 207 followed
by displacement using LiBr in acetone generated the epoxy bromide 208. The allylic
selenide 209 produced from geranyl acetate, was doubly deprotonated with LOA, and
the dianion was alkylated at low temperature on addition of the epoxy bromide 208.
The installed phenyl selenium functionality was then simply removed utilising Raney
nickel in acetone, which upon chromatography over AgN03 impregnated silica gel,
formed epoxide 210. To produce the NHK precursor 211, the allylic alcohol 210 was
transformed to the corresponding allylic chloride and the TBOPS-silyl ether was
subsequently deprotected with TBAF. Oxidation of the resulting alcohol to the
aldehyde function was achieved using Mn02 and transformation of the allylic chloride
to the allylic bromide with LiBr in THF produced the NHK precursor 211.
Exposure of intermediate 211 to CrCh under high dilution efficiently affected the
transformation to the two diastereomeric macrocyc1ic compounds 212 and 213 in 64%
yield with a 4: 1 ratio for the required intermediate 213. Finally deprotection of the
(benzyloxy)methyl group utilising sodium in ammonia at -78°C produced the natural
cembranoid asperdiol 215 and the diastereoisomer 214 shown in Scheme 40.
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Scheme 39. Reagents and conditions: (a) 204, Li2CuCI4, THF, -78 QC to r.t., 75%; (b) BnOCH2CI,
ipr2NEt; (c) LiAIH4' Et20; (d) TBDPS-CI, 1m, DMF, 60% (over 3 steps); (e) Se02, tBuOOH; (t)
VO(acach, tBuOOH; (g) MsCI, Et3N; (h) LiBr, Me2CO, 60% (over 4 steps); (i) 209, LDA, THF,
-55 QC,then 208, -70 QC, 5 mins, 82%; U) Raney-Ni, Me2CO, 95%; (k) (Me2NhP, CCI4, THF, 87%; (I)
IM TBAF, THF, 94%; Cm) Mn02, CH2CI2, 75%; (n) LiBr, THF, 95%.
Work published by Marshall and DuBay in 1994184 towards the rubifolide analogue
221a demonstrated that a Wadsworth-Emmons olefination could be employed as a
macrocyc1isation process in order to construct the furan functionality (Scheme 41).
The synthesis began from the THP-protected allyJic alcohol 216, formed by allylic
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Scheme 40. Reagents and conditions: (a) CrCI2, THF, r.t., 6 hrs. 64%; (b) NalNH) -78°C, I min, 51%.
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oxidation of geranylacetone with Se02-'BuOOH and protection of the resulting
alcohol substituent. Deprotonation of TIPS-protected propargyl alcohol with nBuLi
formed the lithiated species which underwent addition into the ketone functionality of
intermediate 216 to form the tertiary alcohol substituent. The allylic alcohol 217 was
produced by protection of the alcohol functionality as its MOM-ether followed by
deprotection of the primary alcohol functional group with PPTS in MeOH. The
isopropenyl substituent could now be introduced by a homologation procedure.
Treatment of the allylic alcohol 217 with trimethylorthoacetate induced the Johnson
orthoester rearrangement'V to form the ester 218 in 97% yield as a 1:1 mixture of
diastereoisomers. The aldehyde 219 was then formed from the intermediate 218 via
addition of the lithiated diethyl ethylphosphonate species into the ester substituent,
deprotection of the propargyl alcohol with TBAF-AcOH and finally oxidation
utilising the Swern protocol. The Wadsworth-Emmons macrocyclisation process'i'"
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could now be examined. Thus, treatment of the aldehyde 219 with DBU and Liel at
room temperature induced the olefination process to form the macrocyclic enone 220
albeit in an unoptimised 42% yield. Reduction of the enone functionality with
DIBAL-H and treatment of the corresponding allylic alcohol under basic conditions
induced formation of the furan ring to produce the fuanocembrane rubifolide analogue
221a in high yield.
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Scheme 41. Reagents and conditions: (a) 3-[(triisopropylsilyl)oxy]-I-propyne, "BuLi, THF, O°C, 15
mins, then 216, THF, -78°C to 0 -c, 2 hrs, 71%; (b) iprzNH, MOMCI, CHzCb, 0 -c, 6 hrs. 88%; (c)
PPTS, MeOH, r.t., 24 hrs, 62%; (d) trimethylorthoacetate, propionic acid, 140 "C, I hr, 97%; (e) ethyl
diethylphosphonate, nBuLi, THF, -78 -c, 15 mins, then 218, -78 -c to 0 -c, 15 mins, 70%; (t) TBAF,
MeC02H, THF, 0 -c to r.t., 2.5 hrs, 89%; (g) oxalyl chloride, DMSO, EtJN, CH2CI2, -78 cC to r.t., 5
mins, 99%; (h) DBU, LiCI, MeCN, r.t., 2 hrs, 42%; (i) DIBAL-H, EtzO, -78 -c, 15 mins, 93%; (j)
tBuOK, 18-crown-6, tBuOH, THF, r.t., 1.5 hrs, 88%.
In 2007 Darias et al. isolated (+)-deoxypukalide from the Pacific octocoral
Leptogorgia Sp.,186originally in 2001 Marshall and Van Devender synthesised its (-)-
enantiomer 232.187The synthetic material correlated structurally and stereochemically
to the natural substance but deviated in optical rotation, having an equal but opposite
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value. This recently isolated furanobutenolide is similar structurally to pukalide 51l)!!
except it is devoid of epoxy functionality at the C7,C8 position. This synthesis was
achieved using a carbanion displacement of a propargylic iodide function to form the
macrocycle in the initial stages, which was then later reacted with silver (I) nitrate to
form the butenolide fragment in the final stages (Scheme 42 and Scheme 43). The
synthesis started with the acyclic precursor 222, which was subsequently deprotonated
at the p-keto ester position to allow an SN2 displacement of the iodide. Selective
cleavage of the TBS-ether group in intermediate 222 was achieved slowly using PPTS
in ethanol over a 10 day period to produce the a-hydroxyl alkyne macrocycle 223.
Oxidation of the alcohol function was simply achieved with Oess-Martin periodinane
(OMP) to give the ketone 224. Exposure of the ketone 224 to silica gel in hexanes
produced the carboxy furan 225 in one, high yielding step. Reaction with Comins'
pyridyl triflimide reagent 226188 gave a mixture of diastereomeric enol triflates, which
rearranged through Pd-catalysed coupling with Me2Zn to give the trisubstituted Z-
alkene function. Removal of the OPS-protecting group using TBAF afforded the
alcohol 227. Oxidation, again using OMP, simply converted the alcohol 227 into the
ketone 228 in high yield.
The completion of the (-)-deoxypukalide 232 synthesis is shown in Scheme 43. The
ketone 228 was selectively reduced using K-selectride, which gave rise to the single
diastereomeric, cis-propargylic alcohol and conversion to the trifluoroacetate
functional group gave the intermediate 229. Palladium catalysed carbohydroxylation
produced the allenoic acid 230 which, without purification, was reacted in the
presence of 10% AgN03 on silica gel in hexanes to produce the butenolide fragment
231. Finally, functional group inter-conversion from the tert-butoxy ester to the
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carboxylic acid ~SIng high temperature pyrolysis followed by conversion to the
methoxy ester using TMS-diazomethane produced (-)-deoxypukalide 232.
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Scheme 42. Reagents and conditions: (a) KOtBu, THF, -78 QC, 83%; (b) PPTS, EtOH, 10 days, 80%;
(c) DMP, Et3N; (d) silica gel, hexanes, 96% (over 2 steps); (e) 226, LiHMDS, 75%; (f) Me2Zn,
Pd(PPh3)4, 91%; (g) TBAF. 85%; (h) DMP, Et3N.
Earlier work from our own research group aimed to synthesise a furanocembranoid
structure 221h via a novel free-radical cascade approach (Scheme 44).189 The
hesi '1' did' I . 190191 . d 14 d. .. I Isynt eSISun ise an acy ra rca species ' to In uce a -en a-tng mtramo ecu ar
macrocyclisation to produce the furan substituent of the rubifolide analogue 221 h.
The synthesis commenced with the allylic alcohol 233, produced by regiospecific
allylic oxidation of methyl (E,E)-famesoate on treatment with Se02 and tBuOOH. The
alcohol functionality of the allylic alcohol 233 was converted into a vinyl ether, which
upon heating induced a Claisen rearrangernent'" to form the corresponding y,o-
unsaturated aldehyde. Treatment of the aldehyde with isopropenylmagnesium
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Scheme 43. Reagents and conditions: (a) K-selectride; (b) TFAA; (c) Pd(PPh)4, CO, 2,6-lutidine,
TFA,O -c, THF, H20; (d) 10% AgNO), silica gel, hexanes, 58% (over 3 steps); (e) 210°C; (f)
TMSCHN2, 92% (over 2 steps).
bromide at 0 QCnext formed the carbinol 234 in good overall yield. The selenoester
235 was produced by protection of the secondary alcohol as its TBS-ether,
sponification of the methyl ester to the corresponding carboxylic acid and treatment
with phenylselenol in the presence of 1,1' -carbonyldiimidazole (COl) to form the
required selenide product. Deprotection of the intermediate 235 was achieved with
TMS-OTf at -90 QC to form the secondary alcohol functionality, which upon
treatment with PCC underwent oxidation leading to the enone radical precursor, 236.
Finally, a refluxing solution of the selenoester 236 was treated with tributyltin hydride
and AIBN for 3 hours and upon work-up and chromatography the dione 237 was
produced as a I: I mixture of diastereoisorners, in a combined 40% yield. The dione
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237 was then subjected to acidic conditions, i.e. TsOH in ref1uxing CHCh, and gave
the furanocembrane macrocyclic structure 221bin 50% yield.
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Scheme 44. Reagents and conditions: (a) H2C=CHOEt, Hg(OAc), reflux, 16 hrs, 79%; (b) 140 QC, 2
hrs, 97%; (c) isopropenylmagnesium bromide, THF, 0 QC,30 mins, 82%; (d) TBSCI, lm, DMF, r.t., 18
hrs, 90%; (e) K2C03, MeOH, reflux, 18 hrs, 49%; (f) PhSeH, Im2CO, DMF, r.t., 2 hrs, 61%; (g) TMS-
OTf, CH2CI2, -90 QC,25 mins, 95%; (h) PCC, CH2CI2, -85 QCto r.t., 20 hrs, 41%; (i) BU3SnH, AIBN,
PhH, reflux, 3 hrs, 40%; U) TsOH, CHCI3, reflux, 3.5 hrs, 50%.
Later, bis-deoxylophotoxin 24i70.193 was synthesised in our group using a Pd-
mediated Stille cross-coupling reaction':" to form the furanocembrane macrocycle at
the 5-position of the furan ring (Scheme 45). The synthesis started with (R)-
epichlorohydrin and ethyl 2-bromomethyl-3-furoate to synthesise the a-
phenylselenolactone 238 and the stannylfuran 239, in 8 steps and II steps,
respectively. These two fragments were then coupled together by deprotonation of the
lactone ring 238 using LiHMDS followed by addition of the aldehyde 239, which
generated the alkylated product 240. The phenylselenide residue was selectively
eliminated into the lactone ring of 240 by oxidation using H202 to generate the
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butenolide substituent. Macrocyclisation was then achieved by an intramolecular
Stille cross-coupling reactionl94,195 to generate the trisubstituted alkenylfuran function,
which was acetylated in-situ to give a mixture of acetyl protected, furanocembrane
epimers 241, but only in 20% yield. Subsequent removal of the TBS group on the
furan using CSA in methanol revealed the alcohol, which allowed the acetyl protected
diastereoisomers to be separated. Finally, the separated a-acetate epimer was oxidised
using DMP in DCM to produce the furanocembrane bis-deoxylophotoxin 242.
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Scheme 45. Reagents and conditions: (a) 238, LiHMDS, -78 QC, 10 mins; then 239, 50 mins, 93%; (b)
H202, CH2Chi pyridine, 1 hr; (c) Asl'h-, Pd-dba., 40 QC, 14 hrs, 20%; (d) AC20, Et)N, DMAP, r.t., 4
hrs, 54%; (e) CSA, MeOH, CH2CI2, 3 hrs, 0 QC,78%; (t) DMP, pyridine, CH2CI2, 3 hrs. 0 QC,61%.
A synthesis of racemic bipinnatin J (5) was first published by Trauner et al. 196 in 2006
using a nine step stereoselective sequence (Scheme 46). The synthesis utilised an
Alder-ene reaction, a Stille cross coupling and NHK macrocyclisation to establish the
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furanocembrane structure. The synthesis started with commercially available 3-
butynol 243 which underwent zirconium-mediated carboalumination. Chelation
controlled isomerisation at elevated temperature of the aluminium species followed by
iodination produced the Z-vinyl iodide 244a.197 Oxidation of the alcohol function in
244a was achieved using DMP in DCM to form the sensitive p,y-unsaturated
aldehyde 245a. A lithiated ethyl propiolate species was then directly added to the
reactive aldehyde 245a leading to the propargylic alcohol 246a. The next stage was a
ruthenium (H)-catalysed enyne reaction, which was later described as a Trost Alder-
ene reaction.146 The alkyne function installed in intermediate 246a was reacted with
allyl alcohol 110 and under the reaction conditions the resulting enol tautomerised to
the terminal aldehyde 247a and the butenolide was formed from the y-hydroxy a,p-
unsaturated ester via intramolecular transesterification. A Wittig reaction on aldehyde
247a with phosphorane 111198produced an a,p-unsaturated aldehyde function which
was subsequently reduced using NaBH4 leading to the allylic alcohol 248a. The
previously installed vinyl iodide function was then used in an intermolecular Stille
cross coupling reactionl31,194.195with the stannylfuran aldehyde 249 to produce the
alkenylfuran aldehyde 250 in high yield. Finally, conversion of the allylic alcohol 250
to the corresponding allylic bromide using NBS in the presence of PPh3 produced the
precursor 251 to (±)- bipinnatin J (5).
The final stage in the synthesis was the intramolecular NHK couplingl80-182 in the
presence of CrCh and NiCh which produced bipinnatin J (5) in greater than 9: 1
diastereomeric ratio and in 59% yield. This result suggested that one of the 6-
membered chair transition states (similar to that shown in the synthesis of acerosolide
155) was lower in energy and was hence formed preferentially.
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Scheme 46. Reagents and conditions: (a) AIMe3, CP2ZrCI2, CH2Ch, r.t., 72 hrs, then 12,-30°C to r.t., 3
hrs, 60%; (b) OMP, CH2CI2, NaHC03, r.t., 15 mins; (c) ethyl propiolate, LOA, THF, -78°C, 30 mins,
66% (over 2 steps); (d) allyl alcohol,S mol% RuCp(MeCNhPF(" CSA, THF, Me2CO, 50°C, 90 mins,
52%; (e) 111, PhH, reflux, 12 hrs, 71%; (t) NaBH4' MeOH, 20 mins, r.t., 99%; (g) 249, Pd(PPh3)4, Cui,
CsF OMF, 20 mins, r.t., 92% (h) PPh3, NBS, CH2Ch, -5°C, 20 mins, 87%; (i) CrCI2, NiCI2'OME, 4 A
MS, THF, r.t., 12 hrs. 59%.
In a companion publication, Rawal et al. also reported a total synthesis of bipinnatin J
(5).199 The synthesis used similar chemistry to that previously shown Trauner et al.
and also produced the natural product in racemic form. The total synthesis began with
an allylic oxidation of 5-bromo-2-methyl-2-pentene 252 in the presence of Se02 and
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tBuOOH to produce the E-allylic alcohol 253 (Scheme 47). The allylic alcohol 253
was next protected as its MOM-ether, which then allowed the bromide function to be
easily converted into the corresponding iodide 254 via a Finkelstein reaction. With the
iodide 254 in place, y-butyrolactone 255 was deprotonated using LDA-HMPA at
-78 QCto produce the enolate species which, on addition of the iodide 254 led to the
alkylated y-butyrolactone 256. At this stage the butenolide function was installed by
deprotonation of the y-butyrolactone 256, and upon addition of PhSeCI the reaction
was quenched to form a phenylselenide intermediate. Oxidation of the
phenyl selenium functionality by treatment with H202 allowed for a regioselective
selenoxide elimination to occur to produce the butenolide 257. Finally, the butenolide
257 was elaborated further by y-alkylation. This transformation was achieved by
trapping the enolate of intermediate 257 with TBSCI to produce a siloxyfuran species
258. Addition of the allylic bromide 259 to the siloxyfuran 258 in the presence of
Ag(OCOCF3h allowed y-alkylation to occur successfully under SNI conditions to
produce the y-alkylation butenolide 248b.
The butenolide 248b was then reacted in an intermolecular Negishi cross-coupling
reaction200.201with the dioxolane protected 3-methylfuran aldehyde species 260
(Scheme 48). The cross-coupling reaction produced the unstable alkenylfuran 261,
which upon treatment with the mild acid PPTS, removed both the MOM-ether and the
dioxolane protecting groups to produce the allylic alcohol 250. Addition of CBr4 and
Ph3P transformed the allylic alcohol into the corresponding allylic bromide 251 which
NHK I· . 180181 d d . bini . hupon macrocyc isanon:": pro uce racemic ipmnatm J (5), Wit out
incident, in a respectable 73% yield.
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Scheme 47. Reagents and conditions: (a) Se02, tBuOOH, CH2CI2, r.t., 12 hrs, 67%; (b) MOMCI,
ipr2NEt, CH2CI2, r.t., 3 hrs, 91%; Cc) Nal, Me2CO, r.t., 12 hrs, 100%; Cd) 255, LOA, THF, HMPA,
-78 QC,then 254, 90 mins, 72%; (e) LOA, THF, HMPA, -78 QC,then PhSeCI, 30 mins, 66%; (t) H202,
THF, r.t., 12 mins, 82%; (g) LOA, THF, HMPA, -78 QC,then TBSCI, 20 mins, 100%; (h) 259, CH2CI2,
Ag(OCOCF3h, -40 QCto r.t., 4 hrs, 60%.
The first synthesis of (+ )-intricarene 4 was achieved by our research group using an
independent synthesis which started from chiral bipinnatin J (5).110 The synthesis of
(- )-bipinnatin J (5) starting from (+)-glycidol 262 which was first reacted with the
anion of TMS-acetylene to generate an alkyne intermediate that upon treatment with
K2C03 removed the TMS group and formed the vicinal diol 263. The vicinal diol 263
was next reacted under Negishi's anti-carboalumination conditions to form the Z-
vinyl iodide 264.197 Selective tosylation of the primary alcohol in 264, followed by
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treatment with K2C03 produced epoxide 265 (Scheme 49). The epoxide 265
generated was then used later in the synthesis.
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Scheme 48. Reagents and conditions: (a) 260, PdCl2dppf, THF, r.t., 1 hr, 100%; (b) PPTS, 'BuOH,
90 DC, 8 hrs, 81%; (c) CBr4, CH2CI2, PPhJ, 0 QC, 8 mins, 68%; (d) CrCI2, 4 A MS, THF, r.t., 16 hrs,
73%.
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Scheme 49. Reagents and conditions: (a) TMS-actylene, "8uLi, BFJ·OEt2, -78°C to -30 "C, 19 hrs,
97%; (b) K2CO.h MeOH, THF, r.t., 8 hrs, 92 %; (c) AIMeJ, Cp2ZrCI2, (CH2CIh, reflux, 72 hrs, then '2,
THF, -30°C to 0 DC,3 hrs; (d) TsCI, Pyridine, 0 QC, 3hrs, 48% (over 2 steps); (e) K2C01, MeOH, r.t.,
90 mins, 73%.
The synthesis of the second fragment started by acid catalysed addition of methanol
into o-velarolactone 266 (Scheme 50). The alcohol produced from this reaction was
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then oxidised using PCC which gave aldehyde 267. Wittig olefination of the aldehyde
267 using the formyl phosphorane 111198 in reflux benzene produced the a,~-
unsaturated aldehyde 268. The a-selenylester 269 was then easily produced by Luche
reduction of the a,p-unsaturated aldehyde 268 to form the allylic alcohol which was
subsequently protected in the form ofa TBS-ether group. Finally, deprotonation of the
ester formed the lithium enolate which, on addition of PhSeBr produced the a-
selenylester 269. A second deprotonation of the a-selenylester using NaHMDS
followed by addition of the previously synthesised epoxide 265, aided by BF3·0Et2,
gave alcohol 270. Acid catalysed lactonisation between the alcohol and the methyl
ester substituents produced the y-lactone which was sequentially treated with 11202to
induce a .\yn-elimination of PhSeOH and produce the key butenolide function. An
acid catalysed deprotection of the TBS group using PPTS in MeOH-DCM produced
vinyl iodide 248c.
At around the same time, i. e. May 2006, Trauner et al. were also working towards an
enantioselective synthesis of (+)-intricarene 4 via (- )-bipinnatin J (5).111 Their
synthesis is shown in Scheme 51 and produced the same vinyl iodide intermediate
248c but utilising an Alder-ene process. The synthesis started from 3-butyne-l-ol 243
which was subjected to AlMe3 and Cp2ZrCh in refluxing DCE to allow an anti-
carboalumination to occur.!" Subsequent in situ quenching with h in THF at -30 QC
produced the Z-vinyl iodide 244a. Oxidation of the alcohol functional group in 244a
using DMP produced the unstable p,y-unsaturated vinyl iodide, to which the lithium
anion of TMS-acetylene was added to produce the propargylic alcohol. Further
oxidation of the alcohol function again using DMP produced the ynone 271. The
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Scheme 50. Reagents and conditions: (a) MeOH, conc. H2S04, reflux, 24 hrs, 77%; (b) PCC, CH2Ch,
r.t., 5 hrs, 76%; (c) 111, PhH, reflux, 24 hrs, 79%; (d) NaBH4, CeCh.7H20. MeOH, 0 °C. 10 rnins,
99%; (e) TBSCl, imidazole, OMF, 0 °C, 10 mins, 90%; (f) LOA, THF, -78°C, 45 mins, then TMSCl,
-78 QC. 30 mins, then PhSeBr, THF, -78 QC to r.t., I hr, 73%; (g) NaHMOS, THF. -78°C, then
BF)·OEt2, 265, -78°C to r.t., 15 hrs, 60%; (h) p-TSA, CH2Clb r.t., 3 hrs; (i) H202• THF. 0 QCto r.t., 90
mins; U) PPTS, CH2CI2• MeOH. r.t., 15 hrs, 62% (over 3 steps).
ynone 271 was subjected to an asymmetric reduction using Midland's (S)-alpine
borane complex202.2o3which re-introduced the propargylic alcohol functionality but in
92% ee. Removal of the TMS group from the acetylene using K2C03 in MeOH gave
vinyl iodide 272. Protection of the propargylic alcohol of intermediate 272 as the
TES-silyl ether followed by deprotonation of the acetylene and quenching with ethyl
chlorofonnate produced a propargylic ester. Deprotection of the TES-group on the
alcohol substituent using HF in MeCN gave the enantiomerically enriched propargylic
alcohol 246b. A Trost Alder-ene reaction between the propargylic alcohol 246b and
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allyl alcohol llO in the presence of a ruthenium catalyst under acidic conditions
generated.I'" in one step, the aldehyde-butenolide 247b. A Wittig olefination on the
aldehyde function in 247b using the ester phosphorane 273 produced the a,p-
unsaturated ester 274 but unfortunately the ee dropped to 88%. Treatment of
intermediate 274 with DIBAL-H reduced both the a,p-unsaturated ester to the allylic
alcohol and the butenolide to the lactol. The reactive lactol formed was then
reoxidised to the corresponding butenolide using POC, which simultaneously caused
the allylic alcohol to be oxidised to an a,p-unsaturated aldehyde. Finally, selectively
reduction of the aldehyde functionality to the allylic alcohol 248c was achieved
utilising NaBH4 in MeOH.
~~
.....~OH
a • 1 ~ b,c,d~ 1l_e_, f-i... 1 IH ~
(~"OH r----- " (~~
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Scheme 51. Reagents and conditions: (a) AIMcJ, CpzZrClz, (CH2CIh, reflux, 72 hrs, then 12, THF,
-30°C to 0 °C, I hr, 60%; (b) OMP, CH2Ch, NaHCOJ, r.t., 15 mins; (c) TMS-actylene, "BuLi, THF,
o °C, 5 mins, then aldehyde, -78°C, 15 mins, 60% (over 2 steps); (d) OMP, CH2Clz, NaHC03, 0 °C, 25
mins; (e) (S)-alpine borane, r.t., 22 hrs, then propionaldehyde, 30 ruins, then 3M NaOH, 30% HzOz,
THF, r.t., 91% (over 2 steps); (f) K2C03, MeOH, r.t., 45 mins, 99%; (g) TESOTf, 2,6-lutidine, THF,
r.t., 20 mins, 93%; (h) LiHMOS, THF, -78°C to -50 QC,90 mins, then ethyl chloroformate, 15 rnins,
97%; (i) HF, MeCN, r.t., 30 mins, 95%; U) allyl alcohol,S mol% RuCp(MeCNhPF6, CSA, THF,
MezCO, 50°C, 90 mins, 52%; (k) 273, CHzClz, r.t., 5 hrs, 84%; (I) OIBAL-H, en.er, -78 °C, 20
mins; (m) POC, CHzCI2, r.t., 24 hrs, 70% (over 2 steps); (n) NaBH4, McOH, 20 rnins, r.t., 99%.
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The vinyl iodide 248c synthesised by Trauner et al. contained the necessary
functionality to be transformed to (- )-bipinnatin J (5). Thus, following the final three
steps shown in Scheme 46, a Stille cross-coupling reactionl94,19Swith 3-methyl-5-
trimethylstannylfuran aldehyde 249,196bromination of the allylic alcohol function and
a diastereoselective NHK180,181macrocyclisation produced (-)-bipinnatin J (5) in a
high 70% yield.
The syntheses by Paquette,I76-179Still,183Traunerl96 and from our own group, 110have
shown that one of the most reliable methods to form furanobutenolide - based
cembranes is via the NHK coupling reaction. Therefore, we aimed to implement a
NHK macrocyclisation process in order to form E-deoxybipinnatin G (188b).
Formation of E-deoxybipinnatin G (188b) will allow attempts to form the enol ethers
69 and 74 via an oxidation! hydration sequence on the alkenylfuran motif embedded
in 188b. The structure of E-deoxybipinnatin G (188b) is similar to bipinnatin J (5)
and hence there was only one alteration to the bipinnatin J (5) synthesis to consider,
that was the presence of the C13 hydroxyl group.
A retrosynthetic analysis shows that starting from E-deoxybipinnatin G (188b),
removal of the C2 acetyl protecting group gives the intermediate 188d which, upon
retro-NHK coupling reaction, leads back to the allylic bromide 275a (Scheme 52).
The allylic bromide 275a is structurally similar to the intermediate 248 used during
the synthesis (-)-bipinnatin J (5). The furan substituent in 275a can be disconnected
utilising an intermolecular Stille cross-coupling between the stannylfuran aldehyde
249 and the vinyl iodide intermediate 276a. The intermediate vinyl iodide 276a could
then be synthesised via an alkylation reaction between either of the aldehydes, 277 or
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278, and the phenyl selenium compound 238, which had been synthesised previously
. h' 170193WIt In our group. .
:> Br
o
R = Ac, R' = Ac 188b
R = Ac, R' = H 188d
275a
O~OR'
SePh
277
o
249
238
OR'
276a
O~OR'
278
238
Scheme 52. Proposed synthesis of the furanobutenolide - based cembrane macrocycle £-
deoxybipinnatin G (I88b).
The synthesis towards the vinyl iodide 276a commenced with commercially available
5-bromo-2-methyl-2-pentene 252 which, on treatment with Se02 and IBu02H induced
a regioselective allylic oxidation process to produce the allylic alcohol 253.199
Protection of the alcohol functionality in 253 utilising TBDPS-Cl and imidazole in
DMF at 0 "C, next gave the silyl-ether 279. Treatment of the intermediate 279 with
potassium acetate in DMF at 100 QC induced SN2 nucleophilic displacement of the
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alkyl bromide substituent, which on subsequent acetyl deprotection with K2C03 in
MeOH gave the alcohol 280.204 Finally, oxidation of the alcohol 280 using Dess-
Martin periodinane produced the p,y-unsaturated aldehyde 277 (Scheme 53).
Br~
a
Br~OH
b
Br~OTBDPS~ ~
252 253 279
1c, d
O~OTBDPS
e
HO~OTBDPS
277 280
Scheme 53. Reagents and conditions: (a) Se02, tBU02H, CH2CI2, r.t., 12 hrs, 70%; (b) TBDPS-CI, 1m,
DMF, 0 -c, 10 mins, 90%; (c) KOAc, DMF, 100 -c, 24 hrs; (d) KzCO), MeOH, r.t., 90 mins, 84%
(over 2 steps); (e) DMP, CH2CI2, r.t., 30 mins, 100%.
With the p,y-unsaturated aldehyde 277 in hand, the aldol process was tested under
several conditions shown in Scheme 54. Deprotonation of the phenylselenyl lactone
238170.193using several bases (LiHMDS, NaHMOS and LOA) followed by addition of
the p,y-unsaturated aldehyde 277 failed to produce the expected secondary alcohol
281; only decomposition products were isolated. Unfortunately similar conditions on
the lactone 282, did not produce any of the required alcohol 283 and, again, only
degradation was observed. Due to the instability of the p,y-unsaturated aldehyde 277
this approach was abandoned in favour of the alternative aldol approach, which
utilises the mono-protected I J-propanal 278 in order to form the vinyl iodide 276a.
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OTBOPS
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d,e
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OTBOPS
277
282 283
Scheme 54. Reagents and conditions: (a) 238, LiHMOS, THF, -78 QC, I hr, then 277, THF, 30 mins;
(b) 238, NaHMOS, THF, -78 QC, I hr, then 277, THF, 30 mins; (c) 238, LOA, THF, -78 QC, I hr, then
277, THF, 30 ruins; (d) 282, LiHMOS, THF, -78 QC, I hr, then 277, THF, 30 rnins; (e) 282, LiHMOS,
TMSCI, THF, -78 QC, I hr, then 277, THF, 30 mins.
The alternative aldol approach towards the vinyl iodide intermediate 276a
commenced with 1,3-propanediol 284a. Several different protecting groups were
investigated, but only the most reliable synthesis is described here (Scheme 55). The
diol 284a was first mono-protected utilising NaH and TBS-CI to produce the TBS-
protected propanol 284b_205Oxidation of the primary alcohol group in 284b was
achieved using POC in OCM and gave the aldehyde 278.206 Deprotonation of the
phenyl selenium compound 238 using LiHMOS produced the corresponding lithium
enolate which, on addition of the aldehyde 278, produced the a-selenoester 285. The
aldol product was then oxidised directly with H202 in the presence of pyridine, which
led to ,\yn-elimination and formation of the epimeric secondary alcohol 286a and
286b.170,193
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HO~OTBS
b
----~~~O~OTBS
284a 284b 278
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238
+
d
OTBS
..
OTBS OTBS
286a 286b 285
Scheme 55. Reagents and conditions: (a) NaH, TBSCI, THF, r.t., 90 mins, 82%; (b) POC, CH2Ch, r.t.,
24 hrs, 38%; (c) 238, LiHMOS, THF, -78°C, then 278, I hr; (d) H202.H20, pyridine, CH2CI2, r.t., I hr,
59% (over 2 steps, for major diastereoisomer).
The relative configurations of the diastereoisomic alcohols was unknown. Hence, one
of the butenolides was chosen arbitrarily and treated with TBS-OTf in the presence of
2,6-lutidine as base (Scheme 56). The doubly TBS-protected alcohol 286c was then
transformed into the primary alcohol 286d via selective deprotection, under the mildly
acidic conditions of PPTS in MeOH and Df.M, With the primary alcohol accessible it
could be easily oxidised to the aldehyde functionality with Dess-Martin periodinane.
The aldehyde 287 could now be exposed to a variety of conditions with both
stabilised phosphoranes 111198 and 273 to try to induce the Wittig reaction and form
the a,~-unsaturated carbonyl compounds.
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Scheme 56. Reagents and conditions: (a) TBSOTf, 2,6-1utidine, CHzClz, -78 DC, 90 mins, 87%; (b)
PPTS, MeOH, CH2Clz, r.t., 15 hrs, 86%; (c) DMP, CH2Clz, r.t., 30 mins; (d) 273, THF, r.t., 24 hrs, 95%
(over 2 steps).
Initial results demonstrated that the Wittig reaction had to be run at room temperature
since, on heating, the aldehyde intermediate 287 decomposed. The use of the formyl
phosphorane 111198 caused decomposition of the aldehyde 287 even at this reduced
temperature. Therefore, attention shifted to the more reactive ester phosphorane 273,
which gave more positive results when exposed to the aldehyde 287. Treatment of the
aldehyde 287 with the phosphorane 273 in THF produced the a,~-unsaturated ester
288 at room temperature, in a excellent 95% yield for both the oxidation and Wittig
processes. This transformation was also quickly tested utilising a Peterson olefination
reaction (Scheme 57). Deprotonation of the silyl imine 289 with sec-BuLi at -78°C
generated the lithium enamate which on addition into the aldehyde 287 forms the a,~-
unsaturated imine. Addition of TFA caused the imine to hydrolyse to the
corresponding a,~-unsaturated aldehyde 290. Unsurprisingly the use of this highly
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basic silyl imine 289 caused the aldehyde 287 to decompose and no product was
observed.207-209
ND a, bTESyl )( .. hO
OTBS
287 289 290
Scheme 57. Reagents and conditions: (a) 289, sBuLi, THF, -78 -c. 30 mins, then 287, THF, -20 -c, 2
hrs; (b) TFA, THF, r.t., 2 hrs.
The formation of the a,p-unsaturated ester 288 had now been solved but this
simultaneously introduced a new problem; the a,p-unsaturated ester function must be
reduced selectively in the presence of the butenolide substituent, which itself
possesses an a,p-unsaturated ester functionality. This reduction could prove difficult.
The final stage in the synthesis of the vinyl iodide 276a was the transformation of the
a,p-unsaturated ester 288 to the corresponding allylic alcohol. Several conditions
were tried for this transformation (Scheme 58). Initially, LiAlH4 and Super hydride
were used, but these reducing agents were over-powering and caused decomposition.
The a,p-unsaturated ester 288 was then treated with DIBAL-H. Initial results
suggested that both the a,p-unsaturated ester and the lactone functional groups had
been reduced to the corresponding allylic alcohol and the lactol respectively.
Subsequent manipulation to try to form the vinyl iodide 276a in a similar manner to
Trauner et al. III produced unsatisfactory results. The reduction of the vinyl iodide
276a, was unsuccessful, therefore, it was thought that the a,p-unsaturated ester 288
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could be saponified to the a,~-unsaturated carboxylic acid 291, which could in turn be
selectively reduced to corresponding allylic alcohol substituent.
a,b,c
)(
OH
288 276a
Scheme 58. Reagents and conditions: (a) LiAIH4' THF, 0 °C, I hr, 0%; (b) Super Hydride, THF,
-78°C, I hr, 0%; (c) DIBAL-H, DCM, -78°C, 15 mins, 0%.
Saponification of the a,~-unsaturated ester 288 was tested under a variety of
conditions shown in Scheme 59. All reagents which contained a hydroxyl group along
with TMSOK, were too basic for the a,~-unsaturated ester 288, and caused immediate
decomposition. The reagents which did not use a hydroxyl group had varying effects
but unfortunately none produced the required a,~-unsaturated carboxylic acid 291.
The (Bu3SnhO reagent did not react and simply gave back the starting material. The
only reagent to have a positive effect was when the a,~-unsaturated ester 288 was
reacted with TMS-CI and Nal to generate TMS-l in-situ and this removed the TBS-
protecting group from the secondary alcohol.
a-9
X ~
C02Et C02H
OTBS OTBS
288 291
Scheme 59. Reagents and conditions: (a) 2M NaOH (aq.), THF, MeOH, r.t.; (b) NaOH, THF, MeOH,
r.t.; (c) LiOH, THF, MeOH, r.t.; (d) Ba(OH)2.8H20, MeOH, r.t.; (e) TMSOK, THF, r.t.; (t) TMSCI,
Nal, MeCN, reflux, 15 hrs; (g) (Bu,SnhO, MeCN, reflux, 15 hrs.
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All efforts to transform the a,~-unsaturated ester 288 into the vinyl iodide 276a
ending in failure, due to its highly sensitive nature towards basic reagents. Therefore,
an alternative synthetic route towards the vinyl iodide 276a was required.
An area of chemistry that has received a great deal of attention since its discovery is
cross-metathesis (CM) and the ring closing metathesis (RCM) of alkenes.210.211
Originally tungsten was used as the active metal for initiation of alkene
metathesis,212.213but after development, the two processes were commonly facilitated
by either a molybdenum catalyst, i.e. Schrock's catalyst 292,214or a ruthenium based
catalyst, i.e. Grubbs or Grubbs-Hoveyda catalysts (293 - 296).215-220The most
commonly applied catalysts in this area are the Grubbs I st generation 293,215.216and
2nd generation 294 catalysts."?
PCY3
cl",1
,.Ru~
Cl I Ph
PCY3
n
Mes-NyN-Mes
CI",I
,.Ru~
Cl I Ph
PCY3
292 293 294
295 296
Both the CM and the RCM processes occur via a [2+2] cycloaddition between alkenes
to form a ruthenium cyclobutane species, which upon a retro-[2+2] process,
regenerates the olefinic function with the two new functional groups.r" The basic CM
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and ReM reactions using terminal alkenes are shown in Scheme 60. Both processes
connect the alkene functionalities together in a single step, release ethane, and
produce predominantly the more stable E-alkene within the product.
R~ + ~R'
CM
"" R'R~ +
t
[R&:;:J
R~R'
RCM
Scheme 60. Basic processes for cross-metathesis (CM) and ring closing metathesis (RCM).
The Grubbs catalysts have been tested extensively on most substrates and used to
synthesise a wide array of natural products.222-229 Both Clvl and ReM reactions are
highly efficient processes and it was hoped that specifically, the ReM process could
be applied successfully to the furanocembrane structure of E-deoxybipinnatin G
(188b). Therefore, the aim was to implement this process in the formation of the
butenolide functional group, which represents the most obvious point for
disconnection.230-233Starting from the vinyl iodide 276a (Scheme 61) a retro-RCM on
the butenolide gives an allylic ester which can be disconnected further into the allylic
alcohol 297a and the I, I-disubstituted alkene 298. The allylic alcohol 297a could be
produced by addition of a nuc1eophile, e.g. vinyl magnesium halide or a lithiated
acetylene, into the p,y-unsaturated aldehyde 245b, which upon oxidation and
enantioselective reduction would produce the required product. Oxidation of the
known alcohol intermediate 244b will generate the p,y-unsaturated aldehyde 245b.
The I, I-disubstituted alkene 298 could be generated by saponification of the
corresponding ester substituent, functional group manipulation and Wittig reaction
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between the formyl phosphorane 111 and the aldehyde 299. Simple functional group
conversion and a retro-Baylis-Hillman reaction forms the two starting materials,
methyl acrylate 300 and the aldehyde 278. Coupling of the allylic alcohol 297a with
the 1,I-disubstituted alkene 298 will generate the vinyl iodide 276a to allow access to
E-deoxybipinnatin G (188b).
Hot :·f >f0 HO
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Scheme 61. Proposed retrosyntheis of vinyl iodide 276a.
Before the synthesis of the vinyl iodide 276a was initiated, the metathesis process was
tested on a simple model system to ascertain if RCM could be achieved in order to
form a butenolide substituent (Scheme 62). The model system synthesis was started
with a Baylis-Hillman reaction234-237 between methyl acrylate 300 and
propionaldehyde 301 in the presence of DABCO.235 The secondary alcohol function
of the intermediate 302 produced during the Baylis-Hillman reaction, was
subsequently protected using MOM-CI and DIPEA to produce the MOM-ether 303a.
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Saponification of the ester functionality in 303a gave the a,p-unsaturated carboxylic
acid 303b, which was directly coupled with I-buten-3-ol utilising DCC, to produce
the allylic ester 304. The coupling reaction generated the required precursor to analyse
the key RCM process. Fortunately, exposure of the allylic ester 304 to Grubbs 2nd
generation catalyst 294 in refluxing DCM produced the butenolide 305 in a
respectable 67% yield?33
0 0 v \CMeo~~ a bMeO RO
300 301 302 cC;: R = Me 303a
R=H 303b
J:;o !d
o£dyy- ~o e+ oX 4o OH
HO
305 306 304
Scheme 62. Reagents and conditions: (a) DABCO, DMF, r.t., 4 days, 55%; (b) MOMCI, 'Pr2NEt,
CH2CI2, r.t., 24 hrs, 85%; (c) IM LiOH, THF, H20, r.t., 20 hrs; (d) l-buten-3-ol, DCC, DMAP,
CH2CI2, r.t., 24 hrs, 62% (over 2 steps); (e) Grubbs 2nd generation 294, CH2CI2• 40 QC, 24 hrs, 67%
(305) and 23% (306).
The 67% yield produced from the RCM process was also supplemented by a 23%
yield which was due to the dimer 306 formed when the mono-substituted alkene
reacts intermolecularly. This result suggested that with higher dilution and slow
addition of both the precursor 304 and the catalyst 294 that the butenolide could be
potentially produced in a 90% yield.
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The next obvious progression towards the vinyl iodide intermediate 276a was to
produce a model system 308 containing a vinyl iodide to ensure that this functional
group was stable to the Grubbs catalyst and to RCM conditions. The more complex
model system (Scheme 63) began with commercially available 3-butyn-I-ol 243,
which was subjected to AIMe3 and Cp2ZrCh in DCE to allow carboalumination to
occur under Negishi's conditions.r" The aluminium intermediate 307 formed in-situ
was quenched utilising 12 in THF at -30 "C to produce predominantly the E-vinyl
iodide 244b. Oxidation of the alcohol function in 244b was achieved using DMP to
produce the unstable j3,y-unsaturated aldehyde 245b which was immediately treated
with vinylmagnesium bromide at -78 "C to produce the allylic alcohol 297b. The
secondary alcohol substituent of intermediate 297b could then be coupled with the
previously synthesised a,j3-unsaturated carboxylic acid 303b again using DCC.233 The
allylic ester 308 produced from the coupling reaction serves as the precursor for the
RCM process. Therefore, the precursor 308 was treated with Grubbs 2nd generation
catalyst 294217 in refluxing DCM, under high dilution conditions with slow addition
of both the substrate and the catalyst. Fortunately, after work-up and chromatography,
the butenolide 309 was formed in 62% yield as predominantly two separable
diastereoisomers. Limited formation of the dimer was observed. This result
demonstrated that the vinyl iodide function was stable to the RCM conditions and
could therefore be used to form the butenolide on the real vinyl iodide substrate 276a.
At this point, we decided that the NHK macrocyclisation process would give us the
greatest chance of success. To achieve this, simply altering the E-~7.8-alkene bond of
intermediates 188b and 188d to the Z-~7,8-alkene macrocycle 188e and 188f (Scheme
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64) will make the macrocycle less rigid and give more degrees of freedom to allow
the NHK macrocyclisation to occur with maximum effect.
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Scheme 63. Reagents and conditions: (a) AIMe3, CP2ZrCI2, (CH2Clh, reflux, 72 hrs, then 12, THF,
-30 QC to 0 QC, I hr, 81%; (b) DMP, CH2Ch, NaHCO), r.t., 15 rnins; (c) vinyl magnesium bromide,
THF, -78°C, 1 hr. 40% (over 2 steps); (d) 303b, DCC, DMAP, Cl-hCI2, r.t., 20 hrs, 59%; (e) Grubbs
2nd generation 294, CH2CI20 40°C, 24 hrs, 62%.
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Scheme 64. Retrosynthesis of Z-deoxybipinnatin G (188e).
276b 297c
Conversion of the Z-macrocyclic structure of deoxybipinnatin G (188e) through the
retrosynthesis produced the Z-vinyl iodide 276b, which in-tum is produced from the
allylic alcohol 297c. Therefore, the synthesis of Z-deoxybipinnatin G (188e) was
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initiated in an identical manner to the synthesis of (+ )-intricarcne 4 shown by Trauner
et al. (Scheme 51),111 and 3-butyn-l-ol 243 was converted into the propargylic
alcohol272 with 91% ee using {cS}-alpineborane (cl page 85). Attempts were made to
reduce the alkyne functionality in 272 to the corresponding allylic alcohol 297c with
hydrogen in the presence of Lindlar's catalyst.t" Unfortunately all attempts to induce
this transformation failed independent of reaction temperature and time, and only the
starting material was returned (Scheme 65). Further examination of the Lindlar
reduction was undertaken using propargylic alcohol 311,240.241produced by addition
of ethynylmagnesium bromide to benzaldehyde 310 at -78 DC. Lindlar reduction on
propargylic alcohol311 produced the allylic alcohol 312 in 82% yield,242.243but in the
presence of vinyl iodide 244a, only starting materials were returned. This result
demonstrated the vinyl iodide functionality in 272 was inhibiting the catalysts ability
to reduce and form the allylic alcohol 297c.
~'
~
>( •
~
272 297c
cl b ~ c d)
310 311 312
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d d)+ X •
244a 311 312
Scheme 65. Reagents and conditions: (a) H2, Lindlar cat., quinoline, MeOH, 40°C, 24 hrs, 0%; (b)
ethynylmagnesium bromide, THF, -78°C to r.t., 15 hrs, 100%; (c) Hb Lindlar cat., quinoline, MeOH,
40°C, 24 hrs, 82%; (d) H2, Lindlar cat., quinoline, MeOH, 40°C, 24 hrs, 0%.
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To eliminate this problem, the allylic alcohol 297d was synthesised in racemic form
following the same synthetic sequence shown in Scheme 63 for the corresponding E-
vinyl iodide 297b. The synthesis of the a,p-unsaturated carboxylic acid 298 portion is
shown in Scheme 66 and commenced from the simple propanal 278, produced by
TBS-protection of commercially available 1,3-propanediol 284a with oxidation of the
alcohol function utilising the Swem reaction.205,244 The TBS-protected propanal 278
could then be used in a Baylis-Hillman reaction=" with methyl acrylate 300 in the
presence of DABCO to form the alcohol 313a. Protection of the secondary alcohol
functionality in 313a was achieved utilising MOM-CI in the presence of DIPEA as a
base, to produce the MOM-ether 313b. Upon treatment of intermediate 313b with the
mildly acidic conditions of PPTS in MeOH and DCM, the TBS-protecting group was
selectively removed to give the primary alcohol 313c. Oxidation of the alcohol
function was simply achieved using DMP which rapidly formed the aldehyde
substituent. Direct treatment of the aldehyde functional group with the formyl
phosphorane Wittig reagent 111198 produced the a,~-unsaturated aldehyde 314. A
regioselective NaBH4 reduction at 0 QC upon the aldehyde functionality of
intermediate 314 produced the allylic alcohol 315a, albeit in a slightly disappointing
57% yield. Protection of the allylic alcohol 315a as the TBDPS-silyl ether was
achieved utilising the Corey conditions of, TBDPS-Cl and imidazole in DMF,138 to
produce the silyl-ether 315b. The final step to produce the a,~-unsaturated carboxylic
acid 298 was the saponification of the a,~-unsaturated ester 315b using 1M LiOH in
THF-H20.
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Scheme 66. Reagents and conditions: (a) DMP, NaHC03, CH2CI2, r.t., 30 mins; (b) vinylmagnesium
bromide, THF, -78°C, 1 hr, 45% (over 2 steps); (c) DABCO, r.t., 4 days, 51%; (d) MOM-CI, DIPEA,
CH2CI2, 30°C, 24 hrs, 89%; (e) PPTS, CH2CIz, MeOH, r.t., 18 hrs, 85%; (t) DMP, CH2CIz, r.t., 45
mins; (g) lit, PhH, 80°C, 24 hrs, 72% (over 2 steps); Ch) NaBH4' MeOH, 0 QC, 10 mins, 57%; Ci)
TBDPS-CI, 1m, DMF, O°C, 10 mins, 100%; G) IM LiOH, THF, H20 (2: I), r.t., 24 hrs, 100%.
The carboxylic acid 298 could now be coupled with the previously synthesised allylic
alcohol 297d (Scheme 67). Therefore, the allylic alcohol 297d and the u,p-unsaturated
carboxylic acid 298 were treated with Dee in the presence of DMAP as a catalyst to
form the allylic ester 316.233 This produced the metathesis precursor 316 which was
subjected to Grubbs 2nd generation catalyst 294217 in refluxing DeM, under high
dilution conditions (3 mM) and utilising a long addition period (8 hrs). Gratifyingly,
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after a period of 48 hrs under the reaction conditions, the required butenolide
functionality was furnished as separable diastereoisomers 276b and 276c, albeit in a
slightly disappointing 33% yield.23o
o OMOM
HO~OTBDPS
a
OTBDPS297d 298
316
b
+
OTBDPSOTBDPS
o OMOM
276b 27Sc
Scheme 67. Reagents and conditions: (a) DCC. DMAP. CH2Ch. r.t., 24 hrs. 99%; (b) Grubbs 2nd
generation catalyst 294, CH2CI2• 40°C, 48 hrs. 33%.
Both diastereoisomers 276b and 276c have very similar spectral data and it is very
difficult to ascertain which product is due to the anti- and syn-diastereoisomer. For
this reason both the diastereoisomers were utilised in the attempted formation of the
macrocyclic precursor 275b. Thus, the butenolide 276b was deprotected using the
mild HF.Py complex in the presence of extra pyridine as a base to form the
subsequent allylic alcohol 276d. Stille cross_couplingI31,194.195between the vinyl
iodide functionality in 276d and the stannylfuran aldehyde 249 using Pd(Ph3P)4 and
CuI in DMF at room temperature, produced the alkenylfuran aldehyde 317 in 60%
yield. Unlike the previous synthesis of bipinnatin J (5)110.196the Stille reaction had to
be conducted without the use of CsF. With the additive present the allylic alcohol
276d underwent rapid decomposition. The allylic alcohol substituent in 317 could be
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transformed into the corresponding allylic bromide 275b by exposure to CBr4 and
Ph3P in THF. Disappointingly a low yield (40%) was obtained for this reaction and
the material obtained was devoid of the MOM-ether protecting group. This unwanted
side-reaction was presumably due to the formation of a small quantity of HBr during
the reaction which subsequently deprotected the MOM-ether. Reprotection of the
secondary alcohol was attempted with a range of functional groups but all were
unsuccessful. Even though a low yield was obtained for the formation of the allylic
bromide 275b, enough material was generated to test the key NHK macrocyc1isation
process.180-182Exposure of the allylic bromide 275b to CrCb under high dilution
conditions in the presence of 4 A molecular sieves did unfortunately not produce any
of the required macrocyc1ic compound 188g or return any of the starting material
275b. The only material isolated from the reaction was compound 318 produced via
direct reduction of the allylic bromide functionality (Scheme 68). The reason the
macrocycle 188g was not observed is presumably due to the presence of the
secondary alcohol functional group which provides the protic source for the reduction
and simultaneously caused in-situ formation of the stable chromium-oxygen bond.
Quenching the chromium allyl species in this manner stopped the required
macrocyclisation process from occurring via the 6-membered transition state with the
furan aldehyde substituent. Due to the dearth of material further analysis to fully
investigate and alter the outcome of the NHK reaction to produce Z-deoxybipinnatin
G (188e) was not possible.
Unfortunately deoxybipinnatin G (188b/ 188e) could not be produced, which halted
the chemistry to exarmne the proposed biomimetic transformation into
bielschowskysin 1 and verrillin 2.
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Scheme 68. Reagents and conditions: (a) HF.Py, Py, THF, r.t., 24 hrs, 77%; (b) 249, Pd(PPh3)4, CuI,
DMF, r.t., 20 hrs. 60%; (c) CBr4, Ph3P, THF, 0 -c, 30 mins, 40%; (d) c-ci, 4 A MS, THF, r.t., 16 hrs,
0%.
The results obtained utilising the ReM process in the formation of the butenolide
functionality on both model systems, i.e. 305 and 309, and the real substrate 276b
gave hope that it could also be applied as a macrocyclisation process. Therefore, an
alternative synthetic study was run in parallel to the attempted formation of
deoxybipinnatin G (188b/ 188e). The study attempted to form the furanocembrane
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macrocyclic structure of bis-deoxylopholide 319123 utilising a RCM process en route
to plumarellide 3 via the enol ether 81.
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Scheme 69. Proposed formation of enol ether 81, a precursor to verrillin 3, from bis-deoxylopholide
319.
As described earlier in the Discussion (Scheme 33), plumarellide 33 could be
produced from the enol ether 81 which, in-tum, could be formed from bis-
deoxylopholide 319 (Scheme 69). Reduction of the C4 ester group in 319, followed
by directed oxidative cleavage of the furan ring leads to dienedione intermediate 320.
Hydration of the ~ 7,8-alkene bond with subsequent tautomisation next produces enol
ether 321, which upon elimination of the C 13 acetoxy functionality forms the
conjugated butenolide 81, a precursor to plumarellide 3. The furanobutenolide bis-
deoxylopholide 319 contains an E-~7,8-alkene bond to allow implementation a ReM
process directly on the macrocycle. Disconnection of the alkenylfuran moiety in 319,
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as shown in Scheme 70, produces the vinylfuran 322. It was hoped that the
conformational bias inherent in the intramolecular RCM process would induce
formation of the furanocembrane macrocycle 322. Disconnection of vinylfuran 322
gives the aldehyde 323 and the phenylselenide 324, which could be coupled together
in a similar manner to that previously used within the research group during the
synthesis of bis-deoxylophotoxin 242.170,193The two components, i.e. 323 and 324,
could be produced from commercially available furan 326 and the known epoxide
328,193 respectively. The aldehyde intermediate 323 could be produced by
homologation of the ester functionality and implementation of a sp2_sp2coupling, e.g.
a Stille cross-coupling reaction, on the bromofuran 325. Elaboration of the simple
furan, 2-methyl-3-furoic acid 326, via selective bromination processes and a
deconjugative addition should produce the bromofuran 325. Removal of the
phenyl selenium substituent in 324 produces the corresponding lactone 327.
Nucleophilic addition of an isopropenyl functional group into the known epoxide 328,
followed by lactonisation should produce the lactone 327. Coupling of the
phenylselenide 324 with the aldehyde 323 would generate the vinylfuran 322 en route
to bis-deoxylophodione 319.
The synthesis of bis-deoxylopholide 319 started from commercially available 2-
methyl-3-furoic acid 326 (Scheme 71). Treatment of 326 with 2-methylpropene
catalysed by H2S04 resulted in esterification of the carboxylic acid and formation of
the 'butyl ester 329.245Addition of NBS to 329 in DMF next led to bromination at the
5-position of the furan ring which, upon allylic radical bromination with NBS and
AIBN in refluxing CCI4• gave the dibromofuran 330.246,247 Deprotonation of the
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Scheme 70. Retrosynthesis of bis-deoxylopholide 319.
a,p-unsaturated ester 331 using LDA followed by addition of the dibromofuran 330,
allowed a deconjugative SN2 displacement of the allylic bromide substituent, to form
ester 325.193 The tosylate 332 was next produced by reduction of the ester
functionality in 325 using LiBH4 and treatment of the resulting alcohol with Ts-Cl,
Et3N and DMAP. The presence of the tosylate substituent set the stage for a one
carbon homolygation of the side-chain. Thus, treatment of intermediate 332 with
Et4NCN, in DMSO at 60 QCled to displacement of the tosylate and formation of the
nitrile functional group. Addition of TFA saponified the 'butyl ester on the furan ring
to produce the corresponding carboxylic acid 333. Reduction of the nitrile
functionality in the intermediate 333 to the corresponding alcohol 334 was achieved
108
over three relatively simple steps i.e. reduction of the nitrile 333 using DIBAL-H at
-78°C produced the aldehyde functionality, esterification of the carboxylic acid
substituent with TMS-CHN2 in methanol gave the ester and reduction of the aldehyde
with NaBH4 formed the alcohol 334, in a combined 62% yield. The bromofuran
moiety in the alcohol 334 could now be exploited in an intermolecular Stille cross-
coupling reactionl94,195using tributyl(vinyl)tin under Farina conditions, i.e. Pd(OAc)z
and Ph3As in DMF at 45 oC,248which produced the vinylfuran 335. Finally, the
alcohol functionality in 335 was oxidised to the corresponding aldehyde 323 using
OMP. With the aldehyde 323 in hand, attention now turned to the synthesis of the
phenylselenide intermediate 324.
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Scheme 71. Reagents and conditions: (a) 2-methylpropene, H2S04, CH2Ch, r.t., 24 hrs, 68%; (b) NBS,
DMF,O DC, 10 mins, r.t., 20 mins, 50 DC,30 mins, 92%; (c) NBS, AIBN, CCI4, reflux, 12 hrs, 78%; (d)
331, LDA, THF, -78 DC, I hr, then 330, I hr, 58%; (e) LiBH4' Et20, MeOH, 0 DC, 30 mins, 66%; (t)
TsCI, Et3N, DMAP, CH2Clb r.t., 16 hrs; (g) Et4NCN, DMSO, 60 DC, 2 hrs, 78% (over 2 steps); (h)
TFA, CH2Clb 0 DCto r.t., 90 mins; (i) DIBAL-H, PhMe, -78 DC, 15 rnins; U) TMS-CHN2' MeOH, r.t.,
10 mins; (k) NaBH4' MeOH, r.t., 10 mins, 62% (over 4 steps); (I) tributyl(vinyl)tin, Pd(OAcb Ph3As,
DMF, 45 DC, 17 hrs, 100%; (m) DMP, CH2CI2, r.t., 75 mins, 93%.
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The synthesis of the phenylselenide intermediate 324 started from 5-pentenoic acid
336 (Scheme 72), which on treatment with thionyl chloride in methanol first gave the
methyl ester.249.250Epoxidation of the terminal alkene in 336 was achieved using
mCPBA in DCM leading to the epoxide 328 in a combined 75% yield.i" The epoxide
functionality in 328 then underwent Lewis acid catalysed ring opening upon treatment
with BF3'OEt2 and isopropenyl cuprate, generated in-situ from isopropenylmagnesium
bromide and CuCN. This led to a secondary alcohol functionality which upon acid-
catalysed lactonisation produced the lactone 327 in quantitative yield.252
Deprotonation of the lactone 327, utilising LiHMDS, generated the corresponding
lithium enolate species which, on addition of PhSeBr, formed the phenylselenide
intermediate 324. This short synthesis provided the coupling partner to the aldehyde
323.
cod e
336 328 327 324
Scheme 72. Reagents and conditions: (a) SOCIz, MeOH, 0 cC, 25 mins; (b) mCPBA, NaHCOJ,
CH2CIz, r.t., 15 hrs, 75% (over 2 steps); (c) isopropenylmagnesium bromide, CuCN, THF, -78 DC, 30
mins, then BF3'OEt2, 328, THF, I hr, 60%; (d) p-TSA, CH2Ch, r.t., 30 mins, 100%; (e) LiHMDS, THF,
-78 DC, 15 rnins, then TMSCI, 30 mins, then PhSeBr, THF, -78°C to r.t., 30 mins, 51%.
The next stage towards the RCM precursor 322 involved an aldol reaction (Scheme
73). Thus, deprotonation of the phenyl selenide 324 with LiHMDS at -78 DCproduced
the enolate species which, on addition of the aldehyde 323 led to the u-selenoester
337. Oxidation of the phenyl selenium unit in 337 with H202 and elimination of
PhSeOH introduced the alkene bond in the butenolide intermediate 322.193 The
synthesis of the vinylfuran 322 now allowed us to examine the ReM macrocyclisation
process en route to his-deoxylopholide 319.
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Scheme 73. Reagents and conditions: (a) 324, LiHMDS, THF, -78°C, then 323, I hr; (b) H202, H20,
CH2CI2, pyridine, r.t., I hr, 48% (over 2 steps).
It was thought that the secondary alcohol substituent contained within the vinylfuran
322 was not in close enough proximity to the alkene functional groups to cause
interference with the ReM process and hence, protection should not be required. To
give the greatest chance for the ReM process to succeed the 2nd generation catalysts,
i.e. 294 or 296,217.220should be utilised. This is because the Ll-disubstituted alkene
substituent is less susceptible towards the metathesis process. Thus, the vinylfuran
322 was treated with Grubbs 2nd generation catalyst 294 in refluxing OeM, under
high dilution, for 19 hrs but unfortunately the ReM reaction failed to produce the
macrocyclic structure of bis-deoxylopholide 319, shown in Scheme 74. Altering the
solvent, temperature and catalyst loading had no desirable affect on the formation of
the product 319. After work-up and chromatography two 1, 2-disubstituted alkene
compounds, i.e. 338 and 339, were isolated from the reaction mixtures. The first
compound was found to be the phenylvinylfuran 338, which was produced when the
catalyst reacts with the terminal alkene, was then unable to perform the ReM with the
I, l-disubstituted alkene and underwent a Clvl process with the styrene functionality of
the pre-catalyst. The other compound formed was the dimer 339 of the intermediate
II I
322 produced due to the catalysts' inability to react with the I, I-disubstituted alkene,
and undergo an intermolecular eM with another molecule of the vinylfuran 322. The
failure to produce the macrocycle 319 was solely due to the unreactive nature of the
I, l-disubstituted substituent towards all of the metathesis conditions examined.
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Scheme 74. Reagents and conditions: (a) 5 mol% Grubbs 2ndgeneration catalyst 294, CH2CI2, 40°C,
19 hrs; (b) 20 mol% Grubbs 2nd generation catalyst 294, PhH, 40°C, 2 hrs; (c) 20 mol% Grubbs 2nd
generation catalyst 294, PhH, 80°C, 19 hrs.
Unfortunately the attempted ReM did not lead to the furanocembrane macrocycle of
bis-deoxylopholide 319. With the metathesis strategy unsuccessful, another route
towards a furanobutenolide - based cembranes will have to be pursued. Following the
completion of our ReM studies Donohoe et al. published a synthesis of (-)-
deoxypukalide 232 which used two ReM processes.i'"
The 2008 publication by Donohoe et al. complemented the earlier synthetic work of
Marshall et al.187 leading to (- )-deoxypukalide 232.253 Thus Donohoe et al., utilised
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two RCM processes and a Negishi cross coupling reaction, in a concise 12 steps
synthesis of 232 (Scheme 75). The synthesis commenced from S-perillyl alcohol 340,
which had its primary alcohol functional group protected as the corresponding TIPS-
ether. A regioselective ozonolysis of the trisubstituted alkene in the presence of
pyridine and isoprene formed the aldehyde functionality, which upon treatment with a
vinylalane intermediate, generated in situ, produced the secondary alcohol 341.
Formation of the mixed acetal 342 was achieved by treatment of the secondary
alcohol 341 with acrolein diethylacetal under acidic conditions. Exposure of
intermediate 342 to Grubbs 2nd generation catalyst 394217 in refluxing DCM followed
by addition of the mildly acidic PPTS, induced aromatisation of cyclic hemi-acetal
343 next led to the furan 344 in a combined 85% yield. The carboxylic acid 345 was
produced from the furan 344 upon Wittig olefination of the ketone functionality,
deprotection of the primary alcohol with TBAF, and TEMPO oxidation in the
presence of NaCl02 and NaOCI. This fragment was then used in a cross-coupling
process, but first the protected allylic alcohol 297e had to be prepared. A
regioselective sulfonylation was performed on the vicinal diol 264 (previously
prepared in our synthesis of (+)-intricarene 4)110 using a hindered sulfur electrophile,
which upon elimination produced an epoxide functionality. Ring opening of the
epoxide, and alkene formation was achieved upon treatment with trimethylsulfonium
iodide and IlBuLi. Upon protection of the allylic alcohol as its TBS-silyl ether 297e,
by treatment with TBSCI and imidazole in DMF, the stage was now set to combine
the two fragments. Thus, deprotonation at the C5-postion of the furan ring in the
intermediate 345 which, on addition of ZnBr2, quenched the Iithiated species to
produce the zincate in sitU.199 Directed treatment of the zincate with the vinyl iodide
297e and PdCh(dppf) at 50 QC for 4 hours then gave the alkenylfuran
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functionality,200,201which upon deprotection of the secondary alcohol produced the
macrocyclic precursor, i.e. the allylic alcohol 346. Macrolactonisation of the allylic
alcohol 346 was achieved utilising the procedure developed by Shiina et al. 254leading
to the macrocyclic ester 347. Upon exposure of 347 to Grubbs 2nd generation catalyst
in refluxing toluene, the RCM process ensued to form the butenolide functionality and
hence (-)-(Z)-deoxypukalide 232 in 72% yield.
Unfortunately, neither of the attempted NHK reactions and the RCM processes with
intermediates 275b and 322 led to macrocyclisation and the formation of
deoxybipinnatin G (188b/ 188e) and bis-deoxylopholide 319, respectively. In order
for us to evaluate the proposed biomimetic formation of bielschowskysin 1 via the
enol ether cyclic hemi-ketal 69 we now decided that a furanobutenolide - based
cembrane macrocycle must first be produced. This study is described below.
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Scheme 75. Reagents and conditions: (a) TIPSCI, lm, DMF, r.t., 3 hrs, 98%; (b) 0" Py, isoprene,
MeOH, CH2Ch, -78 "C, then Me2S, -78 "C to r.t., 24 hrs; (c) methyl propiolate, DIBAL-H, HMPA,
THF,O "C, 1.5 hrs, then 45 "C, 16 hrs, 49% (over 2 steps); (d) PPTS, acrolein diethylacetal, r.t., I hr;
(e) Grubbs 2ndgeneration catalyst, CH2Cb, reflux, 16 hrs: (f) PPTS, CH2CI2, reflux, 2 hrs, 85% (over 3
steps); (g) BrPh)PMe, nBuLi, THF, r.t., 30 mins, then 344, THF, r.t., 2 hrs, 97%; (h) TBAF, T1-IF, r.t., 2
hrs, 98%; (i) TEMPO, NaC102, NaOCI, MeCN, H20, 35 -c, 48 hrs, 95%; U) Trisylimid, NaH, THF.
r.t., I hr; (k) Me3S), "Bul.i, THF, -ID "C, 3.5 hrs, 85% (over 2 steps); (I) TBSCI, 1m, DMF, r.t., 2 hrs,
97%; (m) 345, LDA, THF, -78 -c, I hr, then ZnBr20 THF, 45 mins, then 297e, PdCI2(dppt), THF,
50 -c, 4 hrs; (n) TBAF, THF, 50 -c, 2 hrs. 78% (over 2 steps); (0) MNBA, Et3N, DMAP, CH2CI2, r.t.,
19 hrs, 73%; (p) Grubbs 2ndgeneration catalyst 294, PhMe, reflux, 16 hrs, 72%.
115
Formation of 19-hydroxyrubifolide 353 via
oxidative cleavage of rubifolide 49
With the problems encountered thus far, it was decided to aim for a simpler
furanobutenolide macrocyclic structure, containing all the relevant functionality in
order to form the cyclobutane tetracyclic core of bielschowskysin 1. Attention turned
to the simplified bielschowskysin core structure 348 shown in Scheme 76, which was
devoid of the C 13-actoxy functionality and the 5-membered ring hemi-acetal between
the C2,C 15 positions. This target structure could be produced by cleavage of the
cyclobutane core via a retro-[2+2] cyc1oaddition into the enol ether cyclic herni-ketal
186. As shown previously, oxidative cleavage of the furan ring of the alkenylfuran 5
would produce the Z,Z-dienedione ofisoepilophodione B (159), which upon hydration
and tautomerism could form the required bielschowskysin core precursor, i.e. the enol
ether 186. The simplified furanobutenolide - based cembrane starting material is the
natural product, bipinnatin J (5) which has been synthesised previously and therefore,
it should be possible to produce the bielschowskysin core 348 via this compound.
To date, the syntheses of bipinnatin J (5) have all been efficient and high yielding, cf.
Trauner's 9 step synthesis.l'" however, following on from the work described earlier,
it was thought that a metathesis process could be implemented to produce an even
more expedient synthesis. The butenolide functionality was again selected as the focal
point for this new metathesis chemistry (Scheme 77). As previously shown, bipinnatin
J (5) can be disconnected back to the vinyl iodide 248c, and our aim now was to form
the butenolide and the allylic alcohol functionalities in a single metathesis process
from the cyclobutene ester 349 and 2-methyl-2-propen-l-ol 350. Esterification of the
previously synthesised allylic alcohol 297c, should form the cyclobutene ester 349.
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Production of bipinnatin J (5) will allow examination of the biomimetic conversion
into the bielschowskysin core structure 348.
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Scheme 76. Retrosynthesis of the bielschowskysin core 348.
Our new approach to a synthesis of bipinnatin J (5) began with the vinyl iodide 244a,
which was produced from Negishi anli-carboalumination of commercially available
3-butyn-I-ol 243 (Scheme 78).197 Oxidation of the primary alcohol group in 244a
followed by addition of vinyl magnesium bromide produced the allylic alcohol 297d in
a combined 45% yield. Treatment of I-cyclobutene-I-carboxylic acid255 with pivaloyl
chloride in the presence of Et3N next formed the mixed anhydride 351 in-situ, which
was then added directly to the deprotonated alcohol functionality in 297d to form the
cyclobutene ester 349.256 Production of 349 allowed the key metathesis process to be
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Scheme 77. Retrosynthesis of bipinnatin J (5) via the vinyl iodide 248c.
analysed. Thus, treatment of the cyclobutene ester 349 with 2-methyl-2-propen-l-ol
350 in the presence of Grubbs 2nd generation catalyst 294,217in refluxing OeM, under
high dilution conditions and with slow addition of both the substrate and the catalyst
produced the butenolide 248a in a surprising 57% yield.256 The butenolide was
produced by addition of the catalyst to the terminal alkene functionality in the
intermediate 349. The catalyst was then able to trigger a simultaneous ReM/ ring-
opening metathesis facilitated by the release of ring strain from the cyclobutene
functional group, and form the butenolide substituent of the transient ruthenium
species 352. Finally, upon eM with 2-methyl-2-propen-l-ol 350 the required vinyl
iodide 248a was produced.257-26oThe substituted vinyl iodide has previously been
shown to be an intermediate in the synthesis of bipinnatin J (5).110,111,196Therefore, we
carried out a Stille cross-coupling between the vinyl iodide 248a and the stannylfuran
aldehyde 249 followed by immediate bromination of the resulting allylic alcohol
functionality to give the macrocycle precursor 25t. Treatment of 251 under the
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standard NHK reaction conditions then produced bipinnatin J (5), along with the syn-
diastereoisomer at Cl, in 70% yield. The formation of bipinnatin J (5) allowed the
biomimetic transformation into the core structure of bielschowskysin 348 to be
examined.
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Scheme 78. Reagents and conditions: (a) DMP, NaHCOJ, CH2CI2, r.t., 30 mins; (b) vinylmagnesium
bromide, THF, -78 QC, I hr, 45% (over 2 steps); (c) LiHMDS, THF, -78 QC, 20 rnins, then 351, THF,
90 mins, 65%; (d) 350, 10 mol% Grubbs 2nd generation catalyst 294, CH2CI2, reflux, 21 hrs, 57%; (e)
3-methyl-5-trimethylstannyl-2-furan aldehyde 249, Pd(PPh1)4, Cui, DMF, r.t., 90 mills. 93%; (f) PPhJ•
NBS, CH2CI20 -5 QC,20 rnins, 83%; (g) c-cr, 4 A MS, THF, r.t., 16 hrs, 70%.
The presence of the hydroxyl group next to the furan ring in 5 posed a problem since
upon oxidative cleavage of the furan ring the dienedione product substituent would
undergo cyclisation into the hydroxypyrone functionality, as shown during our
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groups' synthesis of (+)-intricarene 4.110,111Therefore, the hydroxyl functional group
in 5, along with the corresponding ~yn-diastereoisomer, was removed by treatment
with TFA and Et3SiH at 0 QC to induce an SNl-deoxygenation process leading to
rubifolide 49 as a single diastereoisomer (Scheme 79).111Oxidative cleavage of the
furan ring in 49 was achieved upon addition of a peroxy reagent, i.e. mCPBA, which
led to the dienedione functionality of isoepilophodione B (159). We had hoped that
treatment of the dienedione 159 under the acidic conditions developed in the model
system 163, i.e. p-TSA in THF-H20 would produce either rubifol 185, the enol ether
186 or the bielschowskysin core 348. Unfortunately however none of these structures
were observed. The only compound to be isolated in 40% yield showed signals in the
IH NMR spectroscopic data at bH 4.29 (d, J 16.9) ppm and 4.26 (d, J 16.9) ppm; J3C
DEPT NMR spectroscopic data showed the compound possessed one more CI-h
signal at be 68.3 ppm and one less CH3 signal from be 22.9 ppm, on comparison to
the dienedione 159; IH_IH COSY NMR spectroscopic data displayed a resonance at
8H 6.14 ppm which correlated to 8H 1.94 ppm, indicating that the furan ring had been
re-introduced. Another resonance at bll 4.91 ppm correlated to 811 1.75 ppm, which
indicated that the isopropenyl functionality was still present, and finally, a resonance
at 8H 6.33 ppm correlated to 8H 4.29/ 4.26 ppm and bH 3.17 ppm, indicating that the
there was a trisubstituted t,7,8-alkene bond; mass spectroscopy showed the compound
had a molecular formula of C20H2404, identical to isoepilophodione B (159). All the
data corresponded to the unusual structure of 19-hydroxyrubifolide 353, which on
comparison to the natural product rubifolide 49, displayed similar spectroscopic data.
This assignment was confirmed from the 1H_I3C HMQC and 1H- J3C HMBC NMR
spectroscopic data.
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Scheme 79. Reagents and conditions: (a) TFA, Et3SiH, CH2Ch, 0 QC,20 rnins, 93%; (b) mCPBA,
CH2CI2, 0 QC,90%; (c)p-TSA, THF, H20, r.t., 72 hrs, 40%.
19-Hydroxyrubifolide 353 was thought to have been produced from isoepilophodione
B (159) by protonation of the C3 carbonyl functionality under the acidic conditions
(Scheme 80). Instead of nucleophilic addition of water into the dienedione 159, which
was observed in the model system 163, a tautomerisation processes occurred to
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produce the conjugated enol ether 354. Nucleophilic addition of water into the
conjugated enol ether functionality in 354 facilitated by the acidic conditions, or
intramolecular allylic transposition, simultaneously introduced the alkenylfuran
substituent and the hydroxyl group at C19 of the rubifolide analogue 353.
Interestingly, this has not yet been described in Nature! Possibly more fascinating was
the fact that this was the first furanobutenolide - based cembrane product to possess
oxygenation at the C19 position!
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Scheme 80. Proposed formation of 19-hydroxyrubifolide 353.
Concluding remarks and possible future work
In conclusion, the first model studies with the dienedione 163 set the foundations for
the proposed biomimetic formation of bielschowskysin 1. Initial results demonstrated
that the Z-dienedione functionality in 163 could be transformed into the p-
hydroxyketone 165 and the vicinal diol 178, presumably via the transient enol ether
species 166, under acidic conditions. Utilising iodine induced isomerisation to the
corresponding E-dienedione 194 and finally the 4-hydroxycyclopent-2-enone 193 was
produced under basic conditions. These results highlighted the utility of the
dienedione functionality and the wide array of products which can be obtained. It was
thought these processes could be applied to a macrocyclic structure to gain access to a
range of natural products, particularly, bielschowskysin 1 and verrillin 2.
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Two syntheses were attempted towards the simplified macrocycles 102 and 125, from
the furanmethanol 113a. The route to the first model system 102 was abandoned due
to the difficulties which were encountered with the stabilities of various substrates.
The second synthesis towards the macrocycle 125 proceeded without incident until a
Sml, mediated Reformatsky-type macrocyclisation process proved difficult, but a 14-
membered macrocyc1ic structure 142 was obtained. Due to a dearth of material further
manipulation of the substrate 142 could not be performed. The furan 140b also
underwent oxidative cleavage of the furan ring leading to the enedione 143. Treatment
of the intermediate 143 under aqueous acidic conditions led to the furanmethanols 179
and 180, presumably via the transient enol ether species 144 and 145. No products
due to an intramolecular [2+2] cycloaddition process or Michael addition/ ether-
bridge formation were observed.
This result re-iterated that a macrocyclic structure was required to induce
conformational bias and allow the anticipated [2+2] cycloaddition process between
the enol ether and the butenolide substituent. Therefore, syntheses were attempted
towards the highly oxygenated macrocyclic substrate of deoxybipinnatin G (188b/
188e). The study demonstrated that the presence of the C 13 hydroxyl group makes the
vinyl iodide intermediate 276 a lot more sensitive to basic reagents, in comparison to
248. Initially, the aldol addition of a lithium enolate, i.e. 239 or 282, into the ~;y-
unsaturated aldehyde 277 proved problematic due to the extremely unstable nature of
this intermediate. The next strategy utilised the mono-protected propanal 278 which
successfully underwent the aldol addition and upon oxidation of the phcnylsclcnium
functionality, the a-hydroxyl butenolides 286a and 286b were produced as separable
diastereoisomers. Unfortunately, further elaboration of the alcohol 286a into the
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allylic alcohol 276a gave unsatisfactory results. This disappointing result led us to
examine the use of the ReM process to form the butenolide substituent in 276b.
Initial results were promising as the model allylic esters 304 and 308 were
transformed into the corresponding butenolide substituents 305 and 309 in 67% and
62% yields, respectively. Next, the ReM process was applied to the vinyl iodide
276b. The metathesis precursor 316, generated from 1,3-propanediol 284a and 3-
butyn-I-ol 243, was exposed to Grubbs 2nd generation catalyst 294 in refluxing DCM
and the butenolide functionality of intermediates 276b and 276c was produced in a
disappointing 33% yield. Further elaboration of the butenolides 276b and 276c
produced the macrocyc1e precursor 27Sb but it lacked the protecting group on the
el3-hydroxyl substituent. Unfortunately, the NHK macrocyclisation process failed to
deliver the required macrocyclic furanocembrane 188g and the acyclic structure 318
was observed instead. Further testing of the NHK process could not be achieved due
to the dearth of material.
The route to deoxybipinnatin G (188b/ 188e) was run in parallel to a synthesis of bis-
deoxylopholide 319 using a RCM macrocyc1isation process. It was again hoped that
the conformational bias inherent in the macrocyclic precursor 322 would allow the
anticipated ReM process to occur. Thus, the macrocyclic precursor 322, synthesised
from the aldehyde 323 and the phenyl selenium lactone 324, was treated with Grubbs
2nd generation catalyst in refluxing OeM. Unfortunately, the ReM reaction failed to
produce the required furanocembrane macrocycle 319 under all conditions tested, due
to the lack of reactivity of 1,l-disubstituted alkene functional group in 322.
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Finally, we decided to form the more simple bielschowskysin structure 348 from a
furanobutenolide precursor, i.e. bipinnatin J (5). An expedient synthesis of bipinnatin
J (5) then ensued, which utilised a novel metathesis process to form the vinyl iodide
248a. Further manipulation of 248a produced bipinnatin J (5) which was converted
into isoepilophodione B (159) via rubifolide 49. Treatment of isoepilophodione B
(159) under aqueous acidic conditions failed to form the bielschowskysin core 348
and instead produced the unusual rubifolide analogue 353 via a tautomerisationl
conjugate hydration sequence. The nucleophilic addition of water into the dienedione
functionality in isoepilophodione B (159) could occur to produce rubifol 185,167but
conditions could not be found to induce this transformation.
The aim of the future work will be concerned with generating the natural product
rubifol 185.167 This structure represents the key intermediate in the synthesis of
multiple natural products, especially the bielschowskysin core 348. The analogous
structure which contains an epoxide functionality at the ~ 11.12-butenolide alkene bond
is reported to be the key intermediate in the biosynthesis of coralloidolide B (355),174
C (356),1680 (357)168and F (195).175
o
II """
'UII\
"("
o
355 356 357 195
Rubifol 185 could be produced from the dienedione functionality in 159 by inhibiting
the formation of the conjugated enol ether hemi-ketal structure 354. Therefore, if the
dienedione 159 were to increase the ring strain within the macrocycle, the extra
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rigidity should reduce the production of the intermediate 354. A more rigid
macrocyclic dienedione can be achieved by simply altering the Z,Z-dienedione
functionality in 159 to the corresponding E,Z-dienedione substituent 158. This
dienedione has also been isolated from natural sources, i.e. epilophodione 158. The
macrocyclic structure of epilophodione 158 could be produced from the
corresponding £_L17,8 -alkene isomer 358 of bipinnatin J (5), upon SNl-deoxgenation
and oxidative cleavage of the furan ring. I I I Alternatively, the previously synthesised
isoepilophodione B (159) could undergo isomerisation in the presence of iodine,
similar to that shown for the model dienedione 163.166 This process is less likely to be
selective and could form a complex mixture of four isomeric products. Upon
formation of epilophodione 158 its biomimetic transformation into the
bielschowskysin core 348 could be examined (Scheme 81). Thus, treatment of the
natural product 158 under the conditions developed in the model study, i.e. p-TSA in
THF-H20, should form rubifol 185167 via acid catalysed nucleophilic addition of
water into the C7,C8 alkene bond. Upon formation of rubifol 185, tautomerisation,
isomerisation and transannular [2+2] cycloaddition would produce the
bielschowskysin core 348 via the enol ether cyclic hem i-ketal 186.
Production of the cyclobutane containing structure 348 would then give precedence
for the biomimetic conversion of a furanobutenolide structure into bielschowskysin 1.
Functionalisation of the furanobutenolide - based cembrane E-bipinnatin J (358)
produces E-L17.8-deoxybipinnatin G (188b), which contains all the relevant
functionality to obtain the polycyclic natural product 1. Following the same sequence
as Scheme 81, oxidative cleavage of the furan ring in 188b would produce the
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Scheme 81. Proposed future synthesis of the bielschowskysin core structure 348.
dienedione 359,136 which upon hydration forms the P-hydroxyketone 360 (Scheme
82). Tautomerisation of the intermediate 360 would produce the transient enol ether
69 which via a [2+2] cycloaddition delivers the cyclobutane containing core of
bielschowskysin 71. Finally, selective deprotection of the C2 acetate protecting group
and allylic oxidation of the isopropenyl substituent would form the hem i-acetal
required for the natural product, i.e. 1. Altering this procedure slightly could
potentially deliver verrillin 2 via a Michael addition/ ether-bridge formation. These
bioinspired transformations from E-deoxybipinnatin G (188b) should produce a wide
array of natural products, specifically, bielschowskysin 1 and verrillin 2.
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Scheme 82. Proposed future synthesis ofbielschowskysin I from E-deoxybipinnatin G (188b).
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EXPERIMENT AL
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Proton magnetic resonance chemical shifts (Oil) are recorded in parts per million
(ppm), are referenced to the residual solvent peak (Oil = 7.27 for CHCb), and are
recorded to two decimal places. Abbreviations used in the description of resonances
are, s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br. (broad). Coupling
constants (.1), are reported to the nearest 0.1 Hz. Proton magnetic resonance spectra
were recorded on a Bruker DPX300 (300.13 MHz), Bruker DPX360 (360.13 MHz),
Bruker DPX400 (400.20 MHz), Bruker AV400 (400.13 MHz), Bruker AV(III)400
(400.07 MHz) or Bruker AV(III)500 (500.13 MHz) spectrometer, at ambient
temperature, unless otherwise stated. All assignments are confirmed by IH_IH COSY
and IH_I3CHMQC correlations where necessary.
Carbon magnetic resonance chemical shifts (oc) are recorded in parts per
million (ppm), are referenced to the residual solvent peak (oc = 77.0 for CDCh), and
are recorded to one decimal places. Assignments were made on the basis of chemical
shifts using the DEPT sequence with secondary pulses at 900 and 1350, where
appropriate. In the spectroscopic data, C refers to quaternary carbon, CH to tertiary
methine, CH2 refers to secondary methylene and CH3 to primary methyl. Carbon
magnetic resonance spectra were recorded on a Bruker DPX300 (75.47 MHz), Bruker
DPX360 (90.03 MHz), Bruker DPX400 (100.63 MHz), Bruker AV400 (100.61 MHz)
or Bruker AV(III)500 (125.63 MHz) spectrometer, at ambient temperature, unless
otherwise stated. All assignments are confirmed by IH_I3C HMQC correlations and
DEPT analysis where necessary.
Infra-red spectra were recorded using a Perkin-Elmer FT 1600 spectrometer as
dilute solutions in spectroscopic grade chloroform. Absorption maxima (vmax) of the
major peaks detected are reported in wavenumbers (cm"), quoted to the nearest
integral wavenumber.
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Mass spectra were recorded on a VG Autospec MM-701CF or Mircomass
LCT spectrometer using electron ionisation (El), fast atom bombardment (FAB), or
electro spray (ESI) techniques. High-resolution mass spectra are calculated from the
molecular formula corresponding to the observed signal using the most abundant
isotopes of each element. Only molecular ions and other significant peaks/ fragments
are reported and are quoted as a percentage of the base peak. Some mass spectra were
recorded by the mass spectrometry service. These machines have a tolerance of ±5
ppm and only formulae within ±5 ppm are quoted. All mass spectrometry data is high
resolution and quoted to four decimal places.
Optical rotations were recorded on a JASCO DIP 370 polarimeter and melting
points were measured on a Bibby '" Stuart Scientific SMP3 melting point apparatus.
The melting points given are reported to the nearest QCand are uncorrected.
Thin Layer Chromatography (TLC) was carried out using Merck aluminium
foil backed plates pre-coated with silica gel 60 F254(1.05554.0001). Visualisation was
effected via ultraviolet florescence quenching ("-max = 254 nm) and then developed
with either basic potassium permanganate solution or acidic alcoholic verrillin
solution, followed by heating. Retention factors (R,) are quoted to two decimal places.
Flash column chromatography was performed using ICN silica 32-63, 60 A.
Unless stated otherwise, reactions requiring anhydrous conditions were
conducted under an inert atmosphere of nitrogen in flame-dried or oven-dried
apparatus. When necessary, solvents were dried prior to use. Anhydrous THF was
obtained by distillation from sodium/ benzophenone, under a nitrogen atmosphere, or
via filtration through a nitrogen pressurised, basic, activated, 58 A aluminium oxide
column. Anhydrous OCM was obtained by distillation over calcium hydride, under a
nitrogen atmosphere. Anhydrous diethyl ether was obtained via filtration through a
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nitrogen pressurised, basic, activated, 58 A aluminium oxide column. Anhydrous N.
N-dimethylformamide (DMF) was purchased from Aldrich. Petrol refers to the
fraction of light petroleum ether boiling between 40 - 60°C unless otherwise stated.
Evaporation of solvents was achieved using a Buchi rotavapor R-200.
All reagents used were purified according to C. L. L. Chai and W. L. F.
Armarego "Purification of Laboratory Chemicals" Elsevier Science Plc, fifth edition,
2003 or used as obtained from commercial sources. All chemical were handled and all
procedures were carried out in accordance with the "Organic Chemistry Research
General Safety Manual", Nottingham University, September 2005 booklet.
I thank Dr. C. D. Bray for supplying a sample of the bromofuran 334, and Dr. Yi Li
for the 2D NMR spectroscopic data of 19-hydroxyrubifolide 353.
tert-Butyl-dimethyl-(3-methyl-furan-2-ylmethoxy)-silane 113b
~OTBS
o
tert-Butyldimethylsilyl chloride (6.96 g, 46.2 mmol) was added in one portion to a
stirred solution of (3-methyl-furan-2-yl)-methanol 113a137 (4.71 g, 42.0 mmol) and
imidazole (3.43 g, 50.4 mmol) in anhydrous DMF (11 rnl.) at 0 °C under a nitrogen
atmosphere, and the mixture was then stirred at this temperature for 10 mins. Direct
purification by chromatography on silica gel, using 2% diethyl ether in petroleum
ether as eluent, gave the rBS-protected alcohol (9.13 g, 96%) as a colourless oil.
vmax!cm-I (CHCh solution): 2929, 2857, 1462, 1362, 1059; DJj (400 MHz): 7.29 (d,
1H, J 1.8, CH(O)=CH), 6.20 (d, IH, J 1.8, C=CHCMe), 4.62 (s, 2H, CH20TBS), 2.05
(s, 3H, C=CHCMe), 0.92 (s, 9H, Si(MehC(Meh), 0.09 (s, 611, Si(Meh'Bu): DC (lOO
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MHz): ]49.2 (C), 141.0 (CH), ] ]6.9 (C), 112.9 (CH), 56.0 (Clh), 25.9 (3 x Cl-h),
18.4 (C), 9.8 (CH3), -5.3 (2 x CH3); mlz (El) found ]69.0685 (M! - tBu) (46%),
CgHI302Si requires 169.0679.
5-(tert-Butyl-dimethyl-silanyloxymethyl)-4-methyl-ruran-2-carbaldehyde 117
rl OTBSro~
o
A solution of n-butyllithium (8.9 mL, 22.] mmol, 2.5 M in hexanes) was added
dropwise over 10 mins to a stirred solution of the TBS-protected alcohol 113b (5.01
g, 22.1 mmol) in THF (200 mL) at -78°C under a nitrogen atmosphere. The mixture
was warmed to 0 °C and allowed to stir at this temperature for 30 mins. The mixture
was cooled to -78°C and anhydrous DMF (3.4 rnl., 44.3 mmol) was then added
dropwise over 5 min. The mixture was warmed to room temperature over 4 hrs and
then water (50 mL) and diethyl ether (50 mL) were added. The separated aqueous
phase was extracted with diethyl ether (3 x 50 mL) and the combined organic extracts
were then dried (MgS04) and concentrated in vacuo. Purification by chromatography
on silica gel, using 10% diethyl ether in petroleum ether as eluent, gave the furan
aldehyde (4.34 g, 77%) as a light yellow oil. vmax/cm-I (CHCb solution): 2930,2858,
1682, 1462, 1363, 1079; DH (400 MHz): 9.55 (s, IH, CHO), 7.05 (s, IH,
C(O)=CHCMe), 4.69 (s, 2H, CH20TBS), 2.11 (s, 3H, C(O)=CHCMe), 0.90 (s, 9H,
Si(Me)zC(Me)3), 0.09 (s, 6H, Si(Me)2tBu); 8(' (100 MHz): 177.7 (CH), 156.0 (C),
150.9 (C), ]24.2 (br. C), 120.2 (CH), 56.6 (Clh), 25.8 (3 x CH3), 18.3 (C), 9.6 (Clb),
-5.4 (2 x CH3); mlz (ESI) found 277.]232 (M + Na~), CI3H2203SiNa requires
277.1230.
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tert-Butyl-] 5-(3-( 1,3]dioxolan-2-yl-propenyl)-3-methyl-furan-2-ylmethoxy J-
dimethyl-silane 119
ores
o 0
LJ
A solution of n-butyllithium (4.1 mL, 10.2 mmol, 2.5 M in hexanes) was added
dropwise over 5 mins to a stirred solution of the phosphonium salt 118 (4.52 g, 10.2
mmol) in THF (80 mL) at -78 QC under a nitrogen atmosphere. The mixture was
stirred at this temperature for 40 mins, and then a solution of the furan aldehyde 117
(1.73 g, 6.80 mmol) in THF (30 mL) was added dropwise over 15 mins. The mixture
was warmed to room temperature over 15 hrs, and then water (50 mL) and diethyl
ether (50 mL) were added. The separated aqueous phase was extracted with diethyl
ether (3 x 50 mL) and the combined organic extracts were then dried (MgS04) and
concentrated in vacuo. Pentane (200 mL) was added to the residue which was then
filtered and concentrated in vacuo. Purification by chromatography on silica gel, using
10% diethyl ether in petroleum ether as eluent, gave a 3:2 mixture of E:Z-isomers of
the alkenylfuran (1.73 g, 75%) as a colourless oil. vmax/cm-I(CHCh solution): 2929,
2858,1620; bH (400 MHz): 6.29-6.20 (m, IH, CH=CHCH2), 6.12 (dt, 0.55H,.J 15.9
and 7.1, CH=CHCH2), 6.11 (s, 0.45H, C(O)=CHCMe), 5.99 (s, 0.55H,
C(O)=CHCMe), 5.57 (dt, 0.45H, .J 11.8 and 7.1, CH=CHCH2), 5.02 (t, 0.45H, .14.8,
CH(Oh), 4.97 (t, 0.55H, J 4.6, CH(O)z), 4.60 (s, 0.90H, ClhOTBS), 4.58 (s, 1.1011,
CH20TBS), 4.04-3.96 (m, 2H, OCH2CH20), 3.92-3.84 (m, 2H, OCthCH20), 2.87
(ddd, 0.90H, J 7.1, 4.8 and 1.8, CH2CH=CH), 2.55 (ddd, 1.10H,.J 7.1, 4.6 and 1.1,
CH2CH=CH), 2.02 (s, 1.35H, C(O)=CHCMe) and 1.99 (s, 1.6SH, C(O)=CHCMe),
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0.91 (2 x s, 9H, Si(MehC(Me)J), 0.09 (2 x s, 6H, Si(Me)2tBu); DC (100 MHz): 151.2
(C), 151.1 (C), 148.6 (C), 148.5 (C), 122.7 (CH), 122.2 (CH), 121.7 (CH), 119.7
(CH), 118.5 (2 x C), 113.1 (CH), 110.4 (CH), 103.8 (CH), 103.7 (CH), 65.0 (4 x
CH2), 56.2 (CH2), 56.1 (CH2), 37.7 (CH2), 34.2 (CH2), 25.9 (6 x CH3), 18.4 (2 x C),
9.8 (2 x CH3), -5.2 (2 x CH3), -5.3 (2 x CH3); mlz (ESI) found 361.1796 (M + Na+),
tert- Butyl-(S-(3-[ 1,3)dioxolan-2-y l-propyl)-3-methyl-furan-2-ylmethoxy)-
dimethyl-silane 120
OTBS
o 0
\_j
A suspension of the alkenylfuran 119 (1.79 g, 5.29 mmol) and 5% palladium on
carbon (179 mg) in ethyl acetate (lOO mL) was stirred under 1 atmosphere of
hydrogen at room temperature for 3 hrs. The mixture was filtered through celite,
eluting with diethyl ether, and the filtrate was then concentrated in vacuo. Purification
by chromatography on silica gel, using 10% diethyl ether in petroleum ether as eluent,
gave the furan (1.68 g, 93%) as a colourless oil. vlllax/cm-1 (CHCb solution): 2928,
2858, 1678, 1570; DI1 (400 MHz): 5.80 (s, 1H, C(O)=CHCMe), 4.87 (t, 1H, .J 4.4,
CH(Oh), 4.55 (s, 2H, CH20TBS), 3.98-3.93 (m, 2H, OClhCH20), 3.87-3.81 (m,2H,
OCH2CH20), 2.61 (t, 2H, J 6.9, CH2C(O)=CH), 1.97 (s, 3H, C(O)=CHCMe), 1.79-
0.06 (s, 6H, Si(MehtBu); DC (100 MHz): 154.3 (C), 147.4 (C), 117.5 (C), 108.4 (CH),
104.3 (CH), 64.8 (2 x CH2), 56.0 (CH2), 33.2 (CH2)' 27.8 (C~h), 25.9 (3 x CH]), 22.4
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(CH2), 18.4 (C), 9.9 (CH3), -5.2 (2 x CH3); m/z (ESI) found 363.1961 (M + Na+),
ClsH3204SiNa requires 363.1962.
4-(5-(tert-Butyl-dimethyl-silanyloxymethyl)-4-methyl-ruran-2-yl)-(E)-but-3-en-l-
01 122
OTBS
A solution of n-butyllithium (3.8 mL, 9.43 mmol, 2.5 M in hexanes) was added
dropwise over 5 mins to a stirred solution of the phosphonium salt 121142.143(1.89 g,
4.72 mmol) in THF (30 mL) at -20 QCunder a nitrogen atmosphere. The mixture was
stirred at this temperature for 30 mins and then a solution of the furan aldehyde 117
(l.00 g, 3.93 mmol) in THF (20 mL) was added dropwise over 15 mins. The mixture
was warmed to room temperature over 15 hrs, and then water (40 mL) and diethyl
ether (40 mL) were added. The separated aqueous phase was extracted with diethyl
ether (3 x 40 mL) and the combined organic extracts were then dried (MgS04) and
concentrated in vacuo. Pentane (200 mL) was added to the residue which was then
filtered and concentrated in vacuo. Purification by chromatography on silica gel, using
a gradient of 30% to 40% diethyl ether in petroleum ether (product eluted at 40%) as
eluent, gave the alkenylfuran (0.70 g, 60%) as predominantly the E-isomer. vmax!cm-1
(CHCh solution): 3622, 2929, 2857, 1607; 011 (400 MHz): 6.23 (dt, 1H, .J 15.8 and
1.1, CH=CHCH2), 6.09 (dt, IH, .J 15.8 and 7.2, CH=CHCH2), 5.98 (s, IH,
C(O)=CHCMe), 4.59 (s, 2H, CH20TBS), 3.71 (br. td, 2H, .J 6.5 and 4.0, CH20H),
2.43 (dtd, 1H, J 7.2,6.5 and 1.1, CH2CH=CH), 1.99 (s, 3H, C(O)=CHCMe), 1.80 (br.
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t, IH, J 4.0, CH20H), 0.91 (s, 9H, Si(Me)2C(Me)J), 0.09 (s, 6H, Si(MehtBu); 8c (100
MHz): 151.1 (C), 148.4 (C), 124.8 (CH), 121.3 (CH), 118.6 (C), 110.3 (CH), 61.9
(CH2), 56.0 (CH2), 36.2 (CH2), 25.9 (3 x CH3), 18.4 (C), 9.8 (CH3), -5.2 (2 x CH3);
mlz (ESI) found 319.1691 (M + Na+), Cl6H2S03SiNa requires 319.1700.
7-[S-(tert-Butyl-dimethyl-silanyloxymethyl)-4-methyl-furan-2-yl]-4-hydroxy-
hept-2-ynoic acid ethyl ester 109
OTBS
A suspension of the alkenylfuran 122 (370 mg, 1.25 mmol), triethylamine (0.87 mL,
6.24 mmol) and 5% palladium on carbon (37 mg) in THF (40 mL) was stirred under I
atmosphere of hydrogen at room temperature for 15 hrs. The mixture was filtered
through celite, eluting with diethyl ether, and the filtrate was then concentrated in
vacuo to leave the saturated alcohol as a colourless oil that was used without further
purification. DH (400 MHz): 5.80 (s, IH, C(O)=CHCMe), 4.56 (s, 2H, CH20TBS),
3.65 (t, 2H, J 6.4, CH20H), 2.60 (t, 2H, J 7.1, CH2C(O)=CH), 1.98 (s, 3H,
C(O)=CHCMe), 1.73-1.58 (m, 4H, CH2CH20H and CH2CH2C(O)=C), 1.49 (br. s, 1H,
CH20H), 0.90 (s, 9H, Si(MehC(Me}J), 0.07 (s, 6H, Si(MehtBu).
Tetrapropylammonium perruthenate (22 mg, 0.06 mmol) was added in one portion to
a stirred solution of the crude saturated alcohol, N-methylmorpholine N-oxide (219
mg, 1.87 mmol) and 4 A molecular sieves (670 mg) in DCM (20 mL) at room
temperature under a nitrogen atmosphere. The mixture was stirred at this temperature
for 1 hr and then filtered through celite, eluting with diethyl ether. The filtrate was
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concentrated in vacuo to leave the aldehyde as a light brown oil that was used without
further purification. 8H (300 MHz): 9.76 (t, 1H, J 1.5, CHO), 5.82 (s, 1H,
C(O)=CHCMe), 4.56 (s, 2H, CH20TBS), 2.62 (t, 2H,.J 7.3, CH2C(O)=CH), 2.48 (td,
IH, .J 7.3 and 1.5, CH2CHO), 2.01-1.90 (m, 2H, CH2CH2CHO), 1.98 (s, 3H,
C(O)=CHCMe), 0.90 (s, 9H, Si(MehC(Me)3), 0.07 (s, 6H, Si(Me)2IBu). A solution of
n-butyllithium (1.5 mL, 3.74 mmol, 2.5 M in hexanes) was added dropwise over 2
mins to a stirred solution of diisopropylamine (0.52 mL, 3.74 mmol) in THF (20 mL)
at 0 QCunder a nitrogen atmosphere. The mixture was stirred at this temperature for
20 mins and then cooled to -78 QC, and ethyl propiolate (0.38 mL, 3.74 mmol) was
added dropwise over 5 mins. The mixture was stirred at this temperature for 1 hr and
then a solution of the crude aldehyde in THF (10 mL) was added dropwise over 10
mins. The mixture was stirred at -78 QCfor 1 hr and then water (30 rnl.) and diethyl
ether (30 mL) were added and the mixture was then warmed to room temperature. The
separated aqueous phase was extracted with diethyl ether (3 x 30 mL) and the
combined organic extracts were then dried (MgS04) and concentrated in vacuo.
Purification by chromatography on silica gel, using a gradient of 20% to 30% diethyl
ether in petroleum ether (product eluted at 30%) as eluent, gave the propargylic
alcohol (301 mg, 61%) as a colourless oil. vmax/cm-I (CHCl) solution): 3599, 2929,
2858, 2237, 1709; 8H (300 MHz): 5.81 (s, IH, C(O)=CHCMe), 4.55 (s, 2H,
CH20TBS), 4.51-4.40 (m, IH, CH2CH(OH)C=C), 4.23 (q, 2H,.J 7.1, C02CfhMe),
2.71 (br. s, IH, CH2CH(OH)C=C), 2.65-2.54 (m, 2H, CH2C(O)=CHCMe), 1.97 (s,
3H, C(O)=CHCMe), 1.84-1.74 (m, 4H, CH(OH)CH2CH2 and CfhCH2C(O)=CH),
1.30 (t, 3H, J 7.1, C02CH2Me), 0.89 (s, 9H, Si(Me)2C(Me)3), 0.06 (s, 6H,
Si(MehIBu); 8c (75 MHz): 153.8 (C), 153.4 (C), 147.5 (C), 117.6 (C), 108.7 (CH),
87.7 (C), 76.4 (C), 62.1 (CH2), 61.6 (CH), 56.0 (CH2), 36.1 (Cl-h), 27.4 (CH2), 25.9 (3
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x CH3), 23.4 (CH2), 18.4 (C), 13.9 (CH3), 9.8 (CH3), -5.2 (2 x Cth); mlz (ESI) found
417.2071 (M + Na +), C2I H340sSiNa requires 417.2068.
6- [5-( tert- Buty l-dimethyl-silany loxymethy 1)-4-methyl- furan-Z-y I]-hex -l-en-Ssol
114
OTBS
The aldehyde 112 was prepared in an identical manner to the procedure for
propargylic alcohol109, from the alkenylfuran 122 (3.00 g, 10.1 mmol). A solution of
the crude aldehyde in THF (20 mL) was added dropwise over IS mins to a stirred
solution of vinylmagnesium bromide (20.2 mL, 20.2 mmol, 1.0 M in THF) in THF
(100 mL) at -78°C under a nitrogen atmosphere. The mixture was stirred at this
temperature for I hr, then saturated aqueous NH4CI (50 mL), water (50 mL) and
diethyl ether (50 mL) were added and the mixture was then warmed to room
temperature. The separated aqueous phase was extracted with diethyl ether (3 x 50
mL) and the combined organic extracts were then dried (MgS04) and concentrated in
vacuo. Purification by chromatography on silica gel, using 20% diethyl ether in
petroleum ether as eluent, gave the ally/ic alcohol (l.63 g, 50%) as a colourless oil.
vmax!cm-1 (CHCh solution): 3608, 2928, 2857, 1639, 1570; 8H (400 MHz): 5.91-5.80
(m, IH, CH=CH2), 5.80 (s, IH, C(O)=CHCMe), 5.22 (dm, IH,.J 17.0, CH=CHH),
5.10 (dm, IH, J 10.4, CH=CHH), 4.56 (s, 2H, CH20TBS), 4.15-4.05 (m, IH,
CH(OH)CH=CH2), 2.59 (t, 2H, J 7.3, CH2C(O)=CHCMe), 1.98 (s, 3H,
C(O)=CHCMe), 1.80-1.52 (m, 5H, CH(OH)CH2CH2, ClhCH2C(O)=CH and
CH(OH)CH=CH2), 0.90 (s, 9H, Si(Me)2C(Me)3), 0.07 (s, 6H, Si(Me)/Bu); 8c (lOO
139
MHz): 154.5 (C). 147.4 (C), 141.1 (CH), 117.5 (C), 114.7 (CH2), 108.4 (CH), 72.9
(CH), 56.0 (CH2), 36.4 (CH2), 27.8 (CH2), 25.9 (3 x CH3), 23.8 (CH2), 18.4 (C), 9.9
347.2013.
7-(tert-Butyl-diphenyl-silanyloxy)-6-methyl-(E)-hept-5-enoic acid methyl ester
116b
o
MeO~OTBDPS
tert-Butyldiphenylsilyl chloride (3.22 mL, 12.4 mmol) was added dropwise over I
min to a stirred solution of the allylic alcohol 116a11o (1.94 g, 11.3 mmol) and
imidazole (0.92 g, 13.5 mmol) in DMF (2.9 mL) at 0 °C under a nitrogen atmosphere,
and the mixture was then stirred at this temperature for 10 mins. Direct purification by
chromatography on silica gel, using 5% diethyl ether in petroleum ether as eluent,
gave the silyl ether (3.99 g, 86%) as a colourless oil. vmax/cm-I (CHCh solution):
2932,2858,1731,1589; D'1 (360 MHz): 7.74-7.67 (m, 4H, Si(PhhtBu), 7.48-7.36 (m,
6H, Si(Ph)2tBu), 5.44 (t, 1H, J 7.3, CH=C(Me)CH20), 4.08 (br. s, 2H, CH20TBDPS),
3.70 (s, 3H, C02Me), 2.33 (t, 2H, J 7.5, CH2C02Me), 2.10 (app. q, 2H, J 7.3,
CH=C(Me)CH20Si), 1.09 (s, 9H, Si(PhhC(Me)3); DC (90 MHz): 174.1 (C), 135.5 (4 x
CH), 135.0 (C), 133.8 (2 x C), 129.5 (2 x CH), 127.6 (4 x CH), 123.2 (CH), 68.8
(CH2), 51.4 (CH}), 33.5 (CH2), 26.8 (3 x CH}), 26.8 (CH2), 24.8 (CH2), 19.3 (C), 13.5
(CH3); mlz (ESI) found 433.2163 (M + Na+), C2sH3403SiNa requires 433.2169.
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tert- Buty 1-[4-(3- methyl- furan-2-y 1)-but-3-eny loxy) -dipheny l-silane 135
A solution of n-butyllithium (8.60 mL, 21.5 mmol, 2.5 M in hexanes) was added
dropwise over 5 mins to a stirred solution of the phosphonium salt 130152,153 (14.36 g,
22.5 mmol) in THF (100 mL) at -20°C under a nitrogen atmosphere. The mixture
was stirred at this temperature for 30 mins, and then cooled to -78°C. A solution of 3-
methyl-furan-2-carbaldehyde 129151 (2.06 g, 18.7 mmol) in THF (20 rnl.) was added
dropwise over 10 min. The mixture was warmed to room temperature over 15 hrs and
then water (60 mL) and diethyl ether (60 mL) were added. The separated aqueous
phase was extracted with diethyl ether (3 x 60 mL) and the combined organic extracts
were then dried (MgS04) and concentrated in vacuo. Pentane (200 mL) was added to
the residue which was then filtered and concentrated in vacuo. Purification by
chromatography on silica gel, using 5% diethyl ether in petroleum ether as eluent,
gave a 9: 1 mixture of Z:E-isomers of the alkenylfuran (7.23 g, 99%) as a colourless
oil. vmax/cm-I (CHCh solution): 2930, 2859,1650,1589; 811 (360 MHz): 7.77-7.70 (m,
4H, Si(Ph)2tBu), 7.49-7.35 (m, 6H, Si(Ph)2tBu), 7.30 (d, 0.85H, J 1.7, CH(O)=CH),
7.27 (d, O.ISH, J 1.7, CH(O)=CH), 6.31 (d, 0.I5H, J 15.8, C(O)CH=CH), 6.25 (d,
0.85H, J 1.7, CH=CHCMe), 6.24 (d, O.ISH, J 1.7, CH=CHCMe), 6.20 (dt, 0.8SH,.J
11.8 and 1.4, C(O)CH=CH), 6.11 (dt, O.ISH,.J 15.8 and 7.2, C(O)CH=CHCH2), 5.61
(dt, O.85H, .J 11.8 and 7.5, qO)CH=CHCH2), 3.85 (t, 1.70H, .J 6.7, CH20TBDPS),
3.82 (t, O.30H, J 6.7, CH20Si), 2.90 (dtd, 1.70H, J 7.5, 6.7 and 1.4, CH2CH20Si),
2.50 (dt, OJOH, J 7.2 and 6.7, CH2CH20Si), 2,07 (s, 2.55H, CH(O)=CHCMe), 2.06
(s, O.4SH, CH(O)=CHCMe), 1.12 (s, 1.35H, Si(PhhC(Me)3) and 1.11 (s, 7.6SH,
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Si(PhhC(Me)3); 8c (90 MHz): 149.3 (2 x C), 140.7 (CH), 140.5 (CH), 135.6 (8 x CH),
134.1 (2 x C), 133.9 (2 x C), 129.5 (4 x CH), 127.6 (8 x CH), 125.2 (CH), 124.5
(CH), 118.7 (CH), 118.3 (2 x C), 116.0 (CH), 113.7 (CH), 113.2 (CH), 63.8 (2 x
CH2), 36.4 (CH2), 32.6 (CH2), 26.9 (6 x CH3), 19.3 (C), 19.2 (C), 10.1 (2 x CH3); mlz
(ESI) found 413.1917 (M + Na+), C2sH3002SiNa requires 413.1907.
tert- Bu ty 1-14-(3-methyl- furan-2-yl)-butoxy ]-diphenyl-silane 136
A suspension of the alkenylfuran 135 (1.57 g, 4.02 mmol) and 10% palladium on
carbon (157 mg) in methanol (60 mL) was stirred under 1 atmosphere of hydrogen at
room temperature for 4 hrs. The mixture was filtered through celite, eluting with
diethyl ether, and the filtrate was concentrated in vacuo. Purification by
chromatography on silica gel, using 5% diethyl ether in petroleum ether as eluent,
gave the Juran (1.35 g, 85%) as a colourless oil. vmax/cm-I (CHCb solution): 2931,
2859, 1625, 1589; 8H (360 MHz): 7.72-7.65 (m, 4H, Si(PhhtBu), 7.46-7.35 (m, 6H,
Si(PhhtBu), 7.22 (d, IH, J 1.8, CH(O)=CH), 6.16 (d, IH,.J 1.8, CH(O)=CHCMe),
3.68 (t, 2H, J 6.3, CH20TBDPS), 2.56 (t, 2H, J 7.3, C(O)CH2CH2), 1.94 (s, 3H,
CH(O)=CHCMe), 1.76-1.66 (m, 2H, CH2CH20Si), 1.63-1.53 (m, 2H,
C(O)CH2CH2CH2), 1.06 (s, 9H, Si(Ph)2C(Me))); 8c (90 MHz): 151.2 (C), 139.6 (CH),
135.6 (4 x CH), 134.1 (2 x C), 129.5 (2 x CH), 127.6 (4 x CH), 113.6 (C), 112.6
(CH), 63.6 (CH2), 32.0 (CH2), 26.9 (3 x CH3), 25.6 (CH2), 24.7 (CH2), 19.2 (C), 9.8
(CH3); mlz (ESI) found 415.2066 (M +Na"), C2sH3202SiNa requires 415.2064.
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5-[4-(tert-Butyl-diphenyl-siianyloxy)-butyIJ-4-methyl-furan-2-carbaldehyde 137
A solution of n-butyllithium (0.72 rnl., 1.78 mrnol, 2.5 M in hexanes) was added
dropwise over 5 mins to a stirred solution of the furan 136 (200 mg, 0.51 mmol) in
THF (30 mL) at -78 QCunder a nitrogen atmosphere. The mixture was warmed to
room temperature for 45 mins and then cooled back to -78 QC. Once at this
temperature anhydrous DMF (0.39 mL, 5.09 mmol) was added dropwise over 5 mins
and the mixture was warmed to room temperature over 15 hrs and then water (30 mL)
and diethyl ether (30 mL) were added. The separated aqueous phase was extracted
with diethyl ether (3 x 30 mL) and the combined organic extracts were then dried
(MgS04) and concentrated in vacuo. Purification by chromatography on silica gel,
using a gradient of 5%, 10% to 15% diethyl ether in petroleum ether (product eluted
at 15%) as eluent, gave the Juran aldehyde (107 mg, 50%) as a light yellow oil.
vmax/cm-1 (CHCl) solution): 2932, 2859, 1674; ()H (360 MHz): 9.48 (s, 1H, CHO),
7.71-7.65 (m, 4H, Si(PhhtBu), 7.47-7.36 (m, 6H, Si(Ph)2tBu), 7.04 (s, IH,
C(O)=CHCMe), 3.70 (t, 2H, J 6.3, CH20TBDPS), 2.68 (t, 2H, .J 7.5, C(O)CH2CH2),
2.01 (s, 3H, C(O)=CHCMe), 1.86-1.75 (m, 2H, CH2CH20Si), 1.65-1.55 (m, 2H,
C(O)CH2CH2CH2), 1.07 (s, 9H, Si(PhhC(Meh); Dc (90 MHz): 176.8 (CH), 159.5
(C), 150.6 (C), 135.5 (4 x CH), 133.8 (2 x C), 129.5 (2 x CH), 127.6 (4 x CH), 125.1
(br. C), 118.1 (CH), 63.3 (CH2), 31.9 (CH2), 26.8 (3 x CH3), 26.1 (CH2), 24.2 (CH2),
19.1 (C), 9.6 (CH3); m/z (ESI) found 459.1760 (M + K+), C26H3203SiK requires
459.1752.
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5-[ 5-( tert- Buty I-dimethyl-silanyloxy )-pen t-l-enyIJ-2- (4-(tert-buty I-dipheny 1-
silanyloxy)-butyl]-3-methyl-furan 361
OTBS
A solution of n-butyllithium (4.00 ml., 10.1 mmol, 2.5 M in hexanes) was added
dropwise over 5 mins to a stirred solution of the phosphonium salt 128155 (5.82 g, 10.1
mmol) in THF (120 mL) at -20 QC under a nitrogen atmosphere. The mixture was
stirred at this temperature for 30 mins and then cooled to -78 QC. A solution of the
furan aldehyde 137 (2.83 g, 6.73 mmol) in THF (30 mL) was added dropwise over 10
min. The mixture was warmed to room temperature over 15 hrs and then water (60
mL) and diethyl ether (60 mL) were added. The separated aqueous phase was
extracted with diethyl ether (3 x 60 mL) and the combined organic extracts were then
dried (MgS04) and concentrated in vacuo. Pentane (250 mL) was added to the residue
which was then filtered and concentrated in vacuo. Purification by chromatography on
silica gel, using 5% diethyl ether in petroleum ether as eluent, gave a 4: 1 mixture of
Z:E-isomers of the alkenylfuran (2.85 g, 72%) as a colourless oil. vmax/cm-' (CHCh
solution): 2929,2858,1621; OH (360 MHz): 7.70-7.64 (m, 4H, Si(PhhtBu), 7.46-7.33
(m, 6H, Si(PhhtBu), 6.15-6.01 (m, 1H, CH=CHCO and 0.2H, CH=CHCO), 6.08 (s,
0.80H, C(O)=CHCMe), and 5.91 (s, 0.20H, C(O)=CHCMe), 5.45 (dt, 0.80H, .J 11.7
and 7.3, CH=CHCO), 3.71-3.63 (m, 4H, CH20TBS and CfhOTBDPS), 2.56 (t,
1.60H, J 7.3, C(O)CH2CH2), 2.54 (t, 0.40H, J 7.3, C(O)CH2CH2), 2.45 (dtd, 1.60H, J
7.6, 7.3 and 1.6, CH2CH=CH), 2.22 Cappoq, 0.40H, J 7.1, CH2CH=CH), 1.92 (s,
2.40H, C(O)=CHCMe), 1.89 (s, 0.60H, C(O)=CHCMe), 1.77-1.65 (m, 4H,
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CH2CH20TBS and CH2CH20TBDPS), 1.65-1.54 (m, 2H, C(O)CH2CH2Cl-b). 1.06 (s,
9H, Si(Ph)2C(Meh), 0.91 (s, 9H, Si(Me)2C(Me)3), 0.06 (s, 6H, Si(Me)2'Bu); 8e (90
MHz): 150.4 (2 x C), 150.3 (2 x C), 135.5 (8 x CH), 134.0 (4 x C), 129.5 (4 x CH),
128.7 (2 x CH), 127.6 (8 x CH), 119.0 (CH), 117.9 (CH), 115.5 (C), 115.3 (C), 112.3
(CH), 109.5 (CH), 63.6 (2 x CH2), 62.9 (CH2), 62.5 (CH2), 32.6 (CH2), 32.5 (Cl-h),
32.0 (2 x CH2), 26.9 (6 x CH3), 26.0 (6 x CH3), 25.8 (2 x CH2), 25.7 (2 x CH2), 24.9
(CH2), 24.7 (CH2), 19.2 (2 x C), 18.3 (2 x C), 9.8 (2 x CH3), -5.3 (4 x CH3); m/z (ESI)
found 613.3502 (M + Na+), C36Hs403ShNa requires 613.3504.
5-[5-(tert-Butyl-dimethyl-silanyloxy)-pentyll-2-(4-(tert-butyl-diphenyl-
silanyloxy)-butyl]-3-methyl-furan 127
OTBS
A suspension of the alkenylfuran 361 (2.85 g, 4.82 mmol) and 5% palladium on
carbon (285 mg) in methanol (120 mL) and pentane (50 mL) was stirred under I
atmosphere of hydrogen at room temperature for 4 hrs. The mixture was filtered
through celite, eluting with diethyl ether, and the filtrate was concentrated in vacuo.
Purification by chromatography on silica gel, using 2% diethyl ether in petroleum
ether as eluent, gave the furan (2.60 g, 91%) as a colourless oil. vmax!cm-I(CHCI)
solution): 2931,2859, 1462. 1389, 1361, 1104; 8H (360 MHz): 7.71-7.64 (m, 4H.
Si(Phh'Bu), 7.46-7.34 (m, 6H, Si(Ph)2'Bu). 5.74 (s, 1H, C(O)=CHCMe), 3.68 (t, 2H,
J 6.3, CH20TBDPS), 3.61 (t, 2H, J 6.6, CH20TBS), 2.53 (t, 2H, .17.2, C(O)CH2CH2),
2.51 (t, 2H, J 7.2, CH2C(O)=CH), 1.89 (s, 31--1,C(O)=CHCMe), 1.74-1.49 (m, 81--1.
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CH2CH20TBS, CH2CH20TBDPS, C(O)CH2CH2CH2 and CH2CH2C(O)=CH), 1.43-
1.33 (m, 2H, CH2CH2CH2CO), 1.06 (s, 9H, Si(PhhC(Me)3), 0.90 (s, 9H,
Si(Me)2C(Me)3), 0.05 (s, 6H, Si(MehtBu); Oc (90 MHz): 153.3 (C), 149.1 CC), 135.6
(4 x CH), 134.1 (2 x C), 129.5 (2 x CH), 127.6 (4 x CH), 114.0 (C), 107.7 (CH), 63.6
(CH2), 63.1 (CH2), 32.6 (CH2), 32.0 (CH2), 28.0 (2 x CH2), 26.9 (3 x CH3), 26.0 (3 x
CH3), 25.6 (CH2), 25.5 (CH2), 25.0 (CH2), 19.2 (C), 18.4 (C), 9.9 (CH3), -5.3 (2 x
CH3); m/z (ESI) found 615.3670 (M +Na+), C36Hs603ShNa requires 615.3660.
5- {5-[4-( tert- Butyl-diphenyl-silany loxy j-butyl] -4- methyl- fu ran- 2-y I}-pentan -1-0 I
362
OH
Pyridinium para-toluenesulfonate (1.09 g, 4.33 mmol) was added in one portion to a
stirred solution of the furan 127 (2.57 g, 4.33 mol) in DCM (50 mL) and methanol (50
mL) at room temperature. The mixture was stirred at this temperature for 24 hrs and
then concentrated in vacuo. Diethyl ether (50 mL) and water (50 mL) were added and
the separated aqueous phase was extracted with diethyl ether (3 x 50 mL) and the
combined organic extracts were then dried (MgS04) and concentrated in vacuo.
Purification by chromatography on silica gel, using a gradient of 20% to 30% diethyl
ether in petroleum ether (product eluted at 30%) as eluent, gave the alcohol (1.73 g,
84%) as a colourless oil. vmax/cm-I(CHCh solution): 3626,2932,2860, 1574; 0'1 (360
MHz): 7.72-7.67 (m, 4H, Si(PhhtBu), 7.47-7.36 (m, 6H, Si(Ph)2tBu), 5.76 (s, 1H,
C(O)=CHCMe), 3.69 (t, 2H, J 6.2, CH20TBDPS), 3.65 (t, 2H, J 6.6, CH20H), 2.56
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(t, 2H, J 7.5, C(O)CH2CH2), 2.53 (t, 2H, J 7.3, CH2C(O)=CH), 1.90 (s, 3H,
C(O)=CHCMe), 1.75-1.55 (m, 8H, CH2CH20H, CH2CH20TBDPS, C(O)CI-hCH2CH2
and CH2CH2C(O)=CH), 1.47-1.37 (m, 2H, CH2CH2CH2CO), 1.32 (br. s, I H,
CH20H), 1.07 (s, 9H, Si(Ph)2C(Me)3); be (90 MHz): 153.0 (C), 149.0 (C), 135.4 (4 x
CH), 133.9 (2 x C), 129.4 (2 x CH), 127.5 (4 x CH), 113.9 (C), 107.8 (CH), 63.5
(CH2), 62.6 (CH2), 32.3 (CH2), 31.9 (CH2), 27.8 (2 x CH2), 26.8 (3 x CH3), 25.5
(CH2), 25.2 (CH2), 24.9 (CH2), 19.1 (C), 9.8 (CH3); mlz (ESI) found 479.2972 (M +
H+), C30H4303Sirequires 479.2976.
(E)-2-Bromo-7-{5-[4-(tert-butyl-diphenyl-silanyloxy)-butyl]-4-methyl-furan-2-
yl}-hept-2-enoic acid ethyl ester 140a
Dimethylsulphoxide (33 ul, 0.46 mmol) was added dropwise over 5 mins to a stirred
solution of oxalyl chloride (24 ul, 0.27 mmol) in OCM (20 mL) at -78°C under a
nitrogen atmosphere. The mixture was stirred at this temperature for 10 mins and then
a solution of the alcohol 362 (lOO mg, 0.21 mmol) in OCM (5 mL) was added
dropwise over 5 mins, immediately followed by dropwise addition of triethylamine
(0.15 mL, 1.04 mmol) over 1 min. The mixture was stirred at -78°C for 2 hrs and
then warmed to 0 °C and then water (20 mL) and diethyl ether (20mL) were added.
The separated aqueous phase was extracted with diethyl ether (3 x 20 mL) and the
combined organic extracts were then dried (MgS04) and concentrated in vacuo to
leave the aldehyde as a colourless oil that was used without further purification. The
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phosphonate 139 (0.11 mL, 0.76 mmol) was added dropwise over 5 mins to a stirred
solution of sodium hydride (18 mg, 0.76 mmol, 60% dispersed in mineral oil)
suspended in THF (lO mL) at -30 QCunder a nitrogen atmosphere. The mixture was
stirred at this temperature for 30 mins and then bromine (24 Ill, 0.76 mmol) was added
dropwise over 5 mins. The cloudy, yellow mixture was briefly warmed to room
temperature and then cooled to -78 QCwhere sodium hydride (18 mg, 0.76 mmol,
60% dispersed in mineral oil) was added in one portion. The mixture was warmed up
until gas evolved from the mixture. The resulting cloudy, colourless solution was held
at this temperature (- -30 QC)for 5 mins and then cooled to -78 QCwhere the mixture
was stirred for 25 mins. A solution of the crude aldehyde in THF (lO mL) was added
dropwise over 10 mins to the mixture and then warmed to room temperature over 15
hrs. Water (20 mL) and diethyl ether (20 mL) were added and the separated aqueous
phase was extracted with diethyl ether (3 x 20 mL) and the combined organic extracts
were then dried (MgS04) and concentrated in vacuo. Purification by chromatography
on silica gel, using a gradient of 2% to 5% diethyl ether in petroleum ether (product
eluted at 5%) as eluent, gave the a-bromoester (95 mg, 72%) as a colourless oil.
vmax!cm-I (CHCh solution): 2932, 2860, 1714, 1614; bH (360 MHz): 7.71-7.65 (m,
4H, Si(Ph)/Bu), 7.45-7.34 (m, 6H, Si(Ph)2tBu), 6.65 (t, IH, .J 7.8, CH=C(Br)C02Et),
5.74 (s, IH, C(O)=CHCMe), 4.27 (q, 2H, J 7.1, C02CH2Me), 3.68 (t, 2H, .J 6.2,
CH20TBDPS), 2.61-2.41 (m, 6H, C(O)CH2CH2, CH2C(O)=CH and ClhCH=C), 1.88
(s, 3H, C(O)=CHCMe), 1.73-1.45 (m, 8H, CH2CI-hCH=C, CH2CH20TBDPS,
C(O)CH2CH2CH2 and CH2CH2C(O)=CH), 1.33 (t, 3H, .J 7.1, C02CH2Me), 1.05 (s,
9H, Si(Ph)2C(Meh); be (90 MHz): 162.8 (C), 152.7 (C), 149.3 CC), 148.2 (CH), 135.5
(4 x CH), 134.0 (2 x C), 129.4 (2 x CH), 127.5 (4 x CH), 114.0 (C), 111.3 (C), 108.0
(CH), 63.6 (CH2), 62.0 (CH2), 32.0 (CH2), 31.1 (CH2), 28.2 (CH2), 27.6 (2 x CH2),
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26.8 (3 x CH3), 25.6 (CH2), 24.9 (CH2), 19.2 (C), 14.1 (CH3), 9.8 (CH3): mlz (ESI)
found 647.2162 (M + Na+), C34H4s04SiBrNa requires 647.2163.
(E)-2-Bromo-7-(5-(4-hydroxy-butyl)-4-methyl-furan-2-yl]-hept-2-enoic acid ethyl
ester 140b
70% Hydrogen fluoride-pyridine complex (0.50 mL, 19.2 mmol) was added to a
stirred solution of the a-bromoester 140a (169 mg, 0.27 mmol) and pyridine (0.25
mL, 3.09 mmol) in THF (5 mL) at room temperature under a nitrogen atmosphere.
The mixture was stirred at this temperature for 24 hrs, and then saturated aqueous
NaHC03 (5 mL) and diethyl ether (5 mL) were added. The resulting biphasic mixture
was dried (MgS04) and then filtered through a short plug of silica gel, eluting with
diethyl ether, and the filtrate was then concentrated in vacuo. Purification by
chromatography on silica gel, using a gradient of 20% to 40% diethyl ether in
petroleum ether (product eluted at 40%) as eluent, gave the alcohol (97 mg, 92%) as a
colourless oil. vmaxlcm'( (CHCh solution): 3624,2939,2864, 1716, 1613; OH (360
MHz): 6.66 (t, IH, J7.8, CH=C(Br)C02Et), 5.74 (s, IH, C(O)=CHCMe), 4.27 (q, 2H,
J 7.1, C02CH2Me), 3.65 (t, 2H, J 6.3, CH20H), 2.61-2.41 (m, 6H, C(O)CH2CH2,
CH2C(O)=CH and CH2CH=C), 1.90 (s, 3H, C(O)=CHCMe), 1.73-1.45 (m, 8H,
CH2CH2CH=C, CH2CH20H, C(O)CH2CH2CH2 and CH2CH2C(O)=CH), 1.41 (br. s,
1H, CH20H), 1.34 (t, 3H, J 7.1, C02CH2Me); Oc (90 MHz): 162.6 (C), 152.5 (C),
148.8 (C), 148.0 (CH), 113.8 (C), 111.0 (C), 107.8 (CH), 62.1 (CH2), 61.8 (Cl-h),
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31.9 (CH2), 30.9 (CH2), 27.9 (CH2), 27.4 (2 x CH2), 25.3 (CH2), 24.7 (CH2), 13.8
(CH3), 9.6 (CH3); mlz (ESI) found 411.0963 (M + Na+), CISH27048IBrNa requires
411.0964.
(E)-2-Bromo-7-[4-methyl-5-(4-oxo-butyl)-furan-2-yl]-hept-2-enoic acid ethyl
ester 126
Dess-Martin periodinane (93 mg, 0.22 mmol) was added in three portions over a 1 hr
period to a stirred solution of the alcohol140b (50 mg, 0.13 mmol) in DCM (15 ml.)
at room temperature. The mixture was stirred at this temperature for 45 mins, and then
saturated aqueous Na2S203 and saturated aqueous NaHC03 (15 ml., 1:1) were added
and the resulting biphasic mixture was stirred vigorously for 45 mins. The separated
aqueous phase was extracted with DCM (3 x 20 mL) and the combined organic
extracts were then dried (MgS04) and concentrated in vacuo. Purification by
chromatography on silica gel, using a gradient of 5% to 10% ethyl acetate in
petroleum ether (product eluted at 10%) as eluent, gave the aldehyde (35 mg, 70%) as
a colourless oil. vmaJcm· 1 (CHCh solution): 2932, 2863, 1716, 1614; 811 (360 MHz):
9.71 (t, 1H, J 1.6, CHO), 6.66 (t, 1H, J 7.8, CH=C(Br)C02Et), 5.75 (s, 1H,
C(O)=CHCMe), 4.27 (q, 2H, J 7.1, C02CH2Me), 2.62-2.47 (m, 6H, C(O)CH2CH2,
CH2C(O)=CH and CH2CH=C), 2.43 (td, 2H, J 7.2 and 1.6, CH2CHO), 1.94 (app.
quintet, 2H, J 7.2, C(O)CH2CH2CH2), 1.89 (s, 3H, C(O)=CHCMe), 1.69-1.56 (m, 2H,
CH2CH2C(O)=CH), 1.56-1.45 (m, 2H, CH2CH2CH=C), 1.34 (t, 3H, .J 7.1,
150
C02CH2Me); 8c (90 MHz): 202.2 (CH), 162.9 (C), 153.2 (C), 148.2 (CH), 147.9 (C),
115.0 (C), 111.3 (C), 108.1 (CH), 62.0 (CH2), 43.0 (CH2), 31.1 (CH2), 28.2 (CH2).
27.6 (2 x CH2), 24.9 (CH2), 21.2 (CH2), 14.1 (CH3), 9.8 (CH3); mlz (ESI) found
407.0829 (M +Na+), CISH2S04BrNa requires 407.0828.
7-[4-Methyl-5-( 4-oxo-butyl)-furan-2-yIJ-(Z)-hept-2-enoic acid ethyl ester 141a
and 7-[4-Methyl-5-(4-oxo-butyl)-furan-2-yIJ-(E)-hept-2-enoic acid ethyl ester
141b
A solution of samarium iodide (2.6 mL, 0.26 mmol, 0.1 M in THF) was added
dropwise over 30 mins to a stirred, degassed solution of the aldehyde 126 (25 mg,
0.06 mmol) in THF (lOO mL) at -78 QCunder an argon atmosphere. The mixture was
stirred at this temperature for 30 mins and then opened to the atmosphere. Silica gel
(20 g) and pentane (50 mL) were added and the mixture was warmed to room
temperature and then stirred vigorously for 30 mins. The mixture was filtered through
a short plug of silica gel, eluting with diethyl ether, and the filtrate was then
concentrated in vacuo. Purification by chromatography on silica gel. using a gradient
of 5%, 10% to 20% ethyl acetate in petroleum ether (product eluted at 20%) as eluent,
gave the Z-a,fJ-unsaturated ester (5 mg, 25%) and the E-a,fJ-unsaturated ester (9 mg,
45%) as separable isomers. Z-isomer: vrnax/cm-I(CHCh solution): 2926, 2857, 1716,
1644; 811 (360 MHz): 9.71 (t, IH, J 1.6, CHO), 6.21 (dt, IH, J 11.6 and 7.5,
CH=CHC02Et), 5.77 (dt, IH, .J 11.6 and 1.6, CH=CHC02Et), 5.75 (s, IH,
lSI
C(O)=CHCMe), 4.17 (q, 2H, J 7.1, C02CH2Me), 2.73-2.64 (m, 2H, CH2CH=CH),
2.61-2.51 (m, 4H, C(O)CH2CH2, CH2C(O)=CH), 2.43 (td, 2H, .I 7.2 and 1.6,
CH2CHO), 1.94 (app. quintet, 2H, .I 7.2, C(O)CH2CH2CH2), 1.89 (s, 3H,
C(O)=CHCMe), 1.70-1.57 (m, 2H, CH2CH2C(O)=CH), 1.57-1.46 (m, 2H,
CH2CH2CH=CH), 1.30 (t, 3H, J 7.1, C02CH2Me); Oc (90 MHz): 202.3 (CH), 166.4
(C), 153.6 (C), 150.1 (CH), 147.8 (C), 119.9 (CH), 115.1 (C), 108.0 (CH), 59.8
(CH2), 43.0 (CH2), 29.7 (CH2), 28.7 (CH2), 28.5 (CH2), 27.7 (CH2), 25.0 (CH2), 21.3
(CH2), 14.3 (CH3), 9.8 (CH3); rnlz (ESI) found 329.1723 (M + Na+), CJ8H2(,04Na
requires 329.1723; E-isomer: vrnax/crn·1 (CHCh solution): 2930, 2862,1716,1653; Oil
(360 MHz): 9.70 (t, 1H, .I 1.6, CHO), 6.96 (dt, 1H, J 15.6 and 6.9, CH=CHC02Et),
5.82 (dt, IH, J 15.6 and 1.5, CH=CHC02Et), 5.75 (s, 1H, C(O)=CHCMe), 4.19 (q,
2H, .I 7.1, C02CH2Me), 2.58 (t, 2H, .I 7.2, C(O)CH2CH2), 2.54 (t, 2H, J 7.0,
CH2C(O)=CH), 2.43 (td, 2H, J 7.2 and 1.6, CH2CHO), 2.27-2.18 (m, 2H,
CH2CH=CH), 1.94 (app. quintet, 2H, J 7.2, C(O)CH2CH2CH2), 1.89 (s, 3H,
C(O)=CHCMe), 1.68-1.57 (m, 2H, CH2CH2C(O)=CH), 1.56-1.45 (m, 2H,
CH2CH2CH=CH), 1.29 (t, 3H, J 7.1, C02CH2Me); Oc (90 MHz): 202.3 (CH), 166.7
(C), 153.3 (C), 148.9 (CH), 147.9 (C), 121.5 (CH), 115.1 (C), 108.1 (CH),60.1
(CH2), 43.0 (CH2), 31.9 (CH2), 27.7 (CH2), 27.6 (CH2), 27.5 (CH2), 25.0 (CH2), 21.3
(CH2), 14.3 (CH3), 9.8 (CH3); mlz (ESI) found 307.1910 (M + H+), CI8H2704 requires
307.1904.
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5-Hydroxy-14-methyl-15-oxa-bicyclo[1 0.2.1 ]pentadeca-l (14),12-diene-6-
carboxylic acid ethyl ester 142
A degassed solution of the aldehyde 126 (35 mg, 0.09 mmol) in THF (lOO mL) was
added dropwise over 1 hr to a stirred solution of samarium iodide (18 ml., 1.80 mmol,
0.1 M in THF) at -78 DCunder an argon atmosphere. The mixture was stirred at this
temperature for 30 mins and then opened to the atmosphere. Silica gel (20 g) and
pentane (50 mL) were added and the mixture was warmed to room temperature where
it was stirred vigorously for 30 mins. The mixture was filtered through a short plug of
silica gel, eluting with diethyl ether, and the filtrate was then concentrated in vacuo.
Purification by chromatography on silica gel, using a gradient of 5%, 10% to 20%
ethyl acetate in petroleum ether (product eluted at 20%) as eluent, gave the alcohol (9
mg, 33%) as a mixture of diastereoisomers. vmax/cm-l (CHCh solution): 3524, 2927,
2864,1713; bH (360 MHz): 5.76 (s, IH, C(O)=CHCMe), 4.17 (2 x q, 2H,.J 7.1,
C02CH2Me), 3.81 (br. s, IH, CH(OH)CH2), 2.78-2.67 (m, 3H, C(O)CihCH2 and
CH(OH)CH2), 2.51-2.37 (m, 3H, CH2C(O)=CH and CH(C02Et)CH), 1.90 (s, 3H,
C(O)=CHCMe), 1.81-1.53 (m, 8H, CH2CH2C(O)=CH, CH2CH(C02Et)CH,
C(O)CH2CH2CH2 and CH(OH)CH2CH2), 1.53-1.34 (m, 4H, CH2CH2CHC02Et and
CH2CH2CH2CO), 1.28 (t, 3H,.J 7.1, C02CH2Me); be (90 MHz): 176.7 (2 x C), 153.6
(2 x C), 148.9 (2 x C), 114.9 (2 x C), 108.7 (2 x CH), 71.2 (2 x CH), 60.6 (2 x CH2),
47.3 (2 x CH), 31.1 (2 x CH2), 27.4 (2 x CH2), 27.1 (2 x CH2), 26.3 (2 x CH2), 25.4 (2
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x CH2), 24.4 (2 x CH2), 24.1 (2 x CH2), 23.7 (2 x CH2), 14.3 (2 x CH3), 9.7 (2 x CH3);
mlz (ESI) found 331.1874 (M +Na+), C1sH2S04Na requires 331.1880.
(E)-2-Bromo-l0-methyl-8,1l,15-trioxo-(Z)-pentadeca-2,9-dienoic acid ethyl ester
143
Dess-Martin periodinane (164 mg, 0.39 mmol) was added in one portion to a stirred
solution of the alcohol 140b (50 mg, 0.13 mmol) in OCM (15 mL) at room
temperature. The mixture was stirred at this temperature for 45 mins, and then
saturated aqueous Na2S203 and saturated aqueous NaHC03 (15 mL, 1:1) were added
and the resulting biphasic mixture was stirred vigorously for 45 mins. The separated
aqueous phase was extracted with DCM (3 x 20 mL) and the combined organic
extracts were then dried (MgS04) and concentrated in vacuo. Purification by
chromatography on silica gel, using a gradient of 5%, 10% to 30% ethyl acetate in
petroleum ether (product eluted at 30%) as eluent, gave the enedione (26 mg, 50%) as
a light yellow oil. vrnax/cm· 1(CHCh solution): 2981, 2938, 1732, 1616; DH (360 MHz):
9.81 (t, 1H, J 1.2, CHO), 6.64 (t, 1H, J 7.8, CH=C(Br)C02Et), 6.06 (q, 1H, J 1.5,
C(O)=CHCMe), 4.26 (q, 2H, J 7.1, C02CH2Me), 2.64 (td, 2H, .J 7.0 and 1.2,
CH2CHO), 2.56 (t, 2H, J 7.0, C(O)CH2CH2), 2.55-2.43 (m, 4H, CH2C(O)=CH and
CH2CH=C), 2.02 (app. quintet, 2H, J 7.0, C(O)CH2CH2CH2), 1.97 (d, 3H, J 1.5,
C(O)=CHCMe), 1.67-1.54 (m, 2H, CH2CH2C(O)=CH), 1.54-1.40 (m, 2H,
CH2CH2CH=C), 1.34 (t, 3H, J 7.1, C02CH2Me); Dc (90 MHz): 208.2 (C), 202.3 (CH),
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198.7 (C), 162.8 (C), 155.9 (C), 147.9 (CH), 124.1 (CH), 111.5 (C), 62.1 (CH2), 42.5
(CH2), 42.4 (CH2), 38.8 (CH2), 31.1 (CH2), 28.1 (CH2), 23.1 (CH2), 20.6 (CH3), 15.5
(CH2), 14.1 (CH3); mlz (ESI) found 423.0779 (M + Na+), CISH2S0sBrNa requires
423.0778.
(E)-2-Bromo-7-hydroxy-7-[4-methyl-5-(4-oxo-butyl)-furan-2-yl]-hept-2-enoic
acid ethyl ester 179
A solution of the enedione 143 (5 mg, 0.01 mmol) and para-toluenesulfonic acid (2
mg, 0.01 mmol) in THF (2 mL) and water (l mL) were stirred at room temperature
for 4 hrs and then water (5 mL) and ethyl acetate (5 mL) were added. The separated
aqueous phase was extracted with ethyl acetate (3 x 5 mL) and the combined organic
extracts were then dried (MgS04) and concentrated in vacuo. Purification by
chromatography on silica gel, using a gradient of 10% to 50% ethyl acetate in
petroleum ether (product eluted at 50%) as eluent, gave the Juran methanol (4 mg,
80%) as a light yellow oil. 8H (360 MHz): 9.69 (t, 1H, J 1.6, CHO), 6.66 (t, 1H, J 7.8,
CH=C(Br)C02Et), 6.01 (s, IH, C(O)=CHCMe), 4.59 (t, 1H, J 6.7, CH(OH)CO), 4.27
(q, 2H, J 7.1, C02CH2Me), 2.64-2.50 (m, 4H, C(O)CH2CH2 and CH2CH=C), 2.44 (td,
2H, J 7.1 and 1.6, CH2CHO), 1.97 (app. quintet, 2H, J 7.1, C(O)CH2CH2CH2), 1.92
(s, 3H, C(O)=CHCMe), 1.89-1.79 (m, 2H, CH2CH(OH)CO), 1.70-1.47 (m, 2H,
CH2CH2CH=C), 1.35 (t, 3H, J 7.1, C02CH2Me).
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(E)-2-Bromo-7-[5-(4,4-dimethoxy-butyl)-4-methyl-furan-2-yl]-7-methoxy-hept-2-
enoic acid ethyl ester 180
A solution of the enedione 143 (5 mg, 0.01 mmol) and para-toluenesulfonic acid (2
mg, 0.01 mmol) in THF (2 mL) and methanol (l mL) were stirred at room
temperature for 4 hrs and then water (5 mL) and ethyl acetate (5 mL) were added. The
separated aqueous phase was extracted with ethyl acetate (3 x 5 rnL) and the
combined organic extracts were then dried (MgS04) and concentrated in vacuo.
Purification by chromatography on silica gel, using a gradient of 5%, 10% to 20%
ethyl acetate in petroleum ether (product eluted at 20%) as eluent, gave the methyl
furanmethanol (4 mg, 80%) as a colourless oil. vmax/crn-1 (CHCh solution): 2929,
2859, 1715, 1614; DH (500 MHz): 6.65 (t, IH, J 7.7, CH=C(Br)C02Et), 6.03 (s, IH,
C(O)=CHCMe), 4.37 (t, IH, J 5.5, CH(OMe)2), 4.27 (q, 2H, J 7.1, C02CH2Me), 4.04
(t, IH, J 7.0, CH(OMe)CO), 3.30 (s, 6H, CH(OMeh), 3.23 (s, 3H, CH(OMe)CO),
2.57 (t, 2H, J 7.1, C(O)CH2CH2CH2), 2.52 (app. q, 2H, J 7.7, CH2CH=C), 1.93 (s,
3H, C(O)=CHCMe), 1.92-1.84 (m, IH, CHHCH(OMe)CO), 1.83-1.74 (m, IH,
CHHCH(OMe)CO), 1.70-1.62 (m, 2H, CH2CH2CH=C), 1.62-1.55 (m, 2H,
C(O)CH2CH2CH2), 1.55-1.48 (m, 1H, CHHCH(OMe)2), 1.48-1.38 (m, 1H,
CHHCH(OMe)2), 1.34 (t, 3H, J 7.1, C02CH2Me); Dc (125 MHz): 162.9 (C), 150.9
(C), 150.7 (C), 148.2 (CH), 114.3 (C), 111.4 (C), 111.3 (CH), 104.3 (CH), 76.1 (CH),
62.1 (CH2), 56.2 (CH3), 52.6 (2 x CH3), 33.4 (CH2), 3 1.8 (CH2), 31.1 (CH2), 25.6
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(CH2), 24.9 (CH2), 23.6 (CH2), 14.l (CH)), 9.8 (CH)); m!z (ESI) found 483.1351 (M
+Na+), C2IH3306BrNa requires 483.l353.
2, 3-Dimethyl-5-(2-methylpropenyl)-furan 162
A solution of n-butyllithium (5.25 ml., l3.1 mmol, 2.5 M in hexanes) was added
dropwise over 5 mins to a stirred suspension of isopropyltriphenylphosphonium
iodide (5.70 g, 13.1 mmol) in THF (30 mL) at 0 QCunder a nitrogen atmosphere. The
mixture was stirred at this temperature for 40 mins and then 4, 5-dimethylfuran-2-
carbaldehyde 161 (0.74 g, 5.96 mmol) was added dropwise over 10 min. The mixture
was stirred at 0 QCfor 30 mins and then saturated aqueous NH4CI (20 mL), water (10
mL) and diethyl ether (30 mL) were added. The mixture was warmed to room
temperature and the separated aqueous phase was extracted with diethyl ether (3 x 30
mL) and the combined organic extracts were then dried (MgS04) and concentrated in
vacuo. Pentane (50 mL) was added to the residue which was then filtrated and
concentration in vacuo to leave the alkenylfuran as a light yellow oil that was used
without further purification. A small portion was purified in order to obtain the
spectroscopic data by chromatography on silica gel, using light petroleum as eluent,
which gave the alkenylfuran as a colourless oil. vmax!cm-I(CHCh solution): 2920,
1626, 1442; OH (400 MHz): 5.98 (br. s, IH, (MehC=CH), 5.97 (s, IH,
C(O)=CHCMe), 2.21 (s, 3H, C(O)Me), 1.96 (s, 3H, C(O)=CHCMe), 1.94 (s, 3H,
MeMeC=CH), l.89 (s, 3H, MeMeC=CH); Oc (lOO MHz): 150.7 (C), 145.4 (C), l33.2
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(C), 115.3 (C), 114.4 (CH), 110.5 (CH), 26.9 (CH3), 20.0 (CH3), 11.3 (CH3), 9.8
(CH3); mlz (El) found 150.1037 (M+) (12%), CIOHI40 requires 150.1045.
(Z)-3, 7-Dimethyl-octa-3, 6-diene-2, 5-dione 163
meta-Chloroperbenzoic acid (1.37 g, 5.96 mmol, 70-75 % weight balance) was added
in one portion to a stirred solution of the alkenylfuran 162 (895 mg, 5.96 mmol) in
DCM (50 mL) at 0 DCunder a nitrogen atmosphere. The mixture was stirred at this
temperature for 1 hr and then water (30 mL) was added. The separated organic phase
was washed with saturated aqueous NaHC03 (30 mL) and then dried (MgS04) and
concentrated in vacuo. Purification by chromatography on silica gel, using 20%
diethyl ether in pentane as eluent, gave the dienedione (564 mg, 57% over 2 steps) as
a colourless oil. vmax/cm-I(CHCh solution): 2914, 1699, 1672, 1627; c)H (400 MHz):
6.09 (app. heptet, IH, J 1.1, (MehC=CH), 6.03 (q, IH, J 1.6, CH=CMe), 2.33 (s, 3H,
C(O)Me), 2.17 (d, 3H, J 1.1, MeMeC=CH), 1.98 (d, 3H, J 1.6, CH=CMe), 1.93 (d,
3H, J 1.1, MeMeC=CH); ()c (100 MHz): 207.7 (C), 188.3 (C), 158.7 (C), 155.4 (C),
126.3 (CH), 123.7 (CH), 28.3 (CH3), 28.0 (CH3), 21.0 (CH3), 20.2 (CH3); mlz (ESI)
found 189.0876 (M + Na+), CIOHI402Na requires 189.0886.
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(Z)-7 -Hydroxy-3, 7-dimethyl-oct-3-ene-2,5-dione 165
HO
A solution of the dienedione 163 (25 mg, 0.15 mmol) and para-toluenesulfonic acid
(2.9 mg, 0.02 mmol) in THF (10 mL) and water (5 mL) were stirred at room
temperature for 20 hrs and then water (5 mL) and ethyl acetate (5 mL) were added.
The separated aqueous phase was extracted with ethyl acetate (3 x 5 mL) and the
combined organic extracts were then dried (MgS04) and concentrated in vacuo.
Purification by chromatography on silica gel, using a gradient of 60% to 80% ethyl
acetate in petroleum ether (product eluted at 80%) as eluent, gave the tertiary alcohol
(3 mg, 10%) as a colourless oil. vmax/cm-'(CHCh solution): 3642,3516.2927.1704,
1614; DH (400 MHz): 6.03 (q, IH, J 1.6, CH=CMe), 3.53 (br. s, in,
(Me)2C(OH)CH2), 2.67 (s, 2H, C(OH)CH2), 2.32 (s, 3H, C(O)Me), 2.00 (d, 3H, J 1.6,
CH=CMe), 1.27 (s, 6H, (Me)2C(OH)CH2); Dc (100 MHz): 206.6 (C), 200.2 (C), 156.7
(C), 124.6 (CH), 69.8 (C), 53.3 (CH2), 29.4 (2 x CH3), 28.0 (CH3), 20.3 (CH3); mlz
(ESI) found 207.0989 (M + Na+), CIOHl603Na requires 207.0992.
5-(2-Hydroxy-2-methyl-propylidene)-2,3-dimethyl-2,5-dihydro-furan-2-ol 178
A solution of the dienedione 163 (100 mg, 0.60 mmol) and para-toluenesulfonic acid
(114 mg, 0.60 mmol) in THF (10 mL) and water (5 mL) were stirred at room
temperature for 20 hrs and then water (5 mL) and ethyl acetate (5 mL) were added.
The separated aqueous phase was extracted with ethyl acetate (3 x 5 mL) and the
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combined organic extracts were dried (MgS04) and concentrated in vacuo.
Purification by chromatography on silica gel, using a gradient of 40% to 50% ethyl
acetate in petroleum ether (product eluted at 50%) as eluent, gave the vicinal dial (12
mg, 11%) as a colourless oil. vrnax/cm-I(CHCb solution): 3578,2927, 1704, 1672; 811
(300 MHz): 6.08 (s, IH, C(O)=CHCMe), 4.38 (br. s, IH, CH(OH)C), 2.19 (s, 3H,
C(O)Me), 1.92 (s, 3H, C(O)=CHCMe), 1.28 (s, 3H, MeMeC(OH)CH), 1.26 (br, s, 2H,
(Me)2C(OH)CH and CH(OH)C), 1.19 (s, 3H, MeMeC(OH)CH); 8c (75 MHz): 150.7
(C), 147.0 (C), 114.5 (C), 111.3 (CH), 74.7 (CH), 73.1 (C), 26.0 (CH3), 25.0 (CH3),
11.4 (CH3), 9.8 (CH3); rnJz (ESI) found 207.0988 (M + Na+), CIOH)603Na requires
207.0992.
4-Hydroxy-2-methyl-4-(2-methyl-propenyl)-cyclopent-2-enone 193
A solution of the dienedione 163 (lOO mg, 0.60 mmol) and potassium carbonate (83
mg, 0.60 mmol) in THF (50 mL) and water (25 mL) were stirred at room temperature
for 20 hrs and then water (30 mL) and diethyl ether (30 mL) were added. The
separated aqueous phase was extracted with diethyl ether (3 x 30 mL) and the
combined organic extracts were then dried (MgS04) and concentrated in vacuo.
Purification by chromatography on silica gel, using a gradient of 40% to 50% diethyl
ether in pentane (product eluted at 50%) as eluent, gave the tertiary alcohol (53 mg,
53%) as a colourless oil. vrnax/cm')(CHCh solution): 3592, 2922, 2253, 1709, 1663; 8H
(400 MHz): 7.11 (q, IH, J 1.4, CH=CMe), 5.46 (app. heptet, 1H, J 1.4, (MehC=CH),
2.70 (s, 2H, CH2C=O), 2.32 (br. s, IH, C(OH)CH2), 1.80 (d, 3H, J 1.4, MeMeC=CH),
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1.77 (d, 3H, J 1.4, CH=CMe), 1.73 (d, 3H, J lA, MeMeC=CH); &c(lOO MHz): 207.4
(C), 159.5 (CH), 140.6 (C), 138.4 (C), 127.7 (CH), 75.4 (C), 51.8 (CH2), 26.6 (Cl-h),
19.3 (CH3), 9.7 (CH3); mlz (ESI) found 189.0880 (M + Na+), CIOH)402Na requires
189.0886.
(E)-3, 7-Dimethyl-octa-3,6-diene-2,5-dione 194
A solution of the Z-dienedione 163 (5 mg, 0.03 mmol) and iodine (2 drops of a
solution formed by dissolving 1 crystal of iodine in 5 mL of CDCh) in CDCh (0.60
mL) were allowed to stand at room temperature, exposed to laboratory light, for 20
hrs and then the mixture was concentrated in vacuo. Purification by chromatography
on silica gel, using a gradient of 10% to 15% diethyl ether in pentane (product eluted
at 15%) as eluent, gave the Esdienedione (5 mg, 90%) as a colourless oil. vmax/cm')
(CHCh solution): 2926, 2854, 1674, 1623; &H (400 MHz): 6.86 (q, lH, J 1.4,
CH=CMe), 6.22 (app. hept, IH, J 1.2, (Me)2C=CH), 2.39 (s, 3H, C(O)Me), 2.23 (d,
3H, J 1.2, MeMeC=CH), 2.15 (d, 3H, J 1.4, CH=CMe), 1.97 (d, 3H, J 1.2,
MeMeC=CH); &c(100 MHz): 200.8 (C), 191.9 (C), 158.4 (C), 146.2 (C), 134.9 (CH),
125.2 (CH), 28.0 (CH3), 26.2 (CH3), 21.1 (CH3), 13.1 (CH3); mlz (ESI) found
189.0879 (M +Na+), CIOH)402Na requires 189.0886.
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(R)-5-«E)-3-Iodo-2-methyl-allyl)-dihydro-furan-2-one 282
The lactone 282 was prepared according to the procedures described for the opposite
enantiomer.17o,193 Commercially available (S)-epichlorohydrin was used.
A solution of n-butyllithium (2.70 mL, 6.70 mmol, 2.5 M in hexanes) was added
dropwise over 5 mins to a stirred solution of ethoxyacetylene (1.60 mL, 8.03 mmol,
50% w/w in hexanes) in THF (9 mL) at -78 QCunder a nitrogen atmosphere. The
mixture was stirred at this temperature for 20 mins and then boron trifluoride
diethyletherate (0.85 mL, 6.70 mmol) was added dropwise over I min. The mixture
was stirred at -78 QC for 2 mins and then a solution of (R)-2-«E)-3-iodo-2-
methylallyl)-oxiraneI7o,193 (0.60 g, 2.68 mmol) in THF (5 mL) was added dropwise
over 5 mins. The final mixture was stirred at -78 QC for 2 hrs, and then saturated
aqueous NaHC03 (50 ml.), water (50 mL) and diethyl ether (50 mL) were added and
the mixture was then warmed to room temperature. The separated aqueous phase was
extracted with diethyl ether (3 x 80 mL) and the combined organic extracts were then
dried (MgS04) and concentrated in vacuo to leave the secondary alcohol as a light
yellow oil that was used without further purification. p-Toluenesulfonic acid (51 mg,
0.27 mmol) was added in one portion to a stirred solution of the crude secondary
alcohol in ethanol (12 mL). The mixture was stirred at room temperature for 2 hrs and
then concentrated in vacuo and again directly dissolved in chloroform (25 mL). The
mixture was heated to reflux for 15 hrs, cooled to room temperature and then
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saturated aqueous NaHC03 (20 mL) was added. The separated aqueous phase was
extracted with chloroform (3 x 50 mL) and the combined organic extracts were then
dried (MgS04) and concentrated in vacuo. Purification by chromatography on silica
gel, using a gradient of 20%, 30% to 50% diethyl ether in petroleum ether (product
eluted at 50%) as eluent, gave the lactone (545 mg, 77%) as a colourless oil. [a]~I-
41.3 (c 3.5 in CH2Ch), lit.170,193 [a]~2 +41.8 (c 3.5 in CH2Ch); vrna· '/cm-I (CHCh
solution): 2947, 1770; ~H (360 MHz): 6.08 (q, IH, J 1.0 , ICH=C), 4.66-4.56 (m, 1H,
CH(O)CH2), 2.63 (ddd, IH, J 14.4, 7.4 and 0.8, C=C(Me)CHH), 2.52 (dd, 2H, J 9.6
and 6.9, CH2C=O), 2.49 (ddd, IH, J 14.4, 5.5 and 0.8, C=C(Me)CHH), 2.36-2.26 (m,
IH, CHHCH2C=O), 1.93-1.80 (m, 1H, CHHCH2C=O), 1.88 (d, 3H, .J 1.0,
C=C(Me)CH2); ~c (90 MHz): 176.6 (C), 142.7 (C), 78.5 (CH), 78.3 (CH), 44.8 (CH2),
28.4 (CH2), 27.5 (CH2), 24.3 (CH3); mlz (ESI) found 288.9695 (M + Na+),
CgHII02INa requires 288.9696.
(S)-5-«E)-3-Iodo-2-methyl-allyl)-3-phenylselanyl-dihydro-furan-2-one 238
o
A solution of the lactone 282 (545 mg, 2.05 mmol) in THF (4 mL) was added
dropwise over 10 mins to a stirred solution of LiHMDS (2.25 mL, 2.25 mmol, 1.0 M
in THF) in THF (4 mL) at -78°C under a nitrogen atmosphere. The mixture was
stirred at this temperature for 15 mins and then trimethylchlorosilane (0.29 mL, 2.25
mmol) was added dropwise over 1 min. The mixture was stirred at -78°C for 30 mins
and then a solution of phenylselenium bromide (531 mg, 2.25 mmol) in THF (4 mL)
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was added dropwise over 10 mins. The final mixture was stirred at -78 QCfor 30 mins
and then warmed to room temperature and stirred for 30 mins. Saturated aqueous
NH4CI (15 mL), water (40 mL) and diethyl ether (80 mL) were added to the mixture
and the separated aqueous phase was extracted with diethyl ether (3 x 80 mL). The
combined organic extracts were then dried (MgS04) and concentrated in vacuo.
Purification by chromatography on silica gel, using a gradient of 10%, 20%, to 30%
diethyl ether in petroleum ether (product eluted at 30%) as eluent, gave the seleno-
lactone (691 mg, 80%) as a mixture of diastereoisorners. vrnax/crn-I(CHCh solution):
2920,1770; OH (360 MHz): 7.69-7.62 (m, 2H, SePh), 7.42-7.30 (m, 3H, SePh), 6.03
(q, 0.60H, J 1.0, ICH=C), 5.97 (q, 0.40H, J 1.0, lCH=C), 4.57-4.48 (m, 0.40H,
CH(O)CH2), 4.40-4.31 (m, 0.60H, CH(O)CH2), 4.01 (app. t, 0.40H, J 9.4, CHSePh),
3.93 (dd, 0.60H, J 6.1 and 4.8, CHSePh), 2.72 (ddd, 0.40H, J 13.7, 9.4 and 6.8,
CHHCHSePh), 2.58 (dd, 0.60H, J 14.4 and 7.5, C=C(Me)CHH), 2.47-2.37 (m, 0.40H,
C=C(Me)CHH and 0.60H, C=C(Me)CHH), 2.35-2.25 (m, 0.40H, C=C(Me)CHH,
0.60H, CHHCHSePh and 0.60H, CHHCHSePh), 1.97-1.87 (m, 0.40H,
CHHCHSePh), 1.82 (d, 1.80H, J 1.0, C=C(Me)CH2), 1.80 (d, 1.20H, J 1.0,
C=C(Me)CH2); Oc (90 MHz): 175.3 (C), 175.2 (C), 142.3 (2 x C), 135.8 (2 x CH),
135.7 (2 x CH), 129.4 (2 x CH), 129.3 (2 x CH), 129.2 (CH), 129.0 (CH), 126.7 (C),
126.4 (C), 78.8 (CH), 78.7 (CH), 76.8 (CH), 76.5 (CH), 44.7 (CH2), 44.3 (CH2), 36.9
(CH), 36.5 (CH), 36.2 (CH2), 35.0 (CH2), 24.1 (2 x CH3); rn/z (ESI) found 422.9355
(M + H+), CI4HI602ISe requires 422.9355.
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(5-Bromo-2-methyl-(E)-pent-2-enyloxy)-tert-butyl-diphenyI-silane 279
Br~OTBDPS
tert-Butyldiphenylsilyl chloride (0.34 g, 0.32 mL, 1.23 mmol) was added in dropwise
over 10 mins to a stirred solution of the allylic alcohol 253199 (0.20 g, 1.12 mmol) and
imidazole (91 mg, 1.34 mmol) in anhydrous DMF (0.6 mL) at 0 °C under a nitrogen
atmosphere. After 10 mins of stirring at 0 °C, diethyl ether (20 mL) and silica gel (-2
g) were added and the resulting suspension was concentrated in vacuo. Direct
purification by Purification by chromatography on silica gel (anhydrous loading) with
5% diethyl ether in petroleum ether as eluent, gave the bromide (0.42 g, 90%) as a
colourless oil. vrnax/cm-I(CHCh solution): 2932, 2859, 1590, 643; Oil (360 MHz):
7.75-7.69 (m, 4H, SitBu(Ph)2), 7.49-7.37 (m, 6H, SitBu(Ph)2), 5.53 (tq, 1H, .J 7.2 and
lA, CH=C(Me)CH2), 4.10 (s, 2H, CH20TBDPS), 3.39 (t, 2H, .J 7.2, CH2Br), 2.66
(app. q, 2H, J 7.2, CH2CH2Br), 1.64 (d, 3H, .J lA, CH=C(Me)CH2), 1.11 (s, 9H,
Si(Ph)2C(Me)3); Dc (90 MHz): 137.1 (C), 135.5 (4 x CH), 133.7 (2 x C), 129.6 (2 x
CH), 127.6 (4 x CH), 120.4 (CH) 68.4 (CH2), 32.6 (CH2), 31.1 (CH2), 26.8 (3 x CH3),
19.3 (C), 13.7 (CH3); mlz (ESI) found 439.1041 (M + Na+), C22H290BrSiNa requires
439.1063.
5-(tert-Butyl-diphenyl-silanyloxy )-4-methyl-(E)-pent-3-en-l-ol 280
HO~OTBDPS
Potassium acetate (0.30 g, 3.03 mmol) was added in one portion to a stirred solution
of the bromide 279 (0.42 g, 1.01 mmol) in anhydrous DMF (3.5 mL) at room
temperature under a nitrogen atmosphere. The resulting mixture was heated to 100°C
for 17 hrs, cooled to room temperature and then diethyl ether (30 mL) and water (20
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mL) were added. The separated aqueous phase was extracted with diethyl ether (2 x
30 mL) and the combined organic extracts were then dried (MgS04) and concentrated
in vacuo to leave the acetyl alcohol as a light yellow oil that was used without further
purification. Potassium carbonate (0.49 g, 3.53 mmol) was added in one portion to a
stirred solution of the crude acetyl alcohol in methanol (14 mL) at room temperature.
The mixture was stirred at this temperature for 90 mins and then diethyl ether (30 mL)
and water (20 mL) were added. The separated aqueous layer was extracted with
diethyl ether (3 x 30 mL) and the combined organic extracts were then dried (MgS04)
and concentrated in vacuo. Purification by chromatography on silica gel, using 40%
diethyl ether in petroleum ether as eluent, gave the alcohol (0.30 g, 83%) as a
colourless oil. vmax/cm·1 (CHCh solution): 3625, 2932, 2859, 1589; 811 (360 MHz):
7.76-7.68 (m, 4H, SitBu(Phh), 7.49-7.36 (m, 6H, SitBu(Ph)2), 5.47 (tq, IH, J 7.4 and
1.4, CH=C(Me)CH2), 4.12 (s, 2H, CH20TBOPS), 3.65 (t, 2H, J 6.6, CH20H), 2.35
(dt, 2H, J 7.4 and 6.6, CH2CH20H), 1.67 (d, 3H, J 1.4, CH=C(Me)CH2), 1.66 (br. s,
IH, CH20H), 1.11 (s, 9H, Si(PhhC(Me)3); 8e (90 MHz): 137.3 (C), 135.5 (4 x CH),
133.7 (2 x C), 129.6 (2 x CH), 127.6 (4 x CH), 119.7 (CH) 68.7 (CH2), 62.3 (CH2),
31.0 (CH2), 26.8 (3 x CH3), 19.2 (C), 13.6 (CH3); mlz (ESI) found 377.1904 (M +
Na+), C22H3002SiNa requires 377.1907.
5-(tert-Butyl-diphenyl-silanyloxy)-4-methyl-(E)-pent-3-enal 277
O~OTBDPS
Dess-Martin periodinane (168 mg, 0.40 mmol) was added in one portion to a stirred
solution of the alcohol 280 (94 mg, 0.26 mmol) in OCM (l0 mL) at room
temperature. The mixture was stirred at this temperature for 30 mins, and then
saturated aqueous Na2S203 and saturated aqueous NaHC03 (30 mL, 1:1) were added
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and the resulting biphasic mixture was stirred vigorously for 45 mins. The separated
aqueous phase was extracted with OCM (3 x 20 mL) and the combined organic
extracts were then dried (MgS04) and concentrated in vacuo. Purification of the crude
mixture by filtration through a short plug of silica gel, using diethyl ether as eluent,
gave the aldehyde (93 mg, 100%) as a colourless oil. vmax/cm-I (CHCb solution):
2932,2859, 1724, 1693, 1590; DH (360 MHz): 9.66 (t, 1H, J2.1, CHO), 7.76-7.65 (m,
4H, SitBu(Ph)z), 7.50-7.36 (m, 6H, SitBu(Ph)2), 5.73 (tq, IH, J 7.3 and 1.5,
CH=C(Me)CH2), 4.15 (s, 2H, CH20TBDPS), 3.20 (dd, 2H, J 7.3 and 2.1, CH2CHO),
1.64 (d, 3H, J 1.5, CH=C(Me)CH2), 1.11 (s, 9H, Si(Ph)zC(Me)3); Dc (90 MHz): 199.8
(CH), 139.7 (C), 135.5 (4 x CH), 133.5 (2 x C), 129.6 (2 x CH), 127.6 (4 x CH),
112.5 (CH), 68.2 (CH2), 42.8 (CH2), 26.8 (3 x CH3), 19.2 (C), 13.8 (CH3); mlz (ESI)
found 353.1915 (M + H+), C22H2902Sirequires 353.1931.
3- [3-(tert- Butyl-dimethyl-silanyloxy )-l-hydroxy-propy 1]-(R)-5-( (E)-3-iodo- 2-
methyl-allyl)-5H-furan-2-one 286a and 286b
OTBS OTBS
A solution of the seleno-Iactone 238 (192 mg, 0.46 mmol) in THF (10 mL) was added
dropwise over 20 mins to a stirred solution of LiHMDS (0.50 mL, 0.50 mmol, 1.0 M
in THF) in THF (10 mL) at -78 DC under a nitrogen atmosphere. The mixture was
stirred at this temperature for 50 mins and then a solution of 3-(tert-butyl-dimethyl-
silanyloxy)-propionaldehyde 278205,244(172 mg, 0.91 mmol) in THF (10 mL) was
added dropwise over 20 mins. The final mixture was stirred at -78 DC for 1 hr and
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then saturated aqueous NH4CI (50 mL), water (50 mL) and diethyl ether (50 mL) were
added and the biphasic solution was then warmed to room temperature. The separated
aqueous phase was extracted with diethyl ether (3 x 50 ml.) and the combined organic
extracts were then dried (MgS04) and concentrated in vacuo to leave the seleno-
alcohol as a yellow oil that was used without further purification. A solution of
hydrogen peroxide (0.20 mL, 30% w/w in water) was added dropwise over 1 min to a
stirred solution of the crude seleno-alcohol and pyridine (12 mL) in DCM (12 mL) at
room temperature under a nitrogen atmosphere. The mixture was stirred at this
temperature for 1 hr, and then saturated aqueous NaHC03 (30 ml.), water (30 ml.)
and DCM (40 mL) were added. The separated aqueous phase was extracted with
DCM (3 x 40 mL) and the combined organic extracts were then concentrated in
vacuo. The crude mixture was dissolved in DCM (100 mL), washed with saturated
aqueous CUS04 (3 x 50 mL) and then dried (MgS04) and concentrated in vacuo.
Purification by chromatography on silica gel, using a gradient of 30% to 40% diethyl
ether in petroleum ether (product eluted at 40%) as eluent, gave the alcohol (182 mg,
99%) as separable diastereoisomers. I" isomer (minor): [a]~ +16.2 (c 2.0 in CH2Cb)~
vmax/cm-I(CHCh solution): 3444,2930,2858, 1755, 1618~ DH (360 MHz): 7.32 (app.
t, IH, J 1.7, CH=CCH), 6.14 (q, IH, J 1.0, ICH=C(Me)CH2), 5.08-5.02 (m, IH,
CH(O)CH), 4.71 (ddd, IH, J 8.6, 4.0 and 1.7, CH(OH)CH2), 4.37 (br. s, IH,
CH(OH)CH2), 3.96-3.86 (m, 2H, CH20TBS), 2.62-2.54 (m, 2H, C=C(Me)CH2), 2.17-
2.08 (m, IH, CHHCH20TBS), 1.93 (d, 3H, J 1.0, ICH=C(Me)CH2), 1.85-1.74 (m,
IH, CHHCH20TBS), 0.91 (s, 9H, Si(MehC(Me)3), 0.10 (s, 3H, SitBuMeMe), 0.09 (s,
3H, SitBuMeMe)~ Dc (90 MHz): 171.5 (C), 148.0 (CH), 141.8 (C), 137.3 (C), 79.4 (2
x CH), 68.5 (CH), 62.7 (CH2), 42.8 (CH2), 36.0 (CH2)' 25.8 (3 x CH3), 24.5 (CH3),
18.0 (C), -5.6 (2 x CH3)~mlz (ESI) found 453.0950 (M + H+), CI7H3004ISi requires
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453.0953. 2nd isomer (major): [a]~ -13.5 (c 2.0 in CH2Cb); vmax!cm-I (CHCh
solution): 3449,2930,2858, 1756, 1618; bH (360 MHz): 7.31 (app. t, IH, J 1.7,
CH=CCH), 6.13 (q, IH, J 1.0, ICH=C(Me)CH2), 5.11-5.04 (m, IH, CH(O)CH), 4.72
(br. d, IH, J 8.3, CH(OH)CH2), 4.34 (br. s, IH, CH(OH)CH2), 3.96-3.85 (m, 2H,
CH20TBS), 2.69-2.52 (m, 2H, C=C(Me )CH2), 2.17-2.08 (m, 1H, CHHCH20TBS),
1.93 (d, 3H, J 1.0, ICH=C(Me)CH2), 1.86-1.74 (m, IH, CHHCl-hOTBS), 0.92 (s, 9H,
Si(Me)2C(Me)3), 0.11 (s, 3H, Si'BuMeMe), 0.10 (s, 3H, Si'BuMeMe); be (90 MHz):
171.5 (C), 147.9 (CH), 141.7 (C), 137.5 (C), 79.4 (2 x CH), 68.4 (CH), 62.8 (CH2),
42.7 (CH2), 36.2 (CH2), 25.8 (3 x CH3), 24.7 (CH3), 18.0 (C), -5.5 (CH3), -5.6 (CH3);
mlz (ESI) found 453.0939 (M + H+), C17H3004ISi requires 453.0953.
3- [1,3-Bis-(tert-butyl-dimethyl-silanyloxy )-(R)-1-propyl]-(R)-5-( (E)-3-iodo-2-
methyl-allyl)-5H-furan-2-one 286c
ores
tert-Butyldimethylsilyl trifluoromethanesulfonate (0.13 mL, 0.56 mmol) was added
dropwise over 2 mins to a stirred solution of the alcohol (-)-286a (85 mg, 0.19 mmol)
and 2,6-lutidine (0.54 mL, 4.67 mmol) in DCM (10 mL) at -78°C under a nitrogen
atmosphere. The mixture was stirred at this temperature for 90 mins, and then
methanol (5 mL) was added and the mixture was then warmed to room temperature.
Diethyl ether (25 mL) was added to the mixture and the organic phase was
sequentially washed with saturated aqueous CUS04 (25 ml.), water (25 mL) and brine
(25 mL) and then dried (MgS04) and concentrated in vacuo. Purification by
ores
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chromatography on silica gel. using a gradient of 10% to 20% diethyl ether in
petroleum ether (product eluted at 10%) as eluent, gave the silyl ether (92 mg, 87%)
as a colourless oil. [a]~2 -41.3 (c 2.0 in CH2Cb); vrnax/cm-1 (CHCh solution): 2929,
2857,1757,1618; DH (360 MHz): 7.16 (app. t, IH, J 1.5, CH=CCH), 6.13 (q, IH, J
1.0, ICH=C(Me)CH2), 5.06-4.97 (m, IH, CH(O)CH), 4.70-4.61 (m, IH,
CH(OTBS)CH2), 3.78-3.62 (m, 2H, CH20TBS), 2.63 (dd, IH, J 14.3 and 5.0,
C=C(Me)CHH), 2.51 (dd, IH, J 14.3 and 7.7, C=C(Me)CHH), 2.02-1.89 (m, IH,
CHHCH20TBS), 1.93 (d, 3H, J 1.0, ICH=C(Me)CH2), 1.79-1.69 (m, IH,
CHHCH20TBS), 0.91 (s, 9H, Si(MehC(Me)J), 0.90 (s, 9H, Si(Me)2C(Me)3), 0.09 (s,
3H, SitBuMeMe), 0.06 (s, 3H, SitBuMeMe), 0.05 (s, 3H, SitBuMeMe), 0.00 (s, 3H,
SitBuMeMe); Dc (90 MHz): 171.1 (C), 147.5 (CH), 141.9 (C), 139.2 (C), 79.3 (CH),
79.1 (CH), 64.7 (CH), 58.9 (CH2), 42.8 (CH2), 39.9 (CH2), 25.9 (3 x CH3), 25.8 (3 x
CH3), 24.6 (CH3), 18.3 (C), 18.1 (C), -4.7 (CH3), -5.1 (CH3), -5.2 (CH3), -5.3 (CH3);
mlz (ESI) found 567.1820 (M + H+), C23H4404ISi2requires 567.1817.
3-1(R)-l-(tert- Butyl-dimethyl-silanyloxy )-3-hydroxy-propyl) -(R)-S-( (E)-3-iodo-2-
methyl-allyl)-SH-furan-2-one 286d
orBS
A solution of the silyl ether (-)-286c (336 mg, 0.59 mmol) and pyridinium para-
toluenesulfonate (149 mg, 0.59 mmol) in methanol (15 mL) and DCM (15 mL) was
stirred at room temperature for 15 hrs and then the mixture was concentrated in vacuo.
Water (25 mL) and diethyl ether (25 mL) were added to the residue and the separated
OH
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aqueous phase was extracted with diethyl ether (3 x 25 mL) and the combined organic
extracts were then dried (MgS04) and concentrated in vacuo. Purification by
chromatography on silica gel, using a gradient of 50% diethyl ether in petroleum ether
to 100% ethyl acetate (product eluted at 100% ethyl acetate) as eluent, gave the
alcohol (231 mg, 86%) as a colourless oil. [(l]~-49.8 (c 2.1 in CH2Clz); vma)cm-1
(CHCh solution): 3526,2931,2858,1755,1618; 8H (360 MHz): 7.23 (app. t, IH, J
1.5, CH=CCH), 6.12 (q, IH, J 1.0, ICH=C(Me)CH2), 5.11-5.03 (m, IH, CH(O)CH),
4.79-4.72 (m, IH, CH(OTBS)CH2), 3.74-3.62 (m, 2H, CH20H), 2.68 (dd, IH,.J 14.4
and 4.9, C=C(Me)CHH), 2.52 (dd, 1H, J 14.4 and 7.5, C=C(Me)CHH), 2.44 (br. s,
IH, CH20H), 2.05-1.85 (m, 2H, CH2CH20H), 1.90 (d, 3H, J 1.0, ICH=C(Me)CH2),
0.90 (s, 9H, Si(Me)zC(Me)3), 0.10 (s, 3H, Si'BuMeMe), 0.02 (s, 3H, SitBuMeMe); 8c
(90 MHz): 171.4 (C), 148.4 (CH), 141.6 (C), 138.2 (C), 79.5 (2 x CH), 66.7 (CH),
59.1 (CH2), 42.4 (CH2)' 38.3 (CH2), 25.7 (3 x CH3), 24.7 (CH3), 17.9 (C), -4.9 (CH3),
-5.2 (CH3); mlz (ESI) found 453.0962 (M + H+), C17H3004ISirequires 453.0953.
(R)-5-(tert-Butyl-dimethyl-silanyloxy)-5-(R)-5-«E)-3-iodo-2-methyl-allyl)-2-oxo-
2,5-dihydro-furan-3-yl)-(E)-2-methyl-pent-2-enoic acid ethyl ester 288
Dess-Martin periodinane (397 mg, 0.94 mmol) was added in one portion to a stirred
solution of the alcohol (-)-286d (212 mg, 0.47 mmol) in DCM (25 mL) at room
temperature. The mixture was stirred at this temperature for 45 mins and then
saturated aqueous Na2S203 and saturated aqueous NaHC03 (20 mL, 1:1) were added
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and the resulting biphasic mixture was stirred vigorously for 45 mins. The separated
aqueous phase was extracted with OCM (3 x 30 mL) and the combined organic
extracts were then dried (MgS04) and concentrated in vacuo to leave the aldehyde as
a colourless oil that was used without further purification. bH (360 MHz): 9.73 (dd,
IH, J 2.5 and 1.9, CHO), 7.24 (app. t, IH, J 1.6, CH=CCH), 6.12 (q, IH, J 1.0,
ICH=C(Me)CH2), 5.12-5.03 (m, IH, CH(O)CH), 5.03-4.95 (m, IH, CH(OTBS)CH2),
2.81 (ddd, IH, J 16.0, 4.1 and 1.9, CHHCHO), 2.75-2.61 (m, 2H, CHHCHO and
C=C(Me)CHH), 2.57-2.46 (m, IH, C=C(Me)CHH), 1.90 (d, 3H, J 1.0,
ICH=C(Me)CH2), 0.88 (s, 9H, Si(MehC(Meh), 0.09 (s, 3H, Si'BuMeMe), 0.03 (s, 3H,
Si'BuMeMe). Phosphorane 273 (339 mg, 0.94 mmol) was added in one portion to a
stirred solution of the crude aldehyde in THF (25 mL) at room temperature under a
nitrogen atmosphere. The mixture was stirred at room temperature for 24 hrs and then
concentrated in vacuo. Purification by chromatography on silica gel, using a gradient
of 5%, 10% to 20% diethyl ether in petroleum ether (product eluted at 20%) as eluent,
gave the a,p-unsaturated ester (238 mg, 95%) as a colourless oil. [a]g -40.5 (c 2.0 in
CH2Ch); vrnax/cm') (CHCI3 solution): 2930, 2858, 1755, 1704, 1651; bH (360 MHz):
7.19 (app. t, IH, J 1.5, CH=CCH), 6.75 (ddq, IH, J 8.4, 6.5 and 1.3,
CH=C(Me)C02Et), 6.10 (q, IH, J 1.0, ICH=C(Me)CH2), 5.08-5.01 (m, IH,
CH(O)CH), 4.67-4.60 (m, IH, CH(OTBS)CH2), 4.16 (q, 2H, J 7.1, C02CH2Me),
2.66-2.54 (m, 2H, C=C(Me)CH2), 2.53-2.42 (m, 2H, CH(OTBS)CH2), 1.89 (d, 3H, J
1.0, ICH=C(Me)CH2), 1.80 (d, 3H, J 1.3, CH=C(Me)C02Et), 1.26 (t, 3H, J 7.1,
C02CH2Me), 0.88 (s, 9H, Si(MehC(Me)J), 0.05 (s, 3H, Si'BuMeMe), -0.01 (s, 3H,
Si'BuMeMe); be (90 MHz): 171.0 (C), 167.6 (C), 148.4 (CH), 141.6 (C), 137.9 (C),
136.6 (CH), 130.1 (C), 79.4 (CH), 79.2 (CH), 66.8 (CH), 60.3 (CH2)' 42.7 (CH2), 35.5
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(CH2), 25.6 (3 x CH3), 24.5 (CH3), 18.0 (C), 14.2 (CH3), 12.6 (CH3), -4.9 (CH3), -5.1
(CH3); m/z (ESI) found 552.1646 (M + NH4+), C22H390sNISi requires 552.1642.
3-Methoxymethoxy-2-methylene-pentanoic acid methyl ester 303a
MOM-CI (1.19 mL, 15.6 mmol) was added over 2 mins to a stirred solution of 3-
hydroxy-2-methylene-pentanoic acid methyl ester 302 (500 mg, 3.12 mmol) and
DIPEA (5.4 mL, 31.2 mmol) in DCM (20 mL) at 30 QCunder a nitrogen atmosphere.
The mixture was stirred at this temperature for 24 hrs and then DCM (lOO mL) and
water (50 mL) were added. The separated aqueous phase was extracted with DCM (3
x 50 mL) and the combined organic extracts were then dried (MgS04) and
concentrated in vacuo. Purification by chromatography on silica gel, using a gradient
of 10% to 20% diethyl ether in petroleum ether (product eluted at 20%) as eluent,
gave the MOM-ether (497 mg, 85%) as a colourless oil. (Found C, 57.5; H, 8.5,
C9HI604 requires C, 57.4; H, 8.6); vmax/cm-I (CHCb solution): 2936, 2891, 1715,
1629; DH (360 MHz): 6.26 (d, IH, J 1.5, C=CHH), 5.80 (dd, IH, J 1.5 and 0.8,
C=CHH), 4.56 (d, IH, J 6.7, OCHHOMe), 4.53 (d, IH, J 6.7, OCHHOMe), 4.41
(ddd, IH, J 7.3, 4.6 and 0.8, CH(OMOM)CH2), 3.72 (s, 3H, C02Me), 3.34 (s, 3H,
OCH20Me), 1.78-1.65 (m, IH, CHHMe), 1.63-1.49 (m, IH, CHHMe), 0.90 (t, 3H, J
7.4, CH2Me); Dc (90 MHz): 166.5 (C), 140.9 (C), 125.2 (CH2), 94.7 (CH2), 75.6 (CH),
55.5 (CH3), 51.6 (CH3), 28.4 (CH2), 9.7 (CH3); m/z (ESI) found 211.0931 (M + Na+),
C9H1604Na requires 211.0946.
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3-Methoxymethoxy-2-methylene-pentanoic acid I-methyl-allyl ester 304
A solution oflithium hydroxide (13.3 mL, 13.3 mmol, 1.0 M in water) was added to a
stirred solution of the MOM-ether 303a (250 mg, 1.33 mmol) in THF (10 mL) and
water (5 mL) at room temperature. The mixture was stirred at this temperature for 24
hrs and then acidified to pH 3 using 0.5 M aqueous hydrochloric acid. Diethyl ether
(30 mL) was added to the mixture and the separated aqueous phase was extracted with
diethyl ether (3 x 30 mL). The combined organic extracts were then dried (MgS04)
and concentrated in vacuo to leave the carboxylic acid as a yellow oil that was used
without further purification. I-Buten-3-ol (0.23 mL, 2.66 mmol) in OCM (10 mL)
was added over 5 mins to a stirred solution of the crude carboxylic acid and DMAP
(16 mg, 0.13 mmol) in DCM (10 mL) at 0 °C under a nitrogen atmosphere. DCC (288
mg, 1.39 mmol) was added in one portion and the mixture was warmed to room
temperature and then stirred for 24 hrs. The mixture was filtered, eluting with DCM,
and the filtrate was then concentrated in vacuo. Purification by chromatography on
silica gel, using 10% diethyl ether in petroleum ether as eluent, gave the allylic ester
(188 mg, 62%) as a mixture of diastereoisomers. vrnax/cm-I(CHCh solution): 2934,
2890,1714,1628; OH (360 MHz): 6.30 (d, IH, J 1.5, C=CHH), 5.87 (ddd, 0.50H, J
17.2, 10.6 and 5.8, CH=CHz), 5.86 (ddd, 0.50H, J 17.2, 10.6 and 5.8, CH=CHz), 5.82
(2 x dd, 1H, J 1.5 and 0.8, C=CHH), 5.46-5.37 (m, 1H, CH(O)CH), 5.26 (ddd, O.SOH,
J 17.2, 1.4 and 1.4, CH=CHH), 5.25 (ddd, O.SOH,J 17.2, 1.4 and lA, CH=CHH), 5.15
(dd, O.SOH,J 10.6 and 1.4, CH=CHH), 5.14 (dd, O.SOH,J 10.6 and 1.4, CH=CHH),
4.61 (d, 0.50H, J 6.7, OCHHOMe), 4.60 (d, O.SOH,J 6.7, OCHHOMe), 4.57 (d, 1H, J
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6.7, OCHHOMe), 4.48-4.41 (m, IH, CH(OMOM)CH2), 3.38 (s, 3H, OCH20Me),
1.82-1.69 (m, IH, CHHMe), 1.67-1.53 (m, IH, CHHMe), 1.36 (d, 1.50H, .J 0.9,
MeCH(O)CH), 1.34 (d, 1.50H, .f 0.9, MeCH(O)CH), 0.94 (t, 3H, .J 7.4, CH2Me); Oc
(90 MHz): 165.3 (2 x C), 141.4 (2 x C), 137.5 (2 x CH), 125.0 (CHz), 124.9 (CH2),
115.8 (CH2), 115.7 (CH2), 94.9 (2 x CH2), 75.8 (CH), 75.7 (CH), 71.3 (2 x CH), 55.6
(2 x CH3), 28.5 (2 x CHz), 19.9 (2 x CH3), 9.9 (2 x CH3); m1z (ESI) found 251.1246
(M + Na+), C12H2004Narequires 251.1259.
3-(l-Methoxymethoxy-propyl)-5-methyl-5H-furan-2-one 305
A solution of the allylic ester 304 (40 mg, 0.20 mmol) in OCM (10 mL) was added
over 1 min to a stirred solution of Grubbs second generation catalyst (50 mg, 0.06
mmol) in DCM (10 mL) at room temperature under a nitrogen atmosphere. The
mixture was heated to reflux for 24 hrs, cooled to room temperature and then
concentrated in vacuo. Purification by chromatography on silica gel, using a gradient
of 10%, 20%, 30%, 50% to 100% diethyl ether in petroleum ether (product eluted at
100%) as eluent, gave the butenolide (47 mg, 67%) as a mixture of diastereoisomers.
vmax!cm-I (CHCh solution): 2935, 2891, 1747, 1650; 01-1 (360 MHz): 7.25-7.22 (m,
IH, CH=CCH), 5.09-5.01 (m, IH, CH(O)CH), 4.63 (s, 2H, OCH20Me), 4.42-4.36
(m, IH, CH(OMOM)CH2), 3.37 (s, 3H, OCH20Me), 1.90-1.68 (m, 2H, CH2Me), 1.44
(d, 1.50H, .f2.0, MeCH(O)CH), 1.42 (d, 1.50H,.J 2.0, MeCH(O)CH), 0.93 (2 x t, 3H,
.J 7.4, CH2Me); Oc (90 MHz): 171.9 (C), 171.8 (C), 150.8 (CH), 150.7 (CH), 134.7 (2
x C), 95.2 (2 x CH2), 77.6 (2 x CH), 72.5 (CH), 72.4 (CH), 55.7 (2 x CH3), 26.9
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(CH2), 26.8 (CH2), 19.1 (2 x CH3), 9.3 (CH3), 9.2 (CH3); mlz (ESI) found 223.0931
(M +Na+), CIOHl604Na requires 223.0946.
(E)-6-Iodo-5-methyl-hexa-l,5-dien-3-ol 297b
Dess-Martin periodinane (1.50 g, 3.54 mmol) was added in one portion to a stirred
solution of (E)-4-iodo-3-methyl-but-3-en-I-ol 244b238 (500 mg, 2.36 mmol) and
NaHC03 (1.00 g, 11.8 mmol) in DCM (10 mL) at room temperature. The mixture was
stirred at this temperature for 45 mins, and then saturated aqueous Na2S203, water and
saturated aqueous NaHC03 (30 mL, I:1:I) were added and the resulting biphasic
mixture was stirred vigorously for 45 mins. The separated aqueous phase was
extracted with DCM (3 x 30 mL) and the combined organic extracts were then dried
(MgS04) and concentrated in vacuo to leave the aldehyde as a colourless oil that was
used without further purification. Vinylmagnesium bromide (2.8 mL, 2.83 mmol, 1.0
M in THF) was added dropwise over 15 mins to a stirred solution of the crude
aldehyde in THF (15 mL) at -78 QCunder a nitrogen atmosphere. The mixture was
stirred at this temperature for I hr, then water (l0 mL) and diethyl ether (ID mL) were
added and the mixture was then warmed to room temperature. The separated aqueous
phase was extracted with diethyl ether (3 x 30 mL) and the combined organic extracts
were then dried (MgS04) and concentrated in vacuo. Purification by chromatography
on silica gel, using a gradient of 20% to 30% diethyl ether in petroleum ether (product
eluted at 30%) as eluent, gave the allylic alcohol (226 mg, 40%) as a colourless oil.
vmax/cm-1 (CHCh solution): 3603, 2915, 1710, 1614; DH (360 MHz): 6.02 (q, IH, J
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0.9, ICH=C(Me)CH2)' 5.84 (ddd, 1H, J 17.2, 10.4 and 5.9, CH=CH2), 5.26 (ddd, 1H,
J 17.2, 1.3 and 1.3, CH=CHH), 5.13 (dd, 1H, J 10.4 and 1.3, CH=CHH), 4.29-4.21
(rn, 1H, CH(OH)CH), 2.42 (d, 2H, J 6.9, C=C(Me)CH2), 1.88 (d, 3H, .I 0.9,
ICH=C(Me)CH2) 1.88 (br. s, 1H, CH(OH)CH); Dc (90 MHz): 144.2 (C), 139.8 (CH),
115.1 (CH2), 77.8 (CH), 70.3 (CH), 47.1 (CH2), 24.1 (CH3); mlz (El) found 220.9826
(M+ - OH) (97%), C7HIOI requires 220.9827.
3-Methoxymethoxy-2-methylene-pentanoic acid (E)-4-iodo-3-methyl-l-vinyl-but-
3-enyl ester 308
A solution of lithiurn hydroxide (10.6 mL, 10.6 mrnol, 1.0 M in water) was added to a
stirred solution of the MOM-ether 303a (200 mg, 1.06 mmo1) in THF (10 ml.) and
water (5 mL) at room temperature. The mixture was stirred at this temperature for 24
hrs and then acidified to pH 3 using 0.5 M aqueous hydrochloric acid. Oiethyl ether
(30 rnL) was added to the mixture and the separated aqueous phase was extracted with
diethyl ether (3 x 30 mL) and the combined organic extracts were then dried (MgS04)
and concentrated in vacuo to leave the carboxylic acid as a yellow oil that was used
without further purification. A solution of the vinyl iodide 297b (226 mg, 0.95 mmol)
in DCM (10 mL) was added over 5 mins to a stirred solution of the crude carboxylic
acid and DMAP (13 mg, 0.11 mmol) in OCM (10 mL) at 0 QC under a nitrogen
atmosphere. DCC (230 mg, 1.12 mmol) was added in one portion and the mixture was
warmed to room temperature and then stirred for 24 hrs. The mixture was filtered,
177
eluting with DCM, and the filtrate was then concentrated in vacuo. Purification by
chromatography on silica gel, using a gradient of 10% to 20% diethyl ether in
petroleum ether (product eluted at 20%) as eluent, gave the allylic ester (232 mg,
59%) as a mixture of diastereoisomers. vmax/cm-I(CHCh solution): 2935, 2891, 1714,
1628; DH (360 MHz): 6.27 (d, IH, J 1.5, C=CHH), 5.99 (q, 0.50H, J 1.0,
ICH=C(Me)CH2), 5.98 (q, 0.50H, J 1.0, ICH=C(Me)CH2), 5.82 (dd, IH, J 1.5 and
0.8, C=CHH), 5.79 (2 x ddd, 1H, J 17.2,10.5 and 6.1, CH=CH2), 5.51-5.42 (m, IH,
CH(O)CH), 5.27 (ddd, 0.50H, J 17.2, 1.2 and 1.2, CH=CHH), 5.25 (ddd, 0.50H, J
17.2,1.2 and 1.2, CH=CHH), 5.19 (dd, O.SOH,J 10.5 and 1.2, CH=CHH), 5.18 (dd,
0.50H, J 10.5 and 1.2, CH=CHH), 4.58 (2 x d, IH, J 6.7, OCHHOMe), 4.55 (2 x d,
IH, J 6.7, OCHHOMe), 4.41 (ddd, IH, J 8.2,5.1 and 1.2, CH(OMOM)CH2), 3.36 (2
x s, 3H, OCH20Me), 2.61 (dd, 0.50H, J 14.0 and 8.2, ICH=C(Me)CHH), 2.59 (dd,
0.50H, J 14.0 and 8.2, ICH=C(Me)CHH), 2.48 (dd, 1H, J 14.0 and 5.1,
ICH=C(Me)CHH), 1.86 (d, 3H, J 1.0, ICH=C(Me)CH2), 1.78-1.66 (m, IH, CHHMe),
1.63-1.52 (m, IH, CHHMe), 0.92 (t, 3H, J 7.4, CH2Me); Dc (90 MHz): 165.0 (C),
164.9 (C), 143.0 (2 x C), 141.1 (C), 141.0 (C), 135.4 (2 x CH), 125.3 (2 x CH2), 117.1
(CH2), 117.0 (CH2), 94.8 (2 x CH2), 78.2 (2 x CH), 75.6 (CH), 75.5 (CH), 72.0 (2 x
CH), 55.6 (2 x CH3), 44.2 (CH2), 44.1 (CH2), 28.4 (2 x CH2), 24.0 (CH3), 23.9 (CH3),
9.9 (CH3), 9.8 (CH3); m/z (ESI) found 417.0552 (M + Na+), C1sH2304INa requires
417.0533.
178
5-«E)-3-Iodo-2-methyl-allyl)-3-(1-methoxymethoxy-propyl)-5H-furan-2-one 309
OM OM
A solution of Grubbs second generation catalyst (65 mg, 0.08 mmol) in OCM (8 ml.)
and a solution of the allylic ester 308 (100 mg, 0.25 mmol) in OCM (8 mL) were
added simultaneously over 8 hrs to a refluxing solution of OCM (120 mL) under a
nitrogen atmosphere. The mixture was stirred under reflux for 24 hrs, cooled to room
temperature and then concentrated in vacuo. Purification by chromatography on silica
gel, using a gradient of 30% to 50% diethyl ether in petroleum ether (product eluted at
50%) as eluent, gave the butenolide (57 mg, 62%) as separable diastereoisomers. r
isomer: vmax/Cm,1(CHCb solution): 2930,2853, 1749, 1651, 1617; Oil (360 MHz):
7.22 (app. t, IH, J 1.4, CH=CCH), 6.13 (q, IH, J 1.0, ICH=C(Me)CH2), 5.10-5.04 (m,
IH, CH(O)CH), 4.64 (s, 2H, OCH20Me), 4.44-4.38 (m, IH, CH(OMOM)CH2), 3.39
(s, 3H, OCH20Me), 2.61 (d, 2H, J 6.6, ICH=C(Me)CH2), 1.93 (d, 3H, .J 1.0,
ICH=C(Me)CH2), 1.89-1.67 (m, 2H, CH2Me), 0.94 (t, 3H, .J 7.4, CH2Me); Oc (90
MHz): 171.4 (C), 148.6 (CH), 141.9 (C), 135.8 (C), 95.3 (CH2), 79.3 (CH), 79.2
(CH), 72.6 (CH), 55.8 (CH3), 42.8 (CH2), 26.8 (CH2), 24.6 (CH3), 9.3 (CH3); m/z
(ESI) found 389.0230 (M + Na+), C13HI904INa requires 389.0226; 2nd isomer:
vmax/Cm'l(CHCb solution): 2934,2854,1759,1616; OH (360 MHz): 7.22 (app. t, IH,
.J 1.4, CH=CCH), 6.13 (q, IH,J 1.0, ICH=C(Me)CH2), 5.07 (dddd, IH,.J 7.0,5.8,1.6
and 1.4, CH(O)CH), 4.64 (s, 2H, OCH20Me), 4.42 (dddd, 1H,.J 6.6, 5.1, 1.6 and 1.4,
CH(OMOM)CH2), 3.38 (s, 3H, OCH20Me), 2.65 (dd, IH, .J 14.4 and 5.8,
ICH=C(Me)CHH), 2.59 (dd, 1H, .J 14.4 and 7.0, ICH=C(Me)CHH), 1.92 (d, 3H, .J
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1.0, ICH=C(Me)CH2), 1.90-1.67 (m, 2H, CH2Me), 0.94 (t, 3H, J 7.4, CH2Me); 5e (90
MHz): 171.3 (C), 148.4 (CH), 141.7 (C), l35.9 (C), 95.3 (CH2), 79.5 (CH), 79.2
(CH), 72.5 (CH), 55.8 (CH3), 42.7 (CH2), 26.9 (CH2), 24.8 (CH]), 9.3 (CH3); mlz
(ESI) found 389.0228 (M + Na+), CJ3H1904INa requires 389.0226.
(Z)-6-Iodo-5-methyl-hexa-l,5-dien-3-oI297d
Dess-Martin periodinane (7.50 g, 17.7 mmol) was added in one portion to a stirred
solution of (Z)-4-iodo-3-methyl-but-3-en-l-01 244a 197 (2.50 g, 11.8 mmol) and
NaHC03 (4.95 g, 59.0 mmol) in DCM (60 mL) at room temperature. The mixture was
stirred at this temperature for 45 mins and then saturated aqueous Na2S203, water and
saturated aqueous NaHC03 (45 ml., 1:1:I) were added and the resulting biphasic
mixture was stirred vigorously for 45 mins. The separated aqueous phase was
extracted with DCM (3 x 60 mL) and the combined organic extracts were then dried
(MgS04) and concentrated in vacuo to leave the aldehyde as a colourless oil that was
used without further purification. Vinylmagnesium bromide (35.4 mL, 35.4 mmol, 1.0
M in THF) was added dropwise over 15 mins to a stirred solution of the crude
aldehyde in THF (150 mL) at -78 QCunder a nitrogen atmosphere. The mixture was
stirred at this temperature for 1 hr, then water (60 mL) and diethyl ether (60 mL) were
added and the mixture was then warmed to room temperature. The separated aqueous
phase was extracted with diethyl ether (3 x 60 mL) and the combined organic extracts
were then dried (MgS04) and concentrated in vacuo. Purification by chromatography
on silica gel, using a gradient of 20% to 30% diethyl ether in petroleum ether (product
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eluted at 30%) as eluent, gave the allylic alcohol (1.27 g, 45%) as a colourless oil.
VrnaX/cm-1(CHCh solution): 3605, 2945, 2915, 1645, 1614; cSH (360 MHz): 6.00 (q,
1H, J 1.4, ICH=C(Me)CH2), 5.92 (ddd, IH, .J 17.1, 10.4 and 6.1, CH=CI-b), 5.27
(ddd, 1H, J 17.1,1.3 and 1.3, CH=CHH), 5.12 (dd, IH, J 10.4 and 1.3, CH=CHH),
4.39-4.31 (m, IH, CH(OH)CH), 2.52 (dd, IH, J 13.5 and 8.2, C=C(Me)CHH), 2.42
(dd, IH, J 13.5 and 5.6, C=C(Me)CHH), 1.95 (d, 3H, J 1.4, ICH=C(Me)CH2), 1.93
(br. s, 1H, CH(OH)CH); eSc (90 MHz): 144.3 (C), 140.2 (CH), 114.9 (CH2), 76.9
(CH), 71.2 (CH), 45.8 (CH2), 24.5 (CH3); m/z (El) found 209.9520 (M+ - C2H4)
(100%), CsH701 requires 209.9542.
5-(tert-Butyl-dimethyl-silanyloxy)-3-hydroxy-2-methylene-pentanoic acid methyl
ester 313a
1t IH ~
M80.....1(~ 'OTBS
3-(tert-Butyl-dimethyl-silanyloxy)-propionaldehyde 27820S.244(2.36 g, 12.5 mmol),
methyl acrylate (1.35 mL, 15.0 mmol) and DABCO (1.41 g, 12.5 mmol) in DMF
(0.73 mL) were stirred at room temperature under a nitrogen atmosphere for 4 days
and then diethyl ether (50 mL) and water (50 mL) were added. The separated aqueous
phase was extracted with diethyl ether (3 x 50 mL) and the combined organic extracts
were dried (MgS04) and concentrated in vacuo. Purification by chromatography on
silica gel, using a gradient of 5%, 10%, 20% to 40% diethyl ether in petroleum ether
(product eluted at 20%) as eluent, gave the alcohol (1.75 g, 51%) as a colourless oil.
(Found C, 56.9; H, 9.8, CI3H2604Si requires C, 56.9; H, 9.6); vrnax/cm-I (CHCb
solution): 3461,2930,2858,1714,1631; OH (360 MHz): 6.24 (dd, IH, J 1.5 and 0.8,
C=CHH), 5.92 (app. t, IH,.J 1.5, C=CHH), 4.68-4.61 (m, IH, CH(OH)CH2), 3.95 (d,
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IH, J 4.1, CH(OH)CH2), 3.83-3.75 (m, 2H, CH20TBS), 3.70 (s, 3H, C02Me), 1.97-
1.87 (m, IH, CHHCH20), 1.74-1.63 (m, IH, CHHCH20), 0.86 (s, 91-1,
Si(Me)2C(Me)3), 0.03 (s, 3H, SitBuMeMe), 0.03 (s, 3H, SitBuMeMe); DC (90 MHz):
166.5 (C), 142.3 (C), 124.7 (CH2), 70.2 (CH), 61.8 (CH2), 51.5 (CH), 37.6 (CH2),
25.7 (3 x CH), 18.0 (C), -5.7 (CH3), -5.7 (CH); mlz (ESI) found 297.1488 (M +
5-(tert-Butyl-dimethyl-silanyloxy)-3-methoxymethoxy-2-methylene-pentanoic
acid methyl ester 313b
~ fMO:
MeO .....1( <:»: 'OTBS
MOM-CI (0.97 mL, 12.8 mmol) was added over 2 mins to a stirred solution of the
alcohol 313a (1.75 g, 6.38 mmol) and DIPEA (5.6 mL, 31.9 mmol) in OCM (30 mL)
at 30°C under a nitrogen atmosphere. The mixture was stirred at this temperature for
24 hrs and then OCM (50 mL) and water (50 mL) were added. The separated aqueous
phase was extracted with DCM (3 x 50 mL) and the combined organic extracts were
then dried (MgS04) and concentrated in vacuo. Purification by chromatography on
silica gel, using a gradient of 10% to 20% diethyl ether in petroleum ether (product
eluted at 20%) as eluent, gave the MOM-ether (1.80 g, 89%) as a colourless oil.
(Found C, 56.7; H, 9.6, CIsH300sSi requires C, 56.6; H, 9.5); vrnax/cm-I (CI-ICh
solution): 2929,2856,1714,1631; DH (360 MHz): 6.26 (d, IH, J 1.5, C=CHH), 5.81
(dd, IH, J 1.5 and 0.8, C=CHH), 4.61 (ddd, IH,.J 8.6,4.0 and 0.8, CH(OMOM)CH2),
4.57 (d, IH, J 6.7, OCHHOMe), 4.54 (d, m, J 6.7, OCHHOMe), 3.77-3.62 (m, 2H,
CH20TBS), 3.72 (s, 3H, C02Me), 3.33 (s, 3H, OCH20Me), 1.95-1.85 (m, IH,
CHHCH20), 1.82-1.71 (m, IH, CHHCH20), 0.86 (s, 9H, Si(MehC(Meh), 0.01 (s,
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6H, Si(Bu(Me)2); Oc (90 MHz): 166.2 (C), 141.2 (C), 125.4 (CH2), 94.9 (CH2), 71.9
(CH), 59.3 (CH2), 55.6 (CH3), 51.6 (CH3), 38.7 (CH2), 25.8 (3 x CH3), 18.1 (C), -5.4
341.1760.
5-Hydroxy-3-methoxymethoxy-2-methylene-pentanoic acid methyl ester 313c
K YMO:
MeD ....I( ~'OH
Pyridinium para-toluenesulfonate (1.03 g, 4.08 mmol) was added in one portion to a
stirred solution of the MOM-ether 313b (1.30 g, 4.08 mol) in OCM (30 mL) and
methanol (30 mL) at room temperature. The mixture was stirred at this temperature
for 18 hrs and then concentrated in vacuo. Diethyl ether (50 mL) and water (50 ml.)
were added and the separated aqueous phase was extracted with diethyl ether (3 x 50
mL) and the combined organic extracts were then dried (MgS04) and concentrated in
vacuo. Purification by chromatography on silica gel, using 80% ethyl acetate in
petroleum ether as eluent, gave the alcohol (706 mg, 85%) as a colourless oil.
vmax/cm-I(CHCh solution): 3626, 3541, 2953, 2891, 1715, 1630; 011 (360 MHz): 6.31
(d, 1H, J 1.3, C=CHH), 5.87 (app. t, 1H, J 1.3, C=CHH), 4.68 (ddd, 1H, J 8.1,4.3 and
1.3, CH(OMOM)CH2), 4.56 (d, IH, J 6.7, OCHHOMe), 4.54 (d, IH, J 6.7,
OCHHOMe), 3.78-3.63 (m, 2H, CH20H), 3.73 (s, 3H, C02Me), 3.35 (s, 3H,
OCH20Me), 2.61 (br. s, IH, CH20H), 2.00-1.88 (m, IH, CHHCH20), 1.87-1.76 (m,
IH, CHHCH20); Oc (90 MHz): 166.3 (C), 140.5 (C), 125.7 (CH2), 94.9 (Cl-h), 73.1
(CH), 59.6 (CH2), 55.8 (CH3), 51.8 (CH3), 38.0 (CH2); mlz (ESI) found 227.0883 (M
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3-Methoxymethoxy-6-methyl-2-methylene-7-oxo-(E)-hept-5-enoic acid methyl
ester 314
MeO ~O
Dess-Martin period inane (2.20 g, 5.18 mmol) was added in one portion to a stirred
solution of the alcohol 3l3c (706 mg, 3.46 mmol) in DCM (20 mL) at room
temperature. The mixture was stirred at this temperature for 45 mins and then
saturated aqueous Na2S203 and saturated aqueous NaHC03 (20 mL, I: I) were added
and the resulting biphasic mixture was stirred vigorously for 45 mins. The separated
aqueous phase was extracted with DCM (3 x 50 mL) and the combined organic
extracts were then dried (MgS04) and concentrated in vacuo to leave the aldehyde as
a colourless oil that was used without further purification. DH (360 MHz): 9.77 (dd,
IH, J 2.7 and 1.6, CHO), 6.37 (d, IH, J 1.3, C=CHH), 5.95 (app. t, IH, J 1.3,
C=CHH), 5.02 (ddd, IH, J 7.8,4.3 and 1.3, CH(OMOM)CH2), 4.61 (d, IH, J 6.8,
OCHHOMe), 4.58 (d, IH, J 6.8, OCHHOMe), 3.76 (s, 3H, C02Me), 3.34 (s, 3H,
OCH20Me), 2.80-2.65 (m, 2H, CH2CHO). Phosphorane 111 (2.20 g, 6.91 mmol) was
added in one portion to a stirred solution of the crude aldehyde in benzene (50 mL) at
room temperature under a nitrogen atmosphere, and the mixture was stirred under
reflux for 24 hrs and then cooled to room temperature. Saturated aqueous NH4Cl (50
mL) and diethyl ether (50 mL) were added and the separated aqueous phase was
extracted with diethyl ether (3 x 50 mL) and the combined organic extracts were then
dried (MgS04) and concentrated in vacuo. Purification by chromatography on silica
gel, using a gradient of 30% to 40% diethyl ether in petroleum ether (product eluted at
40%) as eluent, gave the a.B-unsaturated aldehyde (600 mg, 72%) as a light yellow
oil. vrnax/cm-1(CHCb solution): 2953, 2893, 2826,1715,1682,1644; DII (360 MHz):
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9.35 (s, IH, CHO), 6.52 (ddq, IH, J 7.6,6.8 and 1.3, CH=C(Me)CHO), 6.31 (d, 1H,.J
1.5, C=CHH), 5.87 (dd, IH, J 1.5 and 0.8, C=CHH), 4.66 (ddd, 1H, J 7.0,4.4 and 0.8,
CH(OMOM)CH2), 4.55 (d, 1H, J 6.8, OCHHOMe), 4.51 (d, 1H, J 6.8, OCHHOMe),
3.71 (s, 3H, C02Me), 3.29 (s, 3H, OCH20Me), 2.75 (ddd, IH, J 15.6, 6.8 and 4.4,
CHHCH=C), 2.62 (ddd, IH, J 15.6, 7.6 and 7.0, CHHCH=C), 1.68 (d, 3H, .J 1.3,
CH=C(Me)CHO); Oc (90 MHz): 194.7 (CH), 165.9 (C), 149.5 (CH), 140.8 (C), 139.7
(C), 126.1 (CH2), 94.7 (CH2), 73.0 (CH), 55.6 (CH3), 51.8 (CH3), 34.6 (CH2), 9.2
(CH3); m/z (ESI) found 265.1049 (M +Na+), CI2H IsOsNa requires 265.1052.
7-Hydroxy-3-methoxymethoxy-6-methyl-2-methylene-(E)-hept-5-enoic acid
methyl ester 315a
o OMOM
MeO~OH
Sodium borohydride (103 mg, 2.72 mmol) was added in one portion to a stirred
solution of the a,~-unsaturated aldehyde 314 (600 mg, 2.48 mmol) in methanol (15
mL) at 0 DC. The mixture was stirred at this temperature for 10 mins and then
saturated aqueous NH4Cl (25 mL) was slowly added followed by diethyl ether (50
mL). The separated aqueous phase was extracted with diethyl ether (3 x 50 mL) and
the combined organic extracts were dried (MgS04) and concentrated in vacuo.
Purification by chromatography on silica gel, using a gradient of 40% to 50% diethyl
ether in petroleum ether and finally 50% ethyl acetate in petroleum ether (product
eluted at 50% ethyl acetate) as eluent, gave the allylic alcohol (345 mg, 57%) as a
colourless oil. vmax/cm-I (CHCh solution): 3616, 3484, 2951, 2892, 1716, 1630; Oil
(360 MHz): 6.30 (d, IH, J 1.3, C=CHH), 5.85 (app. t, IH, J 1.3, C=CHH), 5.46 (ddq,
IH, J 7.2, 7.2 and 1.2, CH=C(Me)CH2), 4.60-4.51 (m, 3H, CH(OMOM)CH2 and
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OCH20Me), 3.97 (br. s, 2H, CH20H), 3.74 (s, 3H, C02Me), 3.34 (s, 3H, OCH20Me),
2.48 (ddd, IH, J 14.8,7.2 and 4.7, CHHCH=C), 2.33 (ddd, IH, J 14.8,7.2 and 7.2,
CHHCH=C), 1.82 (br. s, IH, CH20H), 1.64 (d, 3H, J 1.2, CH=C(Me)CH2); Dc (90
MHz): 166.4 (C), 140.6 (C), 137.2 (C), 125.6 (CH2), 121.1 (CH), 94.8 (CH2), 74.2
(CH), 68.6 (CH2), 55.6 (CH3), 51.8 (CH3), 33.6 (CH2), 13.8 (CH3); mlz (ESI) found
267.1195 (M +Na+), C12H200sNa requires 267.1208.
7-(tert-Butyl-diphenyl-silanyloxy)-3-methoxymethoxy-6-methyl-2-methylene-(E)-
hept-5-enoic acid methyl ester 315b
MeO OTBDPS
tert-Butyldiphenylsilyl chloride (0.37 ml., 1.44 mmol) was added in dropwise over 1
min to a stirred solution of the allylic alcohol 315a (319 mg, 1.31 mmo1) and
imidazole (107 mg, 1.57 mmol) in DMF (0.66 mL) at 0 °C under a nitrogen
atmosphere. After 10 mins of stirring at 0 "C, diethyl ether (20 mL) and silica gel (-2
g) were added and the resulting suspension was concentrated in vacuo. Direct
purification by Purification by chromatography on silica gel (anhydrous loading)
eluting with a gradient of 10% to 20% diethyl ether in petroleum ether (product eluted
at 20%) as eluent, gave the {}.,fJ-unsaturated ester (630 mg, 100%) as a colourless oil.
vrnax/cm-1 (CHCb solution): 2931, 2893, 2858, 1716, 1630, 1589; DH (360 MHz):
7.74-7.68 (m, 4H, Si(Phh'Bu), 7.49-7.36 (m, 6H, Si(Ph)/Bu), 6.37 (d, IH, .J 1.3,
C=CHH), 5.91 (app. t, lH, J 1.3, C=CHH), 5.64 (ddq, IH, J 7.2, 7.2 and 1.3,
CH=C(Me)CH2), 4.66-4.60 (m, 3H, CH(OMOM)CH2 and OCH20Me), 4.11 (br. s,
2H, CH20TBDPS), 3.80 (s, 3H, C02Me), 3.38 (s, 3H, OCH20Me), 2.59 (ddd, 1H, .J
14.7,7.2 and 4.7, CHHCH=C), 2.42 (ddd, IH,.J 14.7, 7.2 and 7.2, CHHCH=C), 1.66
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(d, 3H, J 1.3, CH=C(Me)CH2), 1.12 (s, 9H, Si(PhhC(Me)3); Se (90 MHz): ]66.4 (C),
140.7 (C), 136.3 (C), 135.5 (4 x CH), 133.7 (2 x C), 129.5 (2 x CH), ]27.6 (4 x CH),
125.7 (CH2), 119.4 (CH), 94.7 (CH2), 74.4 (CH), 68.6 (CH2), 55.6 (CH3), 51.7 (CH3),
33.5 (CH2), 26.8 (3 x CH3), 19.2 (C), 13.7 (CH3); m/z (ESI) found 505.2397 (M +
Na+), C28H380sSiNa requires 505.2386.
7-(tert-Butyl-diphenyl-silanyloxy)-3-methoxymethoxy-6-methyl-2-methylene-(E)-
hept-S-enoic acid (Z)-4-iodo-3-methyl-l-vinyl-but-3-enyl ester 316
OTBOPS
A solution of lithium hydroxide (27 mL, 26.9 mmol, 1.0 M in water) was added to a
stirred solution of the a,~-unsaturated ester 31Sb (1.30 g, 2.69 mmol) in THF (80 rnl.)
and water (40 mL) at room temperature. The mixture was stirred at this temperature
for 24 hrs and then acidified to pH 3 using 0.5 M aqueous hydrochloric acid. Diethyl
ether (50 mL) was added to the mixture and the separated aqueous phase was
extracted with diethyl ether (3 x 50 mL). The combined organic extracts were then
dried (MgS04) and concentrated in vacuo to leave the carboxylic acid as a yellow oil
that was used without further purification. Vinyl iodide 297d (962 mg, 4.04 mmol) in
DCM (20 mL) was added over 5 mins to a stirred solution of the crude carboxylic
acid and DMAP (494 mg, 4.04 mmol) in DCM (50 mL) at 0 °C under a nitrogen
atmosphere. DCC (667 mg, 3.23 mmol) was added in one portion and the mixture was
then warmed to room temperature and stirred for 24 hrs. The mixture was filtered,
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eluting with DCM, and the filtrate was then concentrated in vacuo. Purification by
chromatography on silica gel, using 20% ethyl acetate in petroleum ether as eluent,
gave the allylic ester (1.82 g, 99%) as a mixture of diastereoisomers. vmax/cm· 1
(CHCh solution): 2931, 2858,1713,1628,1589; DH (360 MHz): 7.75-7.68 (m, 4H,
Si(Ph)2tBu), 7.49-7.37 (m, 6H, Si(Ph)2tBu), 6.43 (d, IH, J 1.3, C=CHH), 6.05 (q,
0.50H, J 1.4, ICH=C(Me )CH2), 6.03 (q, 0.50H, J 1.4, ICH=C(Me )CH2), 5.94 (d, 1H,
J 1.3, C=CHH), 5.92 (2 x ddd, IH, J 17.2, 10.5 and 6.3, CH=CH2), 5.68-5.58 (m, 2H,
CH=C(Me)CH2 and CH(O)CH), 5.37 (ddd, 0.50H, J 17.2, 1.1 and 1.1, CH=CHH),
5.34 (ddd, 0.50H, J 17.2,1.1 and 1.1, CH=CHH), 5.25 (ddd, 0.50H, J 10.5, 1.1 and
1.1, CH=CHH), 5.23 (ddd, 0.50H, J 10.5,1.1 and 1.1, CH=CHH), 4.67-4.59 (m, 3H,
CH(OMOM)CH2 and OCH20Me), 4.10 (br. s, 2H, CH20TBDPS), 3.38 (2 x s, 3H,
OCH20Me), 2.79 (2 x dd, IH, J 13.7 and 8.5, ICH=C(Me)CHH), 2.63-2.52 (m, IH,
CHHCH=C), 2.55 (2 x dd, IH, J 13.7 and 5.5, ICH=C(Me)CHH), 2.48-2.37 (m, IH,
CHHCH=C), 1.97 (d, 1.50H, J 1.4, ICH=C(Me)CH2), 1.95 (d, 1.50H, J lA,
ICH=C(Me)CH2), 1.65 (s, 3H, CH=C(Me)CH2), 1.11 (s, 9H, Si(Ph)2C(Me)3); Dc (90
MHz): 164.9 (2 x C), 142.9 (2 x C), 140.7 (C), 140.6 (C), 136.2 (2 x C), 135.4 (8 x
CH), 134.7 (2 x CH), 133.7 (4 x C), 129.5 (4 x CH), 127.5 (8 x CH), 125.9 (CH2),
125.8 (CH2), 119.5 (CH), 11904 (CH), 117.2 (CH2), 117.0 (CH2), 94.8 (CH2), 94.7
(CH2), 77.7 (2 x CH), 74.4 (CH), 74.3 (CH), 72.6 (CH), 72.5 (CH), 68.6 (2 x CH2),
55.5 (2 x CH3), 43.2 (2 x CH2), 33.5 (CH2), 33.4 (CH2), 26.8 (6 x CH3), 23.9 (2 x
CH), 19.2 (2 x C), 13.7 (2 x CH3); mlz (ESI) found 711.1970 (M + Na+),
C34H4s0sISiNa requires 711.1973.
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3-[5-(tert-Butyl-diphenyl-silanyloxy)-1-methoxymethoxy-4-methyl-(E)-pent-3-
enyIJ-5-«Z)-3-iodo-2-methyl-allyl)-5H-furan-2-one 276b and 276c
OMOM
A solution of Grubbs second generation catalyst (l08 mg, 0.13 mmol) in OCM (15
mL) and a solution of the allylic ester 316 (292 mg, 0.42 mmol) in DCM (15 mL)
were added simultaneously over 8 hrs to a refluxing solution of OCM (250 rnl.) under
a nitrogen atmosphere. The mixture was stirred under reflux for 24 hrs, cooled to
room temperature and then concentrated in vacuo. Purification by chromatography on
silica gel, using a gradient of 10%, 20%, 30% to 50% diethyl ether in petroleum ether
(product eluted at 50%) as eluent, gave the butenolide (85 mg, 33%) as separable
diastereoisomers. lSI isomer: vmax/cm-I (CHCb solution): 2931, 2857. 1756, 1698.
1652; SH (360 MHz): 7.69-7.64 (m, 4H, Si(Ph)2tBu), 7.46-7.35 (m, 6H, Si(PhhtBu),
7.29 (app. t, IH, J 1.3, CH=CCH), 6.12 (q, IH, J 1.4. ICH=C(Me)CH2), 5.54 (app. tq,
IH, J 7.0 and 1.3, CH=C(Me)CH2), 5.07-5.01 (m, IH, CH(O)CH), 4.66 (s, 2H,
OCH20Me), 4.61-4.55 (m, IH, CH(OMOM)CH2), 4.06 (br. s, 2H, CHzOTBOPS),
3.37 (s, 3H, OCHzOMe), 2.68 (dd, IH, J 13.7 and 6.2, ICH=C(Me)CHH), 2.58 (dd,
IH, J 13.7 and 7.3, ICH=C(Me)CHH), 2.72-2.46 (m, 2H, CH(OMOM)CH2), 1.97 (d,
3H, J 1.4, ICH=C(Me)CH2), 1.60 (d, 3H, J 1.3, CH=C(Me)CH2), 1.06 (s, 9H,
Si(Ph)2C(Me»)); Se (90 MHz): 171.4 (C), 149.1 (CH), 142.2 (C), 137.1 (C), 135.5 (4 x
CH), 135.0 (C), 133.7 (2 x C), 129.6 (2 x CH), 127.6 (4 x CH). 118.2 (CH), 95.1
(CH2), 79.6 (CH), 78.6 (CH), 70.9 (CH), 68.5 (CH2), 55.7 (CH), 42.3 (CH2), 31.6
(CH2), 26.8 (3 x CH), 24.8 (CH), 19.3 (C), 13.8 (CH): m/z (ESI) found 683.] 667
OTBDPS
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(M +Na+), C32H410sISiNa requires 683.1660; 2nd isomer: vrnax/cm-I(CHCh solution):
2932,2857,1757,1652; CH (360 MHz): 7.69-7.64 (m, 4H, Si(PhhtBu), 7.46-7.35 (m,
6H, Si(Ph)2tBu), 7.30 (app. t, IH, J 1.4, CH=CCH), 6.10 (q, 1H, .J 1.5,
ICH=C(Me)CH2), 5.53 (app. tq, IH, J 7.3 and 1.3, CH=C(Me)CH2), 5.11-5.05 (m,
IH, CH(O)CH), 4.65 (s, 2H, OCH20Me), 4.57-4.51 (m, IH, CH(OMOM)CH2), 4.06
(br. s, 2H, CH20TBDPS), 3.36 (s, 3H, OCH20Me), 2.63 (dd, 1H, .J 13.7 and 5.9,
ICH=C(Me)CHH), 2.50 (dd, IH, J 13.7 and 7.7, ICH=C(Me)CHH), 2.68-2.46 (m,
2H, CH2CH=C), 1.96 (d, 3H, J 1.5, ICH=C(Me)CH2), 1.62 (d, 3H, J 1.3,
CH=C(Me)CH2), 1.06 (s, 9H, Si(Ph)2C(Me)3); Cc (90 MHz): 171.4 (C), 149.2 (CH),
142.2 (C), 137.2 (C), 135.5 (4 x CH), 135.0 (C), 133.7 (2 x C), 129.6 (2 x CH), 127.6
(4 x CH), 118.4 (CH), 95.2 (CH2), 79.6 (CH), 78.6 (CH), 71.1 (CH), 68.7 (Cl-h), 55.7
(CH3), 42.4 (CH2), 31.8 (CH2), 26.8 (3 x CH3), 24.8 (CH3), 19.3 (C), 13.8 (CH3); m/z
(ESI) found 683.1655 (M + Na+), C32H4105ISiNa requires 683.1660.
3-(5- Hydroxy-l-methoxymethoxy-4-m ethyl-(E)-pent-3-enyl )-5-( (Z)-3-iodo- 2-
methyl-allyl)-5H-furan-2-one 276d
OMOM
70% Hydrogen fluoride-pyridine complex (0.50 mL, 19.2 mmol) was added to a
stirred solution of the butenolide 276b (36 mg, 0.06 mmol) and pyridine (0.25 mL,
3.09 mmol) in THF (5 mL) at room temperature under a nitrogen atmosphere. The
mixture was stirred at this temperature for 24 hrs, and then saturated aqueous
NaHC03 (5 ml.) and diethyl ether (10 mL) were added. The resulting biphasic
OH
190
mixture was dried (MgS04) and then filtration through a short plug of silica gel using
a gradient of 50% to 80% diethyl ether in petroleum ether and finally 100% ethyl
acetate (product eluted at 100% ethyl acetate) as eluent, gave the allylic alcohol (I8
mg, 77%) as a colourless oil. vrnax/cm-I(CHCb solution): 3616,2926,2855, 1756; DII
(400 MHz): 7.35 (app. t, IH, J 1.4, CH=CCH), 6.15 (q, IH, J 1.5, ICH=C(Me)CH2),
5.46 (app. tq, ut, J7.2 and 1.3, CH=C(Me)CH2), 5.15-5.09 (m, IH, CH(O)CH), 4.65
(s, 2H, OCH20Me), 4.58-4.52 (m, IH, CH(OMOM)CH2), 4.01 (br. s, 2H, CH20H),
3.37 (s, 3H, OCH20Me), 2.68 (dd, IH, J 13.7 and 6.1, ICH=C(Me)CHH), 2.59 (dd,
IH, J 13.7 and 7.3, ICH=C(Me)CHH), 2.63-2.54 (m, 2H, CH2CH=C), 2.00 (d, 3H, J
1.5, ICH=C(Me)CH2), 1.68 (d, 3H, J 1.3, CH=C(Me)CH2), 1.66 (br. s, m, CH20H);
Dc (IOO MHz): 171.4 (C), 149.2 (CH), 142.1 (C), 137.9 (C), 135.1 (C), 119.9 (CH),
95.2 (CH2), 79.6 (CH), 78.8 (CH), 71.0 (CH), 68.6 (CH2), 55.7 (CH3). 42.3 (CH2),
32.0 (CH2), 24.8 (CH3), 14.0 (CH3); mlz (ESI) found 445.0490 (M + Na+),
CI6H2305INa requires 445.0482.
(Z)-5-{3-[4-(5-Hydroxy-l-methoxymethoxy-4-methyl-(E)-pent-3-enyl)-5-oxo-2,5-
dihyd ro- furan-2-y 1)-2-methyl-propeny I}-3-methyl- furan-2-carbaldehyde 317
OMOM
Tetrakis(triphenylphosphine)palladium(O) (53 mg, 0.05 mmol) and CuI (I8 mg, 0.09
mmol) were added in one portion to a stirred, degassed solution of the allylic alcohol
276d (49 mg, 0.12 mmol) and 3-methyl-5-trimethylstannanyl-furan-2-carbaldehyde
OH
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249196 (50 mg, 0.14 mmol) in DMF (5 mL) at room temperature under an argon
atmosphere. The mixture was degassed again then stirred at room temperature for 20
hrs, and then ethyl acetate (20 mL) and water (20 mL) were added. The separated
organic phase was washed with water (4 x 20 mL) and then dried (MgS04). The
organic phase was filtered through a short plug of celite, eluting with ethyl acetate,
and the filtrate was then concentrated in vacuo. Purification by chromatography on
silica gel, using a gradient of 70%, 90% to 100% ethyl acetate in petroleum ether
(product eluted at 100%) as eluent, gave the alkenylfuran (28 mg, 60%) as a light
yellow oil. vmax/cm-I(CHCh solution): 3450, 2983, 2932, 1732, 1661, 1579; DB (400
MHz): 9.64 (s, 1H, CHO), 7.53 (br. s, IH, CH=CCH), 6.20 (s, IH, C(O)=CHCMe),
6.19 (s, 1H, C(O)CH=C(Me)CH2)' 5.47 (app. tq, 1H, J 7.2 and 1.2, CH=C(Me)CH2),
5.23-5.17 (m, 1H, CH(O)CH), 4.65 (s, 2H, OCH20Me), 4.56-4.51 (m, 1H,
CH(OMOM)CH2), 4.00 (br. s, 2H, CH20H), 3.37 (s, 3H, OCH20Me), 3.19 (dd, 1H, J
13.8 and 3.6, C(O)CH=C(Me)CHH), 2.65-2.46 (m, 3H, C(O)CH=C(Me)CHH and
CH(OMOM)CH2), 2.36 (s, 3H, C(O)=CHCMe), 2.06 (s, 3H, C(O)CH=C(Me)CH2),
1.75 (br. s, 1H, CH20H), 1.67 (d, 3H, J 1.2, CH=C(Me)CH2); Dc (lOO MHz): 175.6
(br. CH), 171.8 (C), 156.8 (C), 150.5 (CH), 147.5 (C), 141.8 (br. C), 138.0 (2 x C),
134.6 (C), 119.9 (CH), 115.7 (CH), 114.1 (CH), 95.3 (CH2), 81.5 (CH), 70.9 (CH),
68.6 (CH2), 55.7 (CH3), 38.0 (CH2), 32.0 (CH2), 26.7 (CH3), 14.0 (CH3), 10.1 (Cl-h);
mlz (ESI) found 427.1727 (M +Na+), C22H2807Na requires 427.1727.
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(Z)-5- {3-[4-(5- Bromo-l- methoxymethoxy-4-methyl-(E)-pent-3-eny 1)-5-oxo-2,5-
dihydro-furan-2-yIJ- 2-methyl-propenyl}-3-methyl-furan-2-carbaldehyde 275b
OH
Carbon tetrabromide (13 mg, 0.04 mmol) was added in one portion to a stirred
solution of the alkenylfuran 317 (5 mg, 0.01 mmol) and triphenylphosphine (10 rng,
0.04 mmol) in DCM (5 mL) at 0 °C under a nitrogen atmosphere. The mixture was
stirred at this temperature for 1 hr, heated to 40°C for 30 mins, cooled to room
temperature and then concentrated in vacuo. Purification by chromatography on silica
gel, using a gradient of 50% to 70% ethyl acetate in petroleum ether (product eluted at
70%) as eluent, gave the allylic bromide (2 mg, 40%) as a light yellow oil. 811 (360
MHz): 9.65 (s, IH, CHO), 7.48 (br. s, IH, CH=CCH), 6.21 (s, 2H, C(O)=CHCCMe
and C(O)CH=C(Me)CH2), 5.66 (app. tq, IH, J 7.2 and 1.3, CH=C(Me)CH2), 5.24-
5.18 (m, IH, CH(O)CH), 4.61-4.55 (m, IH, CH(OMOM)CH2), 3.97 (br. s, 2H,
CH2Br), 3.21 (dd, IH, J 13.8 and 4.6, C(O)CH=C(Me)CHH), 2.68-2.44 (m, 3H,
C(O)CH=C(Me)CHH and CH2CH=C), 2.37 (s, 3H, C(O)=CHCMe), 2.06 (s, 3H,
C(O)CH=C(Me)CH2), 1.79 (d, 3H, J 1.3, CH=C(Me)CH2); mlz (ESI) found 445.0623
(M + Na+), C2oH230sBrNa requires 445.0621.
Br
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2-[2-(2-Hydroxy-ethyl)-3-methyl-but-3-enyl]-5-vinyl-furan-3-carboxylic acid
methyl ester 335
Palladium acetate (35 mg, 0.16 mmol) and triphenyl arsene (193 mg, 0.63 mmol)
were added in one portion to a stirred, degassed solution of the bromofuran 334 (0.25
g, 0.79 mmol) and tributyl(vinyl)tin (0.35 mL, 1.18 mmol) in anhydrous DMF (6 mL)
at room temperature under an argon atmosphere. The mixture was heated to 45°C for
17 hrs and then cooled to room temperature where diethyl ether (20 mL) and water
(20 mL) were added. The separated organic phase was washed with water (5 x 10 mL)
and brine (5 x 10 mL) and then filtered through celite, eluting with diethyl ether. The
filtrate was dried (Na2S04) and concentrated in vacuo. Purification by
chromatography on silica gel, using 40% diethyl ether in petroleum ether as eluent,
gave the vinylfuran (236 mg, 100%) as a colourless oil. vmax/cm-I(CHCl) solution):
3623,3526,2951,1725, 1697,1645,1594; CH (360 MHz): 6.44 (s, IH,
C(O)=CHCC02Me), 6.39 (dd, IH, J 17.5 and 11.3, CH=CH2), 5.62 (dd, IH, J 17.5
and 1.1, CH=CHH), 5.17 (dd, IH, J 11.3 and 1.1, CH=CHH), 4.73-4.68 (m, 2H,
CH2=C(Me)CH), 3.80 (s, 3H, C02Me), 3.70-3.53 (m, 2H, CH20H), 3.08 (d, t H, J 7.4,
C(O)CHHCH), 3.08 (d, IH, J 8.0, C(O)CHHCH), 2.81-2.70 (m, 1H, CH(C)CH2),
1.92 (br. s, tH, CH20H), 1.78-1.60 (m, 2H, CH2CH20H), 1.70 (br, s, 3H,
CH2=C(Me)CH); eSc (90 MHz): 164.3 (C), 161.1 (C), 151.1 (C), 146.3 (C), 124.3
(CH), 114.9 (C), 113.0 (CH2), 112.4 (CH2), 108.1 (CH), 60.9 (CH2), 51.3 (CH3), 43.4
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(CH), 35.2 (CH2), 31.8 (CH2), 18.1 (CH3); m/z (ESI) found 287.1235 (M + Na+),
CISH2004Na requires 287.1254.
2-[3-Methyl-2-(2-oxo-ethyl)-but-3-enylJ-5-vinyl-furan-3-carboxylic acid methyl
ester 323
Dess-Martin periodinane (0.48 g, 1.13 mmol) was added in one portion to a stirred
solution of the vinylfuran 335 (0.22 g, 0.76 mmol) in OCM (IO ml.) at room
temperature. The mixture was stirred at this temperature for 75 mins and then
saturated aqueous Na2S203 and saturated aqueous NaHC03 (40 mL, I: 1) were added
and the resulting biphasic mixture was stirred vigorously for 30 mins. The separated
aqueous phase was extracted with DCM (3 x 50 mL) and the combined organic
extracts were washed with saturated aqueous NaHC03 (50 mL), then dried (MgS04)
and concentrated in vacuo. Purification by chromatography on silica gel, using 30%
diethyl ether in petroleum ether as eluent, gave the aldehyde (199 mg, 93%) as a
colourless oil. vrnax/cm-I(CHCh solution): 2953,2922,2856, 1714, 1646, 1597; DI1
(360 MHz): 9.63 (dd, IH, J2.6 and 1.7, CHO), 6.46 (s, IH, C(O)=CHCC02Me), 6.41
(dd, IH, J 17.5 and 11.3, CH=CH2), 5.65 (dd, IH, J 17.5 and 1.0, CH=CHH), 5.20
(dd, IH, J 11.3 and 1.0, CH=CHH), 4.80-4.74 (m, 2H, CH2=C(Me)CH), 3.82 (s, 3H,
C02Me), 3.24-3.04 (m, 3H, C(O)CH2CH and CH(C)CH2)' 2.58 (ddd, IH, J 16.6, 8.0
and 2.6, CHHCHO), 2.48 (ddd, IH, J 16.6, 5.7 and 1.7, CHHCHO), 1.76 (br. s, 3H,
CH2=C(Me)CH); Dc (90 MHz): 201.5 (CH), 164.0 (C), 159.6 (C), 151.4 (C), 145.2
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(C), 124.2 (CH), 115.6 (C), 113.4 (CH2), 112.5 (CH2), 108.1 (CH), 51.4 (CH3), 46.3
(CH2), 40.5 (CH), 31.6 (CH2), 19.4 (CH3); mlz (ESI) found 285.1083 (M + Na+),
CISHIS04Na requires 285.1097.
3-0xiranyl-propionic acid methyl ester 328249-251
O~C02Me
Thionyl chloride (0.80 mL, 11.0 mmol) was added dropwise over 10 mins to a stirred
solution of 4-pentenoic acid 336 (l.OOg, 1.02 mL, 10.0 mmol) in methanol (11 mL) at
o °C under a nitrogen atmosphere. The mixture was stirred at 0 °C for 25 mins and
then basified to pH 9 using saturated aqueous NaHC03. Oiethyl ether (50 mL) and
water (50 mL) were added to the mixture and the separated aqueous phase was
extracted with diethyl ether (3 x 50 mL) and the combined organic extracts were then
filtered through a short plug of silica gel, eluting with diethyl ether. The filtrate was
dried (Na2S04) and concentrated in vacuo to leave the ester as a colourless oil that
was used without further purification. A solution of meta-chloroperbenzoic acid
(4.92g, 20.0 mmol, 70-75% weight balance) in OCM (10 mL) was added dropwise
over 10 mins to a stirred solution of the crude ester and NaHC03 (4.19 g, 50.0 mmol)
in OCM (33 mL) at 0 °C under a nitrogen atmosphere. The mixture was warmed to
room temperature and stirred for 15 hrs and then filtered, eluting with DCM.
Saturated aqueous Na2S203 (50 mL) was added to the filtrate and the resulting
biphasic mixture was stirred vigorously for 20 mins and then water (lOO mL) and
OCM (100 mL) were added. The separated aqueous phase was extracted with OeM
(3 x 75 mL) and the combined organic extracts were then dried (Na2S04) and
concentrated in vacuo. Purification by chromatography on silica gel, using 30%
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diethyl ether in petroleum ether as eluent, gave the epoxide (0.98 g, 75%) as a
colourless oil. vmax/cm-1(CHCh solution): 2954, 2929, 1732; 8H (360 MHz): 3.66 (s,
3H, C02Me), 2.99-2.92 (m, IH, CH(O)CH2)' 2.74 (dd, IH, J 4.9 and 4.0,
CHH(O)CH), 2.48 (dd, IH, J 4.9 and 2.7, CHH(O)CH), 2.44 (t, 2H, J 7.4,
CH2C02Me), 2.01-1.89 (m, IH, CHHCH2C02Me), 1.80-l.69 (m, IH,
CHHCH2C02Me); .se (90 MHz): 173.2 (C), 51.6 (CH3), 5l.1 (CH), 46.9 (CH2), 30.0
(CH2), 27.5 (CH2); mJz (ESI) found 153.0534 (M + Na+), C6HlO03Na requires
153.0522.
4-Hydroxy-6-methyl-hept-6-enoic acid methyl ester 363
HOCCO,.o
A solution of isopropenylmagnesium bromide (6.1 mL, 3.02 mmol, 0.5 M in THF)
was added dropwise over 10 mins to a stirred solution ofCuCN (68 mg, 0.75 mmol)
in THF (10 mL) at -78°C under a nitrogen atmosphere. The mixture was stirred at
this temperature for 30 mins and then boron trifluoride diethyl etherate (0.40 mL, 3.02
mmol) was added dropwise over 2 mins. The mixture was stirred at -78°C for 2 mins
and then a solution of the epoxide 328 (196 mg, 1.51 mmol) in THF (5 mL) was
added dropwise over 10 mins. The final mixture was stirred at this temperature for 1
hr and then saturated aqueous NH40H and saturated aqueous NH4CI (20 mL, 1:9),
diethyl ether (50 mL) and water (50 mL) were added. The mixture was warmed to
room temperature and the separated aqueous phase was extracted with diethyl ether (3
x 50 mL) and the combined organic extracts were dried (Na2S04) and concentrated in
vacuo. Purification by chromatography on silica gel, using 45% diethyl ether in
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petroleum ether as eluent, gave the alcohol (156 mg, 60%) as a colourless oil.
vrnax/cm-I (CHCh solution): 3584, 2937, 1732, 1647; OH (360 MHz): 4.84-4.79 (m,
IH, CHH=C(Me)CH2), 4.76-4.71 (m, IH, CHH=C(Me)CH2), 3.76-3.67 (m, m,
CH(OH)CH2), 3.63 (s, 3H, C02Me), 2.52-2.36 (m, 2H, CH2C02Me), 2.22 (br. s, IH,
CH(OH)CH2), 2.18-2.06 (m, 2H, CH2=C(Me )CH2), 1.85-1. 75 (m, 1H,
CHHCH2C02Me), 1.74-1.59 (m, 1H, CHHCH2C02Me), 1.70 (br. s, 3H,
CH2=C(Me)CH2); Oc (90 MHz): 174.3 (C), 142.2 (C), 113.4 (CH2), 67.8 (CH), 51.1
(CH3), 46.0 (CH2), 31.7 (CH2), 30.3 (CH2), 22.2 (CH3); mlz (ESI) found 195.1006 (M
+Na+), C9Hl603Na requires 195.0992.
5-(2-Methyl-allyl)-dihydro-furan-2-one 327
o
A solution of the alcohol 363 (70 mg, 0.41 mmol) and para-toluenesulfonic acid (16
mg, 0.08 mmol) in DCM (2 mL) were stirred at room temperature for 30 mins under a
nitrogen atmosphere, and then saturated aqueous NaHC03 (10 ml.), water (10 mL)
and DCM (10 mL) were added. The separated aqueous phase was extracted with
DCM (3 x 10 mL) and the combined organic extracts were then dried (Na2S04) and
concentrated in vacuo to leave the lactone (57 mg, 100%) as a colourless oil that was
used without further purification. vrnax/cm-1 (CHCh solution): 2940, 1770, 1651; 011
(360 MHz): 4.84-4.80 (m, IH, CHH=C(Me)CH2), 4.77-4.72 (m, tH,
CHH=C(Me)CH2), 4.66-4.57 (m, IH, CH(O)CH2), 2.49 (dd, 2H, J 9.3 and 6.9,
CH2C=O), 2.44 (br. dd, IH, J 14.4 and 6.9, CH2=C(Me)CHH), 2.34-2.20 (m, 2H,
CH2=C(Me)CHH and CHHCH2C=O), 1.93-1.77 (m, IH, CHHCH2C=O), 1.73 (br. s,
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3H, CH2=C(Me)CH2); be (90 MHz): 177.0 (C), 140.3 (C), 113.5 (CH2), 79.0 (CH),
43.2 (CH2), 28.4 (CH2), 27.5 (CH2), 22.6 (CH3); mlz (ESI) found 163.0732 (M +
Na+), CgHJ202Na requires 163.0730.
5-(2-Methyl-allyl)-3-phenylselanyl-dihydro-furan-2-one 324
SePh
o
A solution of the lactone 327 (200 mg, 1.43 mmol) in THF (3 rnl.) was added
dropwise over 10 mins to a stirred solution of LiHMDS (1.6 ml., 1.57 mmol, 1.0 M in
THF) in THF (3 mL) at -78 "C under a nitrogen atmosphere. The mixture was stirred
at this temperature for 15 mins and then trimethylchlorosilane (0.20 mL, 1.57 mmol)
was added dropwise over 1 min. The mixture was stirred at -78 "C for 30 mins and
then a solution of phenyl selenium bromide (370 mg, 1.57 mmol) in THF (3 mL) was
added dropwise over 10 mins. The final mixture was stirred at -78 "C for 30 mins,
warmed to room temperature and then stirred for 30 mins. Saturated aqueous NH4CI
(15 mL), water (40 mL) and diethyl ether (80 mL) were added and the separated
aqueous phase was extracted with diethyl ether (3 x 80 ml.) and the combined organic
extracts were then dried (MgS04) and concentrated in vacuo. Purification by
chromatography on silica gel, using a gradient of 10%, 20%, to 30% diethyl ether in
petroleum ether (product eluted at 30%) as eluent, gave the selena-lactone (215 mg,
51%) as a mixture of diastereoisomers. vmax/cm-J(CHCh solution): 2938, 1770, 1651;
OH (360 MHz): 7.71-7.60 (m, 2H, SePh), 7.40-7.26 (m, 3H, SePh), 4.84-4.78 (m, IH,
CHH=C(Me)CH2), 4.73-4.65 (m, IH, CHH=C(Me)CH2)' 4.60-4.50 (m, 0.40H,
CH(O)CH2), 4.42-4.32 (m, 0.60H, CH(O)CH2), 4.01 (app. t, 0.40H, .J 9.5, CHSePh),
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3.93 (dd, 0.60H, J 6.8 and 4.2, CHSePh), 2.71 (ddd, 0.40H, J 13.7, 9.5 and 6.6,
CHHCHSePh), 2.41 (br. dd, 0.60H, J 14.5 and 7.1, CH2=C(Me)CHH), 2.41-2.24 (m,
0.60H, CHHCHSePh, 0.60H, CHHCHSePh, and 0.40H, CH2=C(Me)CHH), 2.20 (br.
dd, 0.60H, J 14.5 and 6.3, CH2=C(Me)CHH), 2.07 (br. dd, 0.40H, J 14.5 and 6.5,
CH2=C(Me)CHH), 1.95 (ddd, 0.40H, J 13.7,9.5 and 8.2, CHHCHSePh), 1.68 (2 x br.
s, 3H, CH2=C(Me)CH2); Qc (90 MHz): 175.6 (C), 175.5 (C), 139.9 (2 x C), 135.7 (2 x
CH), 135.5 (2 x CH), 129.2 (4 x CH), 129.0 (CH), 128.7 (CH), 126.8 (C), 126.5 (C),
113.7 (CH2), 113.6 (CH2), 77.4 (CH), 77.2 (CH), 43.2 (CH2), 42.9 (CH2), 37.2 (CH),
36.7 (CH), 36.2 (CH2), 35.2 (CH2), 22.5 (2 x CH3); mlz (ESI) found 297.0379 (M +
H+), Cl4H1702Se requires 297.0388.
2-(2-{2-Hydroxy-2-(5-(2-methyl-allyl)-2-oxo-2,5-dihydro-furan-3-yIJ-ethyl}-3-
methyl-but-3-enyl)-5-vinyl-ruran-3-carboxylic acid methyl ester 322
A solution of the seleno-lactone 324 (218 mg, 0.74 mmol) in THF (4 mL) was added
dropwise over 10 mins to a stirred solution of LiHMDS (0.81 mL, 0.81 mmol, 1.0 M
in THF) in THF (5 mL) at -78 QC under a nitrogen atmosphere. The mixture was
stirred at this temperature for 50 mins and then a solution of the aldehyde 323 (193
mg, 0.74 mmol) in THF (4 mL) was added dropwise over 10 mins. The final mixture
was stirred at -78 QCfor 1 hr and then saturated aqueous NH4Cl (20 mL), water (50
mL) and diethyl ether (50 mL) were added. The mixture was warmed to room
temperature and the separated aqueous phase was extracted with diethyl ether (3 x 50
200
mL). The combined organic extracts were then dried (NaZS04) and concentrated in
vacuo to leave the selena-alcohol as a yellow oil that was used without further
purification. A solution of hydrogen peroxide (0.24 mL, 30% w/w in water) was
added dropwise over I min to a stirred solution of the crude seleno-alcohol and
pyridine (20 mL) in DCM (20 mL) at room temperature under a nitrogen atmosphere.
The mixture was stirred at this temperature for 1 hr and then saturated aqueous
NaHC03 (30 mL), water (30 mL) and DCM (40 mL) were added. The separated
aqueous phase was extracted with DCM (3 x 75 mL) and the combined organic
extracts were then concentrated in vacuo. The residue was dissolved in DCM (100
mL) then washed with saturated aqueous CUS04 (3 x 50 mL) and then dried (Na2S04)
and concentrated in vacuo. Purification by chromatography on silica gel. using a
gradient of 30%, 40% to 50% diethyl ether in petroleum ether (I st isomer eluted at
40% and the 2nd isomer was eluted at 50%) as eluent, gave the secondary alcohol (141
mg, 48%) as separable diastereoisomers. lSI isomer: vmaxlcm-I (CHCh solution): 3491.
2952,1749,1716,1646,1605; DH (360 MHz): 7.26-7.21 (m, IH, CH=CCH), 6.45 (s,
1H, C(O)=CHCC02Me). 6.40 (dd, IH, J 17.5 and 11.3, CH=Clh), 5.63 (dd, IH, .J
17.5 and 1.0, CH=CHH), 5.18 (dd, IH,.J 11.3 and 1.0, CH=CHH), 5.11-5.04 (m, ru.
CH(O)CH), 4.92 (br. s, IH, CHH=C(Me)CH2), 4.82 (br. s, 1H, CHH=C(Me)CH2),
4.81-4.74 (m, 2H, CH2=C(Me)CH), 4.61-4.55 (m, 0.35H, CH(OH)CB2). 4.47-4.40
(m, 0.65H, CH(OH)CH2), 3.81 (s, 1.05H, C02Me), 3.80 (s, 1.95H, C02Me), 3.23-2.93
(m, 4H, C(O)CH2CH, CH(C)CH2 and CH(OH)CH2), 2.44 (br. dd, 1H . .J 14.4 and 7.0,
CH2=C(Me)CHH), 2.34 (br. dd, IH. J 14.4 and 6.7. CH2=C(Me)CHH), 2.04-1.95 (m,
IH, CH(OH)CHH), 1.80 (br. s, 3H, CH2=C(Me)CHz), 1.75 (br. s, 1.95H,
CH2=C(Me)CH), 1.73 (br. s, 1.05H. CH2=C(Me)CH), 1.68-1.59 (m, IH,
CH(OH)CHH); Dc (90 MHz): 172.2 (C), 172.1 (C). 164.4 (C), 164.2 (C), 161.1 (C),
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160.6 (C), 151.2 (2 x C), 148.6 (CH), 147.9 (CH), 146.5 (C), 145.4 (C). 139.6 (2 x C).
137.0 (2 x C). 124.3 (CH), 124.2 (CH), 115.1 (2 x C), 114.3 (2 x Gb). 113.6 (2 x
CH2), 113.1 (2 x CH2), 108.1 (CH), 108.0 (CH), 80.2 (CH), 80.1 (CH), 65.6 (CH),
65.1 (CH), 51.5 (CH3), 51.4 (CH3), 43.5 (CH), 43.0 (CH), 41.4 (CH2), 41.3 (CH2),
38.5 (CH2), 37.9 (CH2), 32.2 (2 x CH2), 22.9 (2 x CH3), 17.9 (2 x CH3); mlz (ESI)
found 423.1776 (M + Na+), C23H2806Na requires 423.1778; 2nd isomer: vmax/cm-1
(CHCh solution): 3489, 2952, 1750, 1715, 1647, 1604; <>11 (360 MHz): 7.26 (app. t,
0.30H, J 1.5, CH=CCH), 7.24 (app. t, 0.70H, .J 1.5, CH=CCH), 6.44 (s, 1II,
C(O)=CHCC02Me), 6.39 (dd, 1H, J 17.5 and 11.3, CH=CH2), 5.62 (dd, 0.70H, J 17.5
and 1.0, CH=CHH), 5.61 (dd, 0.30H, J 17.5 and 1.0, CH=CHH), 5.17 (dd, 1H,.J 11.3
and 1.0, CH=CHH), 5.10-5.03 (m, 1H, CH(O)CH), 4.91 (s, 1H, CHH=C(Me)CH2),
4.81 (s, IH, CHH=C(Me)CH2), 4.79-4.74 (m, 2H, CH2=C(Me)CH), 4.47-4.39 (m, 1H,
CH(OH)CH2), 3.80 (s, 0.90H, C02Me), 3.79 (s, 2.IOH, C02Me), 3.23-2.91 (m, 4H,
C(O)CH2CH, CH(C)CH2 and CH(OH)CH2), 2.43 (br. dd, 1H, .I 14.4 and 7.2,
CH2=C(Me)CHH), 2.35 (br. dd, IH, J 14.4 and 6.5, CH2=C(Me)CHH), 2.02-1.92 (m,
1H, CH(OH)CHH), 1.79 (br. s, 3H, CH2=C(Me)CH2), 1.74 (br. s, 2.lOH,
CH2=C(Me)CH), 1.72 (br. s, 0.90H, CH2=C(Me)CH), 1.69-1.58 (m, 1H,
CH(OH)CHH); <>c (90 MHz): 172.2 (C), 172.1 (C), 164.4 (C), 164.2 (C), 161.1 (C),
160.5 (C), 151.1 (2 x C), 148.5 (CH), 147.9 (CH), 146.5 (C), 145.3 (C), 139.5 (2 x C),
137.0 (2 x C), 124.2 (2 x CH), 115.0 (2 x C), 114.4 (2 x CH2), 113.5 (2 x Cl-h), 113.0
(2 x CH2), 108.1 (CH), 108.0 (CH), 80.1 (CH), 80.0 (CH), 65.4 (CH), 65.0 (CH), 51.4
(CH3), 51.3 (CH), 43.4 (CH), 42.9 (CH), 41.2 (2 x CH2), 38.6 (CH2), 38.0 (Cl-h),
32.2 (2 x CH2), 22.9 (2 x CH3), 17.8 (2 x CH3); mlz (ESI) found 423.1772 (M + Na+),
C23H2806Na requires 423.1778.
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Cyclobut-l-enecarboxylic acid (Z)-4-iodo-3-methyl-l-vinyl-but-3-enyl ester 349
I
Triethylamine (2.12 ml., 15.2 mmol) was added dropwise over 2 mins to a stirred
solution of l-cyclobutene-I-carboxylic acid255 (1.49 g, 15.2 mmol) and pivaloyl
chloride (1.87 ml., 15.2 mmol) in THF (30 mL) at room temperature under a nitrogen
atmosphere. The mixture was stirred at this temperature for 30 mins. Meanwhile, a
solution of LiHMDS (7.61 ml., 7.61 mol, 1.0 M in THF) was added dropwise over 2
mins to a stirred solution of the allylic alcohol 297d (1.51 g, 6.34 mmol) in THF (75
mL) at -78°C under a nitrogen atmosphere. The mixture was stirred at this
temperature for 20 mins. The mixed anhydride solution was quickly filtered and then
added dropwise over 15 mins to the stirred solution of the allylic alcohol at -78°C
under a nitrogen atmosphere. The mixture was stirred at this temperature for 90 mins,
and then water (50 mL), saturated aqueous NaHC03 (50 mL) and diethyl ether (50
mL) were added and the mixture was then warmed to room temperature. The
separated aqueous phase was extracted with diethyl ether (3 x 75 mL) and the
combined organic extracts were then dried (MgS04) and concentrated in vacuo.
Purification by chromatography on silica gel, using a gradient of 100% petroleum
ether, 5% to 10% diethyl ether in petroleum ether (product eluted at 10%) as eluent,
gave the allylic ester (1.32 g, 65%) as a light yellow oil. vmax/cm-I(CHCh solution):
2928,2852,2254,1712, 1647, 1610; ()H (400 MHz): 6.82 (t, IH, J 1.2, C=CHCH2),
6.02 (q, IH, J 1.4, ICH=C(Me)CH2), 5.88 (ddd, 1H, J 17.2, 10.5 and 6.3, CH=CH2),
5.57-5.50 (m, 1H, CH(O)CH), 5.32 (ddd, 1H, J 17.2, 1.2 and 1.2, CH=CHH), 5.20
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(ddd, IH, J 10.5, 1.2, and 1.2, CH=CHH), 2.77-2.66 (m, 3H, CH2CH2CH=C and
ICH=C(Me)CHH), 2.54-2.45 (m, 3H, CH2CH2CH=C and ICH=C(Me)CHH), 1.94 (d,
3H, J 1.4, ICH=C(Me)CH2); ()c (lOO MHz): 161.2 (C), 147.0 (CH), 143.2 (C), 138.5
(C), 135.7 (CH), 117.0 (CH2), 77.5 (CH), 72.1 (CH), 43.2 (CH2), 29.1 (Cth), 27.1
(CH2), 24.2 (CH3); mlz (ESI) found 341.0017 (M + Na+), CI2HIs02INa requires
341.0009.
3-(5-Hydroxy-4-methyl-(E)-pent-3-enyl)-5-«Z)-3-iodo-2-methyl-allyl)-5H-furan-
2-one 248a
OH
o
A solution of Grubbs second generation catalyst (467 mg, 0.55 mmol) in OCM (10
mL) and a solution of the allylic ester 349 (1.75 g, 5.50 mmol) with 2-methyl-2-
propen-l-ol (0.93 mL, 11.0 mmol) in OCM (10 mL) were added simultaneously over
8 hrs to a refluxing solution of OCM (1.75 Its) under a nitrogen atmosphere. 2-
Methyl-2-propen-l-ol (3.70 ml., 44.0 mmol) was added dropwise over 1 hr and the
mixture was stirred under reflux for 12 hrs. The mixture was cooled to room
temperature and then concentrated in vacuo. Purification by chromatography on silica
gel, using 50% ethyl acetate in petroleum ether as eluent, gave a 7: 1 mixture of E:Z-
isomers of the allylic alcohol (1.13 g, 57%) as a yellow oil. ()II (400 MHz): 7.11 (app.
q, IH, J 1.4, CH=CCH2), 6.11 (q, IH, J 1.4, ICH=C(Me)CH2), 5.44-5.34 (m, IH,
CH=C(Me)CH2), 5.05 (ddd, IH, J 7.4, 6.1 and 1.4, CH(O)CH), 3.99 (br, s, 2H,
CH20H), 2.66 (dd, IH, J 13.6 and 6.1, ICH=C(Me)CHH), 2.54 (dd, IH, .113.6 and
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7.4, ICH=C(Me)CHH), 2.41-2.25 (m, 4H, CH2CH=C and CfhCH2CH=C), 1.98 (d,
3H, J 1.4, ICH=C(Me)CH2), 1.77 (br. s, 1H, CH20H), 1.66 (br. s, 3H,
CH=C(Me)CH2); Oc (100 MHz): 173.4 (C), 147.8 (CH), 142.3 (C), 136.2 (C), 133.9
(C), 123.8 (CH), 79.4 (CH), 78.5 (CH), 68.4 (CH2), 42.4 (CH2), 25.3 (CI-I2), 25.0
(CH2), 24.8 (CH3), 13.7 (CH3). The spectroscopic data were identical to those
published previously by Trauner et. at. 196
(Z)-5-{3-[4-(5-Hydroxy-4-methyl-(E)-pent-3-enyl)-5-oxo-2,5-dihydro-furan-2-yIJ-
2-methyl-propenyl}-3-methyl-furan-2-carbaldehyde 250
OH
o
Tetrakis(triphenylphosphine)palladium(O) (64 mg, 0.06 mmol) and CuI (21 mg, 0.11
mmol) were added in one portion to a stirred, degassed solution of the allylic alcohol
248a (500 mg, 1.38 mmol) and 3-methyl-5-trimethylstannanyl-furan-2-carbaldehyde
249196 (753 mg, 2.76 mmol) in DMF (10 mL) at room temperature under an argon
atmosphere. The mixture was degassed again then stirred at room temperature for 90
mins, and then diethyl ether (20 mL) and saturated aqueous NH4CI (20 mL) were
added. The separated aqueous phase was extracted with diethyl ether (3 x 20 ml.) and
the combined organic extracts were washed with brine (20 mL), dried (MgS04) and
concentrated in vacuo. Purification by chromatography on silica gel, using a gradient
of 65% ethyl acetate in petroleum ether as eluent, gave the alkenylfuran (443 mg,
93%) as a light yellow oil. OH (400 MHz): 9.61 (s, IH, CHO), 7.35 (hr. s, IH,
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CH=CCH2), 6.19 (s, lH, C(O)=CHCMe), 6.18 (s, IH, C(O)CH=C(Me)CH2), 5.45-
5.37 (m, 1H, CH=C(Me)CH2), 5.17-5.10 (m, 1H, CH(O)CH), 4.00 (br. s, 2H,
CH20H), 3.30-3.20 (m, IH, C(O)CH=C(Me)CHH), 2.48-2.26 (m, 6H,
C(O)CH=C(Me)CHH, CH2CH=C, CH2CH2CH=C and CH20H), 2.36 (s, 3H,
C(O)=CHCMe), 2.07 (s, 3H, C(O)CH=C(Me)CH2), 1.66 (br. s, 3H, CH=C(Me)CH2);
Dc (lOO MHz): 175.3 (br. CH), 173.9 (C), 157.0 (C), 149.2 (CH), 147.5 (C), 142.2 (br.
C), 136.5 (2 x C), 133.4 (C), 123.9 (CH), 115.2 (CH), 113.9 (CH), 81.7 (CH), 68.6
(CH2), 38.3 (CH2), 26.8 (CH3), 25.3 (CH2), 24.8 (CH2), 13.8 (CH3), 10.1 (CH3). The
spectroscopic data were identical to those published previously by Trauner et. al. 196
(Z)-S-{3-[4-(S-Bromo-4-methyl-(E)-pent-3-enyl)-5-oxo-2,S-dihydro-furan-2-yIJ-2-
methyl-propenyl}-3-methyl-furan-2-carbaldehyde 251
Br
o
N-Bromosuccinimide (249 mg, 1.40 mmol) was added in one portion to a stirred
solution of the alkenylfuran 250 (437 mg, 1.27 mmol) and triphenylphosphine (366
mg, 1.40 mmol) in OCM (10 mL) at -5°C under a nitrogen atmosphere. The mixture
was stirred at this temperature for 20 mins and then water (20 mL) was added. The
separated aqueous phase was extracted with DCM (3 x 20 mL) and the combined
organic extracts were then dried (MgS04) and concentrated in vacuo. Purification by
chromatography on silica gel, using 35% ethyl acetate in petroleum ether as eluent,
gave the allylic bromide (430 mg, 83%) as a light yellow oil. DII (400 MHz): 9.67 (s,
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IH, CHO), 7.27 (br. s, IH, CH=CCH2), 6.20 (s, IH, C(O)=CHCMe), 6.19 (s, IH,
C(O)CH=C(Me)CH2), 5.60-5.53 (m, IH, CH=C(Me)C~h), 5.18-5.11 (m, I H,
CH(O)CH), 3.96 (br. s, 2H, CH2Br), 3.20 (dd, IH, .J 13.8 and 4.1,
C(O)CH=C(Me)CHH), 2.55 (dd, IH, J 13.8 and 8.3, C(O)CH=C(Me)CHH), 2.42-
2.26 (m, 4H, CH2CH=C and CH2CH2CH=C), 2.37 (s, 3H, C(O)=CHCMe), 2.06 (s,
3H, C(O)CH=C(Me)CH2), 1.76 (br. s, 3H, CH=C(Me)CH2); (')e (lOO MHz): 175.5 (br.
CH), 173.4 (C), 156.5 (C), 148.9 (CH), 147.3 (C), 141.0 (br. C), 135.8 (br. C), 133.4
(C), 133.0 (C), 129.2 (CH), 115.6 (CH), 113.9 (CH), 81.1 (CH), 41.1 (CH2), 38.0
(CH2), 26.6 (CH3), 25.8 (CH2), 24.5 (CH2), 14.6 (CH3), 10.0 (CH3). The spectroscopic
data were identical to those published previously by Trauner et. al.l96
12-Hydroxy-ll-isopropenyl-3, 14-dimethyl-6,16-dioxa-
tricyclo [11.2.1.15,8]heptadeca-(Z)-1 (15),2,8( 17),13-tetraen-7 -one (bipinnatin J) 5
o
A solution of the allylic bromide 251 (254 mg, 0.62 mmol) in THF (260 ml.) was
added over 1 hr to a stirred mixture of CrCh (1.54 g, 12.5 mmol) and 4 A molecular
sieves (2.90 g) at room temperature under an argon atmosphere. The mixture was
stirred at this temperature for 16 hrs and then filtered through celite, eluting with
diethyl ether, and the filtrate was concentrated in vacuo. Diethyl ether (150 mL) was
added to the residue which was washed with water (2 x 20 mL) and brine (20 ml.),
dried (MgS04) and concentrated in vacuo. Purification by chromatography on silica
gel, using 30% ethyl acetate in petroleum ether as eluent, gave bipinnatin .J (143 mg.
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70%) as a colourless crystalline solid. ()H (400 MHz): 6.86 (app. t, IH, J 1.6,
CH=CCH2), 6.12 (br. s, IH, CH=C(Me)CH2), 6.04 (s, IH, C(O)=CHCMe), 5.18 (br.
s, IH, C=CHH), 5.07 (br. s, IH, C=CHH), 5.03-4.95 (m, IH, CH(O)CH), 4.51 (dd,
IH, J 10.9 and 3.0, CH(CH)OH), 3.21 (dd, IH, J 11.8 and 11.8, CH=C(Me)CHH),
2.74 (dd, IH, J 11.8 and 4.4, CH=C(Me)CHH), 2.47-2.33 (m, 2H, CHC(Me)=Cl-h
and CH=CCHH), 2.15-2.06 (m, IH, CH=CCHH), 2.06 (s, 311, C(O)=CIICMe), 2.01
(br. s, 3H, CH=C(Me)CH2), 1.86 (d, IH, J 3.0, CH(CH)OH), 1.81 (br. s, 3H,
CHC(Me)=CH2), 1.68 (dtd, IH, J 14.0, 10.9 and 3.3, CH2CHHCH), 0.91 (dt, IH, J
14.0 and 3.7, CH2CHHCH); ()c (lOO MHz): 174.3 (C), 152.3 (CH), 151.0 (C), 149.2
(C), 142.1 (C), 132.6 (C), 129.0 (C), 121.1 (C), 118.8 (CH2), 117.4 (CH), 113.9 (CH),
78.7 (CH), 65.0 (CH), 51.2 (CH), 39.7 (CH2), 30.1 (CH2), 25.9 (CH3), 19.7 (Cl-h),
17.5 (CH3), 9.5 (CH3). The spectroscopic data were identical to those published
previously by Trauner et. al.196
11-Isopropenyl-3, 14-dimethyl-6, 16-dioxa-tricycloll1.2.1.1 s,sl heptadeca-(Z)-
1(15),2,8(17),13-tetraen-7-one (rubifolide) 49
"('.
o
Trifluoroacetic acid (11 ul., 0.14 mmol) was added dropwise over I min to a stirred
solution of bipinnatin J 5 (43 mg, 0.13 mmol) and triethylsilane (46 ul., 0.29 mmol) in
DCM (10 mL) at 0 QCunder a nitrogen atmosphere. The mixture was stirred at this
temperature for 20 mins and then saturated aqueous NaHC03 (10 ml.) was added. The
208
separated aqueous phase was extracted with DCM (3 x 10 mL) and the combined
organic extracts were then dried (MgS04) and concentrated in vacuo. Purification by
chromatography on silica gel, using 12% ethyl acetate in petroleum ether as eluent,
gave rubifolide (38 mg, 93%) as a colourless crystalline solid. DH (400 MHz): 6.91
(app. t, 1H, J 1.6, CH=CCH2), 6.07 (br. s, 1H, CH=C(Me )CH2), 6.00 (s, 1H,
C(O)=CHCMe), 5.00-4.93 (m, IH, CH(O)CH), 4.93-4.86 (m, 2H, C=CH2), 3.24 (dd,
IH, J 11.8 and 11.8, CH=C(Me)CHH), 2.70 (dd, lH, J 11.8 and 4.2,
CH=C(Me)CHH), 2.61-2.31 (m, 4H, C(O)CH2CH, CHC(Me)=CH2 and CH=CCHH),
2.14-2.04 (m, IH, CH=CCHH), 1.99 (br. s, 3H, C(O)=CHCMe). 1.93 (br. s, 3H,
CH=C(Me)CH2), 1.75 (br. s, 3H, CHC(Me)=CH2), 1.65 (dtd, IH,.J 14.0,10.8 and 3.4,
CH2CHHCH), 1.18 (dtd, IH, .J 14.0, 3.5 and 1.0, CH2CHHCH). The spectroscopic
data were identical to those published previously by Trauner et. al. III
4-Isopropenyl-7 ,11-dimethyl-14-oxa-bicyclolll.2.1 )-(Z,z)-hexadeca-l (16),7,10-
triene-6,9,15-trione (isoepilophodione B) 159
"("
o
meta-Chloroperbenzoic acid (7 mg, 0.03 mmol, 70-75 % weight balance) was added
in one portion to a stirred solution of rubifolide 49 (9 mg, 0.03 mmol) in OCM (l O
mL) at 0 °C under a nitrogen atmosphere. The mixture was stirred at this temperature
for 1 hr and then saturated aqueous Na2S03 (5 mL) was added. The separated aqueous
phase was extracted with OCM (3 x 10 mL) and the combined organic extracts were
then dried (MgS04) and concentrated in vacuo. Purification by chromatography on
209
silica gel, using a gradient of 35% to 40% ethyl acetate in petroleum ether (product
eluted at 40%) as eluent, gave isoepilophodione B (8 mg, 90%) as a colourless
crystalline solid. ()H (400 MHz): 7.16 (br. s, IH, CH=CCH2), 6.25 (br. s, IH,
CH=C(Me)CH2), 6.21 (q, IH, J 1.4, C(O)CH=CMe), 5.27 (br. s, IH, CH(O)CH), 4.83
(br. s, lH, C=CHH), 4.64 (br. s, IH, C=CHH), 4.03 (br. s, lH, CH=C(Me)CHH),
2.93-2.61 (m, 2H, CH=C(Me)CHH and C(O)CHHCH), 2.61-2.19 (m, 4H,
C(O)CHHCH, CHC(Me)=CH2 and CH=CCH2), 2.07 (d, 3H, .J lA, C(O)CH=CMe),
2.03-1.85 (m, IH, CH2CHHCH), 1.88 (br. s, 3H, CH=C(Me)CH2), 1.69 (br, s, 3H,
CHC(Me)=CH2), 1.47-1.35 (m, 1H, CH2CHHCH). The spectroscopic data were
identical to those published previously by Trauner et. al. III
3-Hydroxymethyl-ll-isopropenyl-14-methyl-6, 16-dioxa-
tricycloj l Lz.Ll s.8]heptadeca-(Z)-1(15),2,8(17),13-tetraen-7-one
(19-hydroxyrubifolide) 353
o
A solution of isoepilophodione B (159) (19 mg, 0.06 mmol) and para-toluenesulfonic
acid (II mg, 0.06 mmol) in THF (I2 mL) and water (6 mL) were stirred at room
temperature for 72 hrs and then saturated aqueous NaHC03 (5 mL) and ethyl acetate
(5 mL) were added. The separated aqueous phase was extracted with ethyl acetate (3 x
5 mL) and the combined organic extracts were then dried (MgS04) and concentrated
in vacuo. Purification by chromatography on silica gel, using 40% ethyl acetate in
210
petroleum ether as eluent, gave J 9-hydroxyrubifolide (8 mg, 40%) as a colourless
crystalline solid. vmax/cm-I (CHCI3 solution): 3452, 2930, 2868, 1748, 1646, 1628,
1452, 1366, 1068; DH (400 MHz): 6.90 (app. t, 1H, .J 1.5, CH=CCH2), 6.33 (br. s, IH,
CH=C(CH20H)CH2), 6.14 (br. s, IH, C(O)=CHCMe), 5.10-5.03 (m, IH, CH(O)CH),
4.94-4.87 (m, 2H, C=CH2), 4.29 (d, IH, J 16.9, CH=C(CHHOH)CH2), 4.26 (d, IH,.J
16.9, CH=C(CHHOH)CH2), 3.17 (dd, IH,.J 12.1 and 12.1, CH=C(ClbOH)CflH),
2.87 (dd, IH,.J 12.1 and 4.4, CH=C(CH20H)CHH), 2.64-2.33 (m, 4H, C(O)CH2CH,
CHC(Me)=CH2 and CH=CCHH), 2.14-2.05 (m, IH, CH=CCHH), 1.94 (hr. s, 3H,
C(O)=CHCMe), 1.75 (br. s, 3H, CHC(Me)=CH2), 1.70-1.58 (m, 2H, ClhCHHCH and
CH20H), 1.17 (dtd, 1H, J 13.8, 3.3 and 0.8, CH2CHHCH); Dc (100 MHz): 174.5 (C),
151.9(CH), 150.6(C), 149.3(C), 145.4(C), 132.9(C), 129.1 (C), 117.6(C), 117.6
(CH), 116.0 (CH), 113.1 (CH2), 79.6 (CH), 68.3 (CH2), 43.4 (CH), 35.9 (CH2), 31.2
(CH2), 30.6 (CH2), 20.1 (CH2), 19.2 (CH3), 9.6 (CH3); mlz (ESI) found 351.1566 (M
+ Na+), C2oH2404Narequires 351.1567.
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